New routes to chiral Evans' auxiliaries by enzymatic desymmetrisation and resolution by Neri, Claudia
        
University of Bath
PHD








Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
Download date: 13. May. 2019
New Routes to Chiral Evans’ Auxiliaries by
Enzymatic Desymmetrisation and Resolution
Submitted by Claudia Neri 
for the degree of PhD 
of the University of Bath 
2003
COPYRIGHT
Attention is drawn to the fact that copyright of this thesis rests with its author.
This copy of the thesis has been supplied on the fact that anyone who consults it is 
understood to recognize that its copyright rests with its author and that no quotation 
from the thesis and no information derived from it may be published without the prior
written consent of the author.
This thesis may be made available for consultation with the University Library and
may be photocopied or lent to other libraries for the purposes of consultation.
UMI Number: U159754
All rights reserved
INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a complete manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
Dissertation Publishing
UMI U159754
Published by ProQuest LLC 2013. Copyright in the Dissertation held by the Author.
Microform Edition © ProQuest LLC.
All rights reserved. This work is protected against 
unauthorized copying under Title 17, United States Code.
ProQuest LLC 
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106-1346
UBftAftY  
S o  2 0 MAY 2003
 .........
New Routes to Chiral Evans’ Auxiliaries by
Enzymatic Desymmetrisation and Resolution
Submitted by Claudia Neri 
for the degree of PhD 
of the University of Bath 
2003
COPYRIGHT
Attention is drawn to the fact that copyright of this thesis rests with its author.
This copy of the thesis has been supplied on the fact that anyone who consults it is 
understood to recognize that its copyright rests with its author and that no quotation 
from the thesis and no information derived from it may be published without the prior
written consent of the author.
This thesis may be made available for consultation with the University Library and 
may be photocopied or lent to other libraries for the purposes of consultation.
New Routes to Chiral Evans’ Auxiliaries by
Enzymatic Desymmetrisation and Resolution
Submitted by Claudia Neri 
for the degree of PhD _  
of the University of Bath 
2003
COPYRIGHT
Attention is drawn to the fact that copyright of this thesis rests with its author.
This copy of the thesis has been supplied on the fact that anyone who consults it is 
understood to recognize that its copyright rests with its author and that no quotation 
from the thesis and no information derived from it may be published without the prior
written consent of the author.
This thesis may be made available for consultation with the University Library and
may be photocopied or lent to other libraries for the purposes of consultation.
New Routes to Chiral Evans’ Auxiliaries by
Enzymatic Desymmetrisation and Resolution
Submitted by Claudia Neri 
for the degree of PhD 
of the University of Bath 
2003
COPYRIGHT
Attention is drawn to the fact that copyright of this thesis rests with its author.
This copy of the thesis has been supplied on the fact that anyone who consults it is 
understood to recognize that its copyright rests with its author and that no quotation 
from the thesis and no information derived from it may be published without the prior
written consent of the author.
This thesis may be made available for consultation with the University Library and
may be photocopied or lent to other libraries for the purposes of consultation.







Chapter 1. Lipases as Biocatalysts in Organic Synthesis
1.1 Introduction 1
1.2 Lipases. General applications 1
1.3 Lipase origins and preparation 3
1.4 Lipase structure and mechanism 4
1.5 Lipase immobilisation 6
1.6 Lipases in organic solvent. Solvent engineering 8
1.7 Lipases in organic synthesis 10
1.7.1 Lipase-catalysed reactions 10
1.7.1.1 Hydrolysis and formation of C-O bonds 10
1.7.1.2 Hydrolysis and formation of N-O bonds 17
1.7.1.3 Hydrolysis and formation of S-O bonds 18
1.7.2 Selectivity of lipases towards organic substrates. Kinetic and dynamic
resolution 19
1.8 References 23
Chapter 2. Evans’ Auxiliaries. Features and General Applications
2.1 Introduction 28
2.2 Chiral Evans’ auxiliaries 31
2.2.1 Chiral auxiliary approach to asymmetric synthesis 31
2.2.2 Evans’ auxiliaries’ stability: attachment and cleavage 32
2.2.3 Evans’ auxiliaries’ main applications 33
2.2.3.1 Stereoselective alkylation of chiral enolates 33
2.2.3.2 Stereoselective aldol reactions 35
2.2.3.3 Stereoselective conjugate additions and Diels-Alder reactions 36
2.3 Towards the ideal chiral auxiliary. Chemically designed chiral Evans’
auxiliaries 38
2.4 Other uses of enantiomerically pure 2-oxazolidinones 44
2.5 References 46
I
Claudia Neri -  University of Bath Contents
Chapter 3. Preparation of 2-Oxazol id i nones by Enzymatic Desymmetrisation
3.1 Introduction 49
3.2 Background. Enzymatic desymmetrisation of diols 50
3.3 Desymmetrisation of A/-Boc-serinol 53
3.4 Synthesis of enantiomerically enriched oxazolidinones 57
3.4.1 Synthesis of racemic 4-acetoxymethyl-2-oxazolidinone and kinetic
resolution by enzymatic hydrolysis 57
3.4.2 Synthesis of enantiomerically enriched (S)- 4-acetoxymethyl-2-
oxazolidinone 58




Chapter 4. Enzymatic Kinetic Resolution of Racemic Evans’ Auxiliaries
4.1 Introduction 64
4.2 Background 64
4.3 The attempted enzymatic kinetic resolution of chiral Evans’ auxiliaries 69
4.3.1 4-Benzyl-2-oxazolidinone enzymatic /V-acylation 70
4.3.2 3-Propionyl-4-benzyl-2-oxazolidinone enzymatic hydrolysis 74
4.4 Conclusions 76
4.5 References 77
Chapter 5. Racemic Auxiliaries: Applications to Asymmetric Synthesis
5.1 Introduction 80
5.2 Background. Asymmetric aldol reactions with Evans’ chiral auxiliaries 81
5.3 Approaching the synthesis of the racemic aldol adduct 87
5.3.1 Synthesis of aldol adducts via Li-enolate and their enzymatic resolution 87
5.3.2 Synthesis of aldol adducts via TiCI/Pr2NEt-enolate 88
5.3.3 Enzymatic kinetic resolution of the diastereomeric aldol adducts from
TiCI/Pr2NEt-enolate mediated aldol reaction 90
5.3.3.1 Enzymatic resolution of aldols (4/?,2’S,3’fl)- and (4R,2’S>3’S)-5.8 90
5.3.3.2 Enzymatic resolution of aldols (4SJ2’R,3’S)- and (4S,2’R,3’R)-5.8 95
5.3.4 Synthesis of aldol adducts via TiCl4/(-)-sparteine/NMP-enolate and their
enzymatic resolution 102
5.4 Synthesis of the racemic aldol adduct and its enzymatic resolution 106
n
Claudia Neri -  University of Bath Contents
5.4.1 Synthesis of racemic /V-(3-acetoxy-2-methylbutanoyl)-4-benzyl-2-
oxazolidinone and its enzymatic resolution 108
5.4.2 Synthesis of racemic A/-(3-acetoxy-2-ethylbutanoyl)-4-benzyl-2-
oxazolidinone and its enzymatic resolution 112




Chapter 6. Towards the One-Pot Synthesis of JV-acyl Oxazolidinones
6.1 Introduction 119
6.2 Background. Synthesis of A/-acylated Evans’ auxiliaries 120
6.3 The one-pot synthesis of AA-acyl-5-substituted-2-oxazolidinone 126





7.1 General experimental 133
7.2 Experimental for Chapter 3 135
7.3 Experimental for Chapter 4 142
7.4 Experimental for Chapter 5 144
7.5 Experimental for Chapter 6 168
7.6 References 173
Appendix I
X-Ray crystal structure determination of (4f?,2’R>3’S)-A/-(3-hydroxy-2- 
methylbutanoyl)-4-benzyl-2-oxazolidinone (4/?,2,/7,3,S)-5.8 175
Appendix II
X-Ray crystal structure determination of (4R>2’R,3’S)-A/-(3-hydroxy-2- 
ethylbutanoyl)-4-benzyl-2-oxazolidinone (4f?,2’fl,3’S)-5.16 181
Appendix III
CAL B activity assay 187
III
Claudia Neri -  University of Bath Acknowledgements
Acknowledgements
I would like to thank many people for supporting my PhD.
First of all I am very grateful to EPSRC for funding my research project and to my 
supervisor Jon. Working with him during the three years of my PhD has been very 
motivating. He has given me the opportunity to learn a lot about chemistry and he 
has always supported me with his brilliant ideas.
I would also like to thank all the people from the Chemistry Department at the 
University of Bath. Particular mention goes to Michael, Jean Philippe, Aliki and Chris, 
who I am indebted to for their friendship and good humor, and to Mike Edwards, who 
has always been there whenever I needed answers to my questions.
Finally I would like to thank my family and Diego for playing the key part in the last 
three years.
IV
Claudia Neri -  University of Bath Abstract
Abstract
This report describes how enantiomerically enriched Evans’ auxiliaries can be 
successfully prepared by either an enzymatic desymmetrisation strategy or an 
asymmetric synthesis using racemic auxiliaries and an enzymatic resolution.
Desymmetrisation of /V-Boc-protected serinol has been achieved in good yield and 
high enantiomeric excess using porcine pancreas lipase. This has been exploited in 
different ways to prepare enantiomerically enriched (4Ft)- and (4S)-substituted 2- 
oxazolidinones.
Starting from racemic Evans’ auxiliary, by means of a diastereoselective aldol 
reaction coupled with a lipase-catalysed resolution, we achieved the preparation of 
enantiomerically enriched p-hydroxy acids and enantiomerically enriched 2- 
oxazolidinones.
Our methodology allows the use of not only racemic amino acids but also racemic 
amino alcohols to achieve asymmetric synthesis. It also offers, for the first time in 
chiral auxiliary-based chemistry, the possibility of using designed racemic auxiliaries, 
instead of the difficult to prepare enantiomerically pure equivalents. In addition the 
procedure acts as an indirect enzyme-catalysed resolution of Evans’ auxiliaries.
Enzymatic resolution of racemic Evans’ auxiliaries and their A/-acyl equivalents has 
been attempted.
Racemic A/-acylated-5-substituted-2-oxazolidinone was synthesised using a one-pot 
synthesis from a carbamate and a monosubstituted epoxide, but the reaction 
proceeded in low yield. Nevertheless, we have demonstrated that there is a scope for 
successful future attempts with some variations for the one-pot synthesis of N- 
acylated-4,5-disubstituted-2-oxazolidinones.
V
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1. Lipases as Biocatalysts in Organic Synthesis
1.1 Introduction
Enzymes’ role in Nature is to catalyse and coordinate a multitude of chemical 
reactions necessary to life. Chemical reactions, without the presence of enzymes, 
would be too slow to be effective under the conditions prevalent in normal living 
systems (aqueous environment with pH 7 and temperatures between 20 and 40 °C). 
Since the end of the 19th century, it has been known that enzymes do not require the 
environment of a living cell to be active. This opened the way to many applications in 
food technology, in the production of leather, textiles and paper, in diagnostics and 
food analysis and finally in the production of chemicals by biotransformations. 
Enzymes may be chosen as catalysts for one or more of the following reasons:
- high selectivity in complex mixtures;
- high stereo- and regioselectivity of reactions;
- absence of side reactions leading to higher yields and simpler separation 
processes;
- savings in energy costs owing to mild reaction conditions.
Of course, enzymes have limitations, as any other highly specialised catalysts. The 
most notable consequence arises from the selectivity of enzymes with respect to the 
substrate bound and the type of reaction catalysed. Such high selectivity means that 
that it may be difficult to cover the variety of chemical reactions desired in organic 
synthesis. The enzyme needed in a particular case may not be readily available. 
However, there are many enzymes discovered all the time and an increasing number 
can be obtained commercially.
1.2 Lipases. General applications
Lipids are key elements in the biological chemistry. Most organisms use the 
supramolecular chemistry of phospholipids to form their exterior and compartmental 
membranes. Many plants and animals store chemical energy in the form of
1
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triglycerides, which are poorly soluble in water. For the metabolism of these and 
other biochemicals, they produce hydrolases, enzymes that can hydrolyse bonds of 
water-soluble esters. Lipases are, more systematically, triacylglycerolacyl hydrolases 
(E.C.3.1.1.3), which can hydrolyse triglycerides at the water/oil interface. Many 
lipases exhibit 1,3-specificity, as illustrated in Scheme 1.1.
R"OCO/ V ^^OCOR lipaS6>
OCOR' h20 OCOR’
Scheme 1.1. Lipase-catalysed hydrolysis of triglycerides
Although the natural role of lipases is the degradation of food and fat and their use as 
useful drugs against digestive disorders and diseases, the application of lipases in 
biotechnology (as detergent additives) and as catalysts for the manufacture of 
specialty (oleo)chemicals and for organic synthesis has been widely exploited.1 
Their broad synthetic application is mainly due to the fact that lipases, if compared to 
other enzymes, are very versatile, and thus, changing the solvent system, they can 
be used to perform hydrolysis reactions or ester syntheses (Schemel. 2).
h2o
AcCT "OAc AcO
OAc HOAc w™' HOAc HOAc
Scheme 1.2. General hydrolysis and ester synthesis with lipases
In addition, lipases can accommodate a wide range of substrates other than 
triglycerides as aliphatic, alicyclic, bicyclic and aromatic esters.2,3 With respect to 
racemic esters or substrates with several hydroxyl groups, lipases also react with 
high enantio- and regioselectivity.4
Finally, the acyl enzyme complex in lipase-catalysed reactions can be formed not 
only from carboxylic esters but also from a wide range of other substrates such as 
thioesters or activated amines and amides, which expands the synthetic utility of 
lipases considerably.5’9
As a result, today chemists may choose their preferred lipase from a great number of 
commercially available preparations or even explore a range of different lipases and 
esterases marketed as a kit.
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1.3 Lipase origins and preparation
Lipases are widely distributed amongst animals, plants and microorganisms. They 
are usually obtained by either extraction from animal or plant tissue or by 
fermentation by microorganisms. Commercially available lipases are usually derived 
from microorganisms. One of the reasons why lipases are so popular enzymes in 
organic synthesis is that lipases are extracellular enzymes, which are secreted into 
liquid and solid culture and are relatively stable in cultivation media. This makes them 
easy and inexpensive to extract.
Last generation lipases are from recombinant bacterial and yeast. Produced by 
genetic engineering techniques, many of them are today commercially available. For 
example, the “detergent lipase” from fungus Humicula lanuginosa is commercially 
produced in large scale (several 100 tons per year) through fermentation of 
Aspergylius oryzae into which the gene coding for Humicula lanuginosa lipase was 
cloned.10
The molecular weight of the known lipases in their active, native form ranges from 30 
to 65 kDa. Lipases are generally soluble in water and insoluble in organic solvents, 
and may be strongly adsorbed at the air/water interface.
Usually, commercially available lipases are a mixture of proteins that may contain 
other hydrolases together with stabilizing supports. Pig pancreas lipase is, for 
example, a glycoprotein, which exists as a mixture of isoenzymes differing in the 
glycan moiety of the enzyme. Crude pancreas lipase contains presumably another 
carboxyl esterase that may be responsible at least in part for the high 
enantioselectivity frequently observed with this enzyme in hydrolysis and 
esterification.11-14
Therefore, an isolated lipase of the same origin may have different activities and 
selectivities depending on the isolation and purification procedures used by the 
individual suppliers. The lipase of interest can be separated from other esterases and 
proteases occurring in the crude enzyme preparation. However, purification protocols 
are often long and complex, because the affinity of lipases is high not only at the 
oil/water boundary, but to any interface of lower polarity than water (e.g. water- 
immiscible organic solvents, glass and plastic surfaces and air bubbles); lipases may 
irreversibly adsorb and denature at such interfaces.15'19
Table 1.1 summarises commercially available lipases most frequently used in organic 
synthesis and their abbreviation codes.
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Table 1.1. Commercially available lipases most used in organic synthesis
ORIGIN CODE
Mammalian origin
Porcine pancreas lipase PPL
Fungal origin
Candida rugosa or Candida cylindracea 
Candida antarctica type B 
Candida antarctica type A 
Mucor miehei or Rhizomucor miehei






Pseudomonas fluorescens or Pseudomonas cepacia PFL or PCLa
a Some microbial lipases, used in the past with a name, were recently re-identified with regard to their 
origin and name.
1.4 Lipase structure and mechanism
The first definition of a lipase is dated 1958. It was given by Sarda and Desnuelle20 in 
kinetic terms and was related to the phenomenon of interfacial activation. This 
derived from the observation that lipase activity is low on monomeric substrates but 
strongly enhanced once an aggregate “supersubstrate” (such an emulsion or a 
micellar solution) is formed above its saturation limit. For a long time lipases were 
considered as a special class of hydrolases, which are highly efficient at hydrolysing 
molecules aggregated in water.
Only in 1990 the two first lipase structures were solved by X-ray crystallography. A 
unique mechanism of catalysis, unlike that of any other enzyme, was revealed. 
These three dimensional structures suggested that interfacial activation might be due 
to the presence of an amphiphilic peptidic loop covering the enzyme active site in 
solution, just like a lid or a flap.21,22 From the X-ray structure of cocrystals between 
lipases and substrate analogues, it was evident that when contact occurs with a 
lipid/water interface, this lid undergoes a conformational rearrangement which makes
4
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the active site accessible to the substrate.23 The position of the flap and the active 
site in Candida rugosa lipase is shown in Figure 1.1.
Fig. 1.1. Lipase from Candida rugosa active site (SER 209, GLU 341, HIS 449) and 
flap (LEU 78 and GLN 83)
However, subsequent studies provided evidence that not all lipases subscribe to the 
phenomenon of interfacial activation. Thus, Candida antarctica type B, whose tertiary 
structure is known, has an amphiphilic lid covering the active site, but does not show 
interfacial activation.24 Among the pancreatic lipases whose tertiary structures have 
been solved, human pancreatic lipase contains a lid with 23 amino acids,25 whereas 
coypu pancreatic lipase does not, although it has a lid of homologous size.26 As a 
consequence, neither the phenomenon of interfacial activation nor the presence of a 
lid domain is appropriate criteria to classify an hydrolase into the lipase subfamily. 
The best experimental evidence remains whether or not it can catalyse the hydrolysis 
of long-chain acyl glycerols.
As can be seen in Fig. 1.1, the active site of lipase is in the form of a catalyic triad, 
composed of a nucleophilic serine residue activated by a hydrogen bond in relay with 
histidine and aspartate or glutamate (Scheme 1.3). Crucial to the catalytic function of 
the enzyme are, beside the interplay of the residues of these amino acids, the 
stabilization of the oxy anion intermediates and the corresponding transition states. 
The stabilisation occurs through hydrogen bonds provided by amide bonds or other
5
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amino acid residues of the active site. Serine proteases follow essentially the same 
mechanism.
*  VH - N  . . . . .  / \
>
Glu 341 Glu 341 |_j—n
0 ^ 9  R- o - c f  hV N  _____  ° ^ ?  > .
>  h' n^  i |vr2 'h“ nx
L > - h - o  L  / ’ - n - 0,  >




° ^ ?  Ri - 0 < A  >•
? Inr2 'h" \
I nN h Qk > *
Ser 209His 449
✓ W ' 'V
acyl-enzyme complex
Scheme 1.3. Catalytic mechanism of lipase based on the catalytic triad. The 
numbering of amino acids refers to lipase from Candida rugosa
In summary, all lipases investigated so far exhibit a surprising degree of structural 
and functional similarity, regardless of the organism from which they are isolated and 
even if the observed amino acid sequence homologies are low.27,28 However, 
variations in the architecture of the substrate binding site may have a strong effect on 
the catalytic properties, the temperature and the stability of a lipase in a solvent.
1.5 Lipase immobilisation
Despite the potentiality of lipases as catalysts for the synthesis of a variety of 
intermediates, the practical application of enzymes as catalysts in organic chemistry 
is often limited by the inherent differences between the conditions in which lipases 
catalyse biological reactions and the conditions required in a preparative chemical 
synthesis. Moreover, while biological systems destroy and regenerate enzymes as 
they are needed, catalysts used in chemical manufacture must be often recovered 
and recycled many times for economical reasons.
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The most commonly used strategy to give the desirable features of conventional 
heterogeneous catalysts to biological catalysts is immobilisation.
By definition, enzyme immobilisation is the conversion of an enzyme to a form with 
restricted mobility but with retention of its catalytic function.29 This limited mobility is 
generally achieved by either conversion to an insoluble form (for example by 
attaching the enzyme to insoluble particles) or by containment within a semi- 
permeable barrier (for example entrapment within a membrane). During this 
immobilisation process, enzymes acquire advantageous properties:
♦ Immobilised enzymes can be recycled.
♦ They can be used continuously.
♦ They can be easily separated from soluble reaction products and unreacted 
substrate, thus simplifying work-up and catalyst recovery.
♦ Catalytic properties and enzyme stability can be increased in the immobilised 
form.
♦ The immobilised preparation prevent microbial contamination usually found in 
the soluble protein.
Of course, there are some limitations on the utility of immobilised enzymes. First, the 
carrier can be quite expensive and its cost may even exceed the cost of the enzyme 
itself. Second, the activity of the resulting immobilised enzyme is often reduced 
because of the chemical modification of the protein and mass transfer limitation. 
Finally, the yield of the protein binding is hardly quantitative and this dramatically 
reduces catalytic activity per weight of solid.
Despite these limitations, many commercially available lipases are actually 
immobilised. The immobilisation on solid supports can be achieved in different ways; 
The technique used can be a non-covalent adsorption, covalent attachment, 
entrapment of the lipase in a polymeric gel, membrane or capsule, cross-linking with 
a polyfunctional agent.
For example, lipases from Candida antarctica, Humicola lanuginosa and Mucor 
miehei have been immobilised by ionic attachment to synthetic resins. Methacrylate 
resin crossed-linked with divinylbenzene have been employed for the 
transesterification of fats and oils, affording virtually quantitative binding of the 
protein. The preparation of Candida antarctica lipase B has been widely used for the 
resolution of carboxylic acids and alcohols.30 A variety of immobilised Pseudomonas
7
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cepacia lipase preparations have also been compared for their activity and selectivity 
in organic solvents.31
More recently, cross-linked enzyme crystals (CLEC®) have been shown to be highly 
active and stable heterogeneous biocatalyst preparations. In this method, protein 
microcrystals are produced from aqueous solution. The protein molecules in the 
microcrystals are then covalently cross-linked by treatment with an appropriate multi­
functional reagent, usually glutaraldehyde. This renders the crystals insoluble on 
transfer to different aqueous media.32 Reetz33 and others34,35 have found that 
entrapment of lipases within a hydrophobic silica sol-gel can result in a biocatalyst 
whose activity in organic media is enhanced in comparison to the corresponding 
lipase powder under the same conditions. A silica matrix is generated in the 
presence of an aqueous solution of the lipase by treating hydrophobic alkyl 
alkoxysilanes with a catalytic amount of sodium fluoride. The gel is allowed to set, 
then dried and crushed to the desired average particle size.
1.6 Lipases in organic solvent. Solvent engineering
The use of lipases in organic solvents has proved to be an advantageous alternative 
to reactions in water, especially for poor water-soluble substrates and products, e.g. 
in the synthesis of esters, lactones or selected peptides. The choice of organic 
solvent in a lipase-catalysed reaction is often crucial and can influence enzyme 
activity and selectivity. Even if the knowledge of how this happens is not yet 
available, there is much work about the solvent engineering of lipase-catalysed 
reactions.
Organic solvents can have both stabilising and destabilising effects on lipase activity. 
A reasonably good measure of the compatibility of solvents with enzymes is the log P 
value, where P is defined as the distribution coefficient of a solvent between water 
and 1-octanol in a two-phase system.36 Solvents with a log P value above 4 are 
usually suitable (e.g. aromatic, aliphatics) whereas water-miscible solvents with a log 
P value below 2 (short chain esters, DMF, short-chain alcohols) are not suitable for 
employment with enzymes. These solvents with log P<2 seem to interfere with the 
water at the boundary of the protein itself and so with the binding forces necessary to 
maintain the enzyme in its active form.
Lipases can be used in one-phase systems, which may consist of water, water plus a 
water-miscible solvent or a pure organic solvent. Most water-miscible solvents can be 
used in concentrations up to 20% before enzyme deactivation occurs and the 
benefits obtained by better solubility of substrates and/or selectivity are lost. Using
8
Claudia Neri - University of Bath____________________ Lipase as Biocatalysts in Organic Synthesis
Chapter 1
this approach, enzyme activity and selectivity have to be examined carefully to select 
appropriate reaction conditions.
Several approaches can be employed to use mainly water non-miscible solvents. In 
most cases, the organic solvent has to be saturated with water in order to maintain 
the boundary water surrounding the enzyme and to avoid deactivation. The control of 
water activity can be achieved by addition of salts or utilization of saturated salt 
solutions.37,38 The simplest way of using a lipase in organic solvent is to suspend the 
insoluble enzyme in the required solvent (straight from the bottle!). This technique 
has become general practice over the last few years.39,40
Supercritical carbon dioxide, which exhibits similar properties to hexane, can also be 
used as an alternative to organic solvents. This possesses a liquid like density (and 
thus high solvent strength) and gas like transport properties (low viscosity), which 
allow good mass transfer and facile extraction.41
To achieve true homogeneous catalysis, enzyme solubility may be increased by 
adding polyethylene glycol to its surface 42 By use of detergents and small amounts 
of water or buffer, reversed micelles can also be formed. These contain the enzyme 
in the water phase while the organic solvent forms the bulk phase.43,44 
Just like one-phase systems, two-phase systems may consist mainly of water or 
mainly of organic solvent. In the aqueous-based system an insoluble substrate is 
dispersed, using a non-miscible solvent (oil-in-water emulsion). A water-in-oil 
emulsion is obtained when the aqueous phase is dispersed in a water-immiscible 
solvent. Hydrolysis reactions of poorly water-soluble substrates (e.g. fat hydrolysis) 
may be performed in this way. Enzymes immobilised on an insoluble support also 
belong to two-phase systems.
Very recently ionic liquids have been introduced as a new class of solvents. These 
are salts with melting points below 100 °C and are non-volatile. Some typical 
structures are shown in Scheme 1.4. Many substrates and catalysts are soluble in 
ionic liquids45,46 and they can be used to replace organic solvents in enzymatic 
reactions.47'49 For example, the lipase-catalysed resolution of phenylethanol was 
carried out in a ionic liquid and an improved enantioselectivity at higher temperatures 
was observed compared to the selectivity obtained in methyl-tert-butylether 
(MTBE).48,49
9
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(CF3S 02)2N-
Scheme 1.4. Typical structures of ionic liquids
1.7 Lipases in organic synthesis
Lipases are one of the most versatile classes of biocatalysts in organic synthesis. 
The application of lipases as biocatalysts has been reviewed in a number of books 
and journals.50'53 Lipases are a unique class of hydrolases54'56 for asymmetric 
synthesis based on prochiral and racemic substrates, for different important reasons:
s  Lipases accept non-natural substrates of enormous structural diversity. The 
wide substrate specificity of this enzyme class allows acylation of 
nucleophiles other than those with hydroxyl groups, while still showing 
regioselectivity or chiral recognition.
*  Lipases act at the water/lipid boundary, which exhibits high interfacial energy. 
To withstand the denaturing effect of the interface, lipases have evolved 
unusually stable structures that may be active in water, in almost anhydrous 
organic solvents, and in supercritical fluids.57'59
S The free energy of lipase-catalysed fat hydrolysis is close to 0 KJmol'1. As a 
result, thermodynamic equilibria are largely governed by reactant 
concentrations, and lipase-catalysed ester hydrolysis in water can easily be 
reversed into ester synthesis or transesterification, in non-aqueous media.
1.7.1 Lipase-catalysed reactions
1.7.1.1 Hydrolysis and formation of C-0 bonds
Catalysis of the hydrolysis and formation of C-O bond if an ester, lactone or 
carbonate by lipases are among the most useful enzyme-catalysed reactions in 
organic synthesis.2,3 The most important application is in the field of asymmetric 
synthesis.
10
Claudia Neri - University of Bath ________ Lipase as Biocatalysts in Organic Synthesis
Chapter 1
The first class of compounds that are appropriate substrates for lipase-catalysed 
reactions are principally those compounds which bear enantiotopic groups. These 
enantiotopic groups can be, for example, ester groups with the prochirality contained 
in the diol part of the molecule, like in diacetates 1.1,60 1.361,62 and 1.563 (Scheme 
1.5).
ppl
N3'" - (   ■
V ^ S ^ O A c  H20 , pH 7
N3n -
/-'■«Y '^'T>Ac






° ^ O A c
PCL
H20 , pH 7
1.3
/— OH 




Hv /  OAc PFL
l-UO P h r \ — t
41% yield 
94% e.e.
OAc HzO r " >— OAc
1.5 1.6
Scheme 1.5. Enantiotopos-differentiating lipase-catalysed hydrolysis of diacetates
Primary acyclic diacetates, such as compound 1.5 in Scheme 1.5, are substrates per 
excellence for lipases. Unsaturation in the alkyl chain frequently leads to the 






Scheme 1.6. Lipase-catalysed hydrolysis of saturated and analogous 
unsaturated diacetates
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Comparison of the enantioselectivities of the hydrolysis of diacetates to the 
corresponding monoacetates is often complicated by the lack of information on the 
amount of diol formed. The latter arises from the hydrolysis of the monoacetate that 
may proceed under enantiomer differentiation, and thus the e.e. value of the 
monoacetate will be a composite of two enantioselective processes.
Glycerol diacetate derivative 1.11, with a substituent in the 2-position, is hydrolysed 
with crude pig pancreas lipase in a two-phase system composed of water and 
hexane to the monoacetate 1.12 with good enantioselectivity (Scheme 1.7).65 
Hydrolysis in aqueous solution alone is much less selective.
ci— ( (  \ - 0 ( H 2C ) e „ / ~ OAo PPL , Cl— ^  y — 0(H2C)6/, ^ ~ OAc 75% yield
Hc/ X — oac  H20/hexane Hc/ \ _ o h  9 1 % e a
1.11 1.12
Scheme 1.7. Lipase-catalysed hydrolysis of diacetate 1.11 in a water/hexane system
Alternatively, lipase substrates can be compounds that carry enantiotopic hydroxyl 










OCH2Ph 8™ * eki97% e.e.
1.15 1.16
Scheme 1.8. Enantiotopic-differentiating lipase-catalysed transesterification of diols
A limited number of acyclic and cyclic prochiral dicarboxylic acid diesters were also 
found to be good substrates for lipase-catalysed hydrolysis reactions. Examples are 
the hydrolyses of diesters 1.1768 and 1.1969 (Scheme 1.9).
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r ^ Y ^ C 0 2Me PPL  ^ rj/ N ^ VC02H
^ ^ L s ^ C O g M e  H20  l i^ J s ^ C O g M e
1.17 1.18
M eO ^^C O gM e MgOl ^CO^H
MeCJ^CC^Me H20  MeO'/ ^ C 0 2Me
1.19 1.20
Scheme 1.9. Enantiotopos-differentiating lipase-catalysed hydrolysis of
dicarboxylic diesters
A second and no less important class of substrates for lipase-catalysed reactions is 
the racemates. The usefulness of lipases for the resolution of carboxylic acid esters 
and lactones by hydrolysis has been demonstrated.2 Two examples are the lipase- 
catalysed hydrolysis reactions of racemic carboxylic acid 1.2170 and lactone 1.23,71 




Scheme 1.10. Resolution of carboxylic acid esters and lactones 
by lipase-catalysed hydrolysis
The broad substrate range, in the hydrolysis of carboxylic acid esters, is covered 
mainly by lipases from Candida cylindracea (rugosa), pig pancreas lipase and 
several Pseudomonas sp. lipases. Carboxylic acid esters having the alkoxycarbonyl 
group attached to a secondary, tertiary or even quaternary carbon atom are also
13
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substrates. Thus, in contrast to uncatalysed ester hydrolysis, steric hindrance, at 
least for the known examples 1.2572 and 1.27,73 represents no problem (Scheme 
1.11).
.o C02nBu ppL ^ 0 __vvSC 02f1Bu ^ o ^ ^ C° 2 H
» ■  > c r '  •
1.25 1.25a 1.26







Hi3C6^ C 02R +
BnO. .Me 




Scheme 1.11. Resolution of hindered racemic carboxylic esters
Functional group selectivity or chemoselectivity is also observed between an ester 
group and a thioester group or an ester and a lactone moiety as exemplified in 























Scheme 1.12. Group selectivity in the hydrolysis of racemic carboxylic acid esters
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a-Amino ester 1.33, in Scheme 1.13, with unprotected amino group is hydrolysed to 
amino acid 1.34 with high enantioselectivity.76
C 02”Octyl C 02nOctyl
I ANL




73% e.e. 93% e.e.
Scheme 1.13. Hydrolysis of unprotected amino acid 1.33.
Lipase-catalysed resolution of acylated racemic primary alcohols by hydrolysis cover 
a broad range of substrates,2 including amino alcohol 1.3577 and acylated y- 





























Scheme 1.14. Lipase-catalysed hydrolysis of acylated primary racemic alcohols
Because of the experimental simplicity, lipase-catalysed resolution of racemic 
acylated secondary alcohols by hydrolysis reaction is today one of the best methods 
for the synthesis of enantiomerically pure secondary alcohols. There is almost no 
restriction in regard to the substrate structure. Highly enantiomer-selective hydrolysis 
of esters of a wide structural range of secondary alcohols by the different lipases is 
possible. An example79 is illustrated in Scheme 1.15.
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1.39 1.39a 1-40
48% yield 48% yield
>99% e.e. >99% e.e.
Scheme 1.15. Lipase-catalysed hydrolysis of acylated secondary racemic alcohols
A series of cyanohydrin acetates have also been prepared by a lipase-catalysed 
reaction. Isolation of the cyanohydrin itself is usually not possible because of the 
alkaline pH. With Alcaligens sp. lipase, whose pH optimum is between 4 and 5, 




c n  ►
H20 , pH 4-5
1.41 1.41a 1.42
40% yield
98% e.e. 98% e.e.
Scheme 1.16. Lipase-catalysed resolution of cyanohydrins
Several racemic secondary mono-, bi- and tricyclic acylated alcohols have also been 
resolved by a lipase-catalysed enantiomer differentiating hydrolysis. Usually these 
compounds bear a functional group in 2-position, such as compound 1.43 (Scheme 
1.17).81 The cycloalkanol can be cis- or trans-\ hydrolysis is generally selective when 
both an acylated alcohol and a carboxylic acid ester are present in the molecule.
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OAc










Scheme 1.17. Lipase-catalysed resolution of acylated cyclic 
racemic secondary alcohols
1.7.1.2 Hydrolysis and formation of N-O bonds
Lipases have been widely used for the preparation of enantiomerically enriched 
alcohols, esters and carboxylic acids through the corresponding asymmetric 
esterification and transesterification reactions (see previous paragraph). Recently, 
these enzymes have also been used in the preparation of enantiomerically pure 
amines and amides. Gotor and co-workers82 have done most of the work, in this field. 
The utility of lipases for the preparation of enantiomerically pure amides was first 
demonstrated in the reaction of racemic chloropropionate with several aliphatic and 









R = alkyl, 2-25 °C 








Scheme 1.18. Lipase-catalysed preparation of enantiomerically pure amides 
from racemic chloropropionate
A series of pharmacologically interesting amines, such as amine 1.48 has been 
resolved by Candida antarctica lipase type B-catalysed enantioselective acylation 
(Scheme 1.19)84
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Scheme 1.19. Lipase-catalysed enantioselective acylation of amine 1.48
/V-unsubstituted acrylic amides 1.51 have also been prepared by a lipase-catalysed 
ammonolysis reaction (Scheme 1.20).85
o
CAL, NH3 11
R OMe  R NH2
60 °C
R = H, Me, Ph, 2-Furyl
R-i = H, Me 77-88% e.e.
1.50 1.51
Scheme 1.20. Lipase-catalysed ammonolysis of esters
1.7.1.3 Hydrolysis and formation of S-0 bonds
There are a few examples of lipase-catalysed kinetic resolution of thiols in the 
literature.
Phenylethanethiol 1.54 has been successfully resolved by a CAL B-catalysed 
transesterification reaction, as illustrated in Scheme 1.21.8
Me O Me
X X  + A
P h ' ' S ^ 1 C H 2)5CH3 ph SH
u  ^  . .  1.52a 1.54
M® {■? M® CAL B
I I I  + I . ____► - 42% conversion
P h '^ S ^ ^ ( C H 2)5CH3 P h ^ T H H  39 °C 75% e.e. 95% e.e.
1.52 1.53 j f 6 H
P h ^ O ^ (C H 2 )5CH3 P h ^ O H
1.55 1.53a
20% conversion 
24% e.e. 96% e.e.
Scheme 1.21. CAL B-catalysed resolution of phenylethanethiol 1.54
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Mercapto ester 1.56 has been resolved by a lipase-catalysed transesterification, 
using n-propanol as organic solvent (Scheme 1.22).86
1.7.2 Selectivity of lipases towards organic substrates. Kinetic and Dynamic 
resolution
The success of a lipase-catalysed kinetic resolution is limited by the maximum 
chemical yield of 50% for each enantiomer (see above). However, as lipase- 
catalysed reactions are usually reversible, it must be kept in mind that the reverse 
reaction may lead to racemisation. Measures must be taken to drive the reaction in 
the desired direction. Thus, water liberated during esterification can be removed in 
vacuo or absorbed in molecular sieves. Alternatively, a large excess of the acyl donor 
can be introduced using, for example, ethyl acetate as both the acylating agent and 
the solvent. The method of choice to increase the reaction rate and to shift the 
equilibrium towards product synthesis is the use of activated esters such as vinyl 
acetate.87'89 The alcohol freed from the transesterification rapidly tautomerizes to 
acetaldehyde or acetone, making the process irreversible (Scheme 1.23).








Scheme 1.22. Lipase-catalysed resolution of mercapto ester 1.56
OH OH
t
Scheme 1.23. Irreversible acylation with enol esters
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Which of the above-mentioned methods is used, the maximum conversion obtainable 
by a conventional kinetic resolution procedure remains 50%. This limitation can be 
overcome by a process called dynamic kinetic resolution (DKR).
The key idea of this principle is to racemise the slow reacting enantiomer 
continuously reproducing the faster one. In an ideal case, at the end of conversion 
one enantiomer is formed in 100% yield with 100% enantiomeric excess. This is 
illustrated in Scheme 1.24, where a conventional kinetic resolution and a dynamic 
kinetic resolution reaction are compared. In both cases enantiomer S reacts to form 
product P more quickly than enantiomer S’. In the conventional kinetic resolution 
enantiomer S’ is simply left behind as unreacted starting material; in the dynamic 
kinetic resolution S and S’ are in equilibrium and all the starting material can ideally 
be converted into product P. The reaction conditions must be chosen so that whilst 
the starting material enantiomers (S/S’) undergo rapid equilibration (racemisation), 
the product P must be inert to racemisation.
Conventional kinetic resolution Dynamic kinetic resolution
S ---------- ► P S -----------► P
I
S' X  *  p‘ S- —x —  P*
Scheme 1.24. Conventional kinetic resolution and dynamic kinetic resolution
Lipases are very often used to achieve dynamic kinetic resolution.90 Cyanohydrins, 
for example, are suitable substrates for dynamic kinetic resolution, because they are 
easily racemised with base. Several cyanohydrins, such as cyanohydrin 1.59, formed 
by transhydrocyanation with acetone cyanohydrin, catalysed by the hydroxide form of 
an anion exchange resin, have been obtained in their enantiomerically enriched form 
by this method.91,92 The reversible nature of cyanohydrin formation allows 
racemisation to proceed during the course of the lipase-catalysed acetylation, to 
afford acetylated cyanohydrin 1.60 in 81% yield and 91% enantiomeric excess 
(Scheme 1.25).
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i) acetone cyanohydrin, IRA-904 resin (HO' form)
ii) Pseudomonas cepacia lipase, isopropenyl acetate, 40 °C
Scheme 1.25. Lipase-catalysed dynamic kinetic resolution of cyanohydrins
Successful dynamic kinetic resolution reactions have been performed using cyclic 
hemiacetals as substrates. The lipase-catalysed acetylation of 6-hydroxypyranone 
1.61 has been achieved with reasonable enantioselectivity with essentially complete 
conversion (Scheme 1.26). The rate of reaction was found to greatly increase when 






Scheme 1.26. Dynamic resolution of cyclic hemiacetals
However, most substrates for lipase-catalysed kinetic resolution reactions do not 
undergo spontaneous racemisation under conditions that are suitable for enzyme 
activity. To solve this problem, mild transition metal-catalysed methods for in situ 
racemisation has been designed. Racemisation must occur without affecting 
negatively the enzyme. At the same time, the enzyme must not inhibit the 
racemisation method. The first example was reported by Allen and Williams.95 In this 
case, a palladium (II) catalyst was employed to racemise the allylic acetate substrate
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0.1 M psosphate buffer
5 mol% PdCI2(MeCN)2
1.64 PFL: (+)-1.65, 96% e.e., 96% conv. 
Acetylcholine esterase: (-)-1.65 , 85% e.e., 68% conv.
Scheme 1.27. Dynamic kinetic resolution using transition metal/enzyme combinations
Backvall and co-workers have achieved successful results for a wide range of 
substrates, using different ruthenium catalysts. Their procedure works well for 
secondary alcohols containing aryl and alkyl groups,96 diols, 97 and a-hydroxy 
esters.98 An example of dynamic kinetic resolution of y-hydroxy acid derivative 1.6699 
is illustrated in Scheme 1.28.
o h  p c l  OAc o  0 0
OfBu PCIC6H4OAc _ I  0 fBu II 0 fBu Ph V ^ P h H P h ^ y PhA \ ,h. /r-f.. 6 mol% Ru catalyst Ph \  A h phU • ii Ru Ru
u  toluene, 60 °C u  u  oc ccco "co
1.66 1.67 1.68
70% yield 3% yield
94% e.e.
Ru catalyst
Scheme 1.28. Example of dynamic kinetic resolution of secondary alcohols
The challenge in the field of dynamic kinetic resolution is, of course, to discover 
racemisation methods that are compatible with the lipase-catalysed reaction.
22
Claudia Neri - University of Bath ________ Lipase as Biocatalysts in Organic Synthesis
Chapter 1
1.8. References
1. Schmidt, R. D. and Verger, R. Angew. Chem. Ed. Int. 1998, 37,1608.
2. Gais, H. -J. and Theil, F. in Enzyme Catalysis in Organic Synthesis; Drauz, 
K. and Waldman, H. Eds.; VCH: Weinheim, 2002; Vol. II, pp. 412-569.
3. Wong, C.- H. and Whitesides, G. M. Enzymes in Synthetic Organic 
Chemistry, Tetrahedron Organic Chemistry Series Vol. 12; Pergamon: 
Oxford, 1994; pp.70-108.
4. Chen, C. -S. and Sih, C. J. Angew. Chem. Ed. Int. 1989, 28, 695.
5. Chang, C. -S.; Tsai, S. -W. and Lin, C. -N. Tetrahedron: Asymmetry 1998, 9, 
2799.
6. Chang, C. -S. and Tsai, S. -W. Biochem. Eng. J. 1999, 3 ,239.
7. de Castro, M. S.; Dommguez, P. and Sinisterra, J. V. Tetrahedron, 2000, 56, 
1387.
8. Oherner, N.; Orrenius, C.; Mattson, A.; Norin, T. and Hult, K. Enz. Microb. 
Tech. 1996, 19, 328.
9. Adamczyk, M. and Grote, J. Bioorg. Med. Chem. Lett. 1999, 9, 245.
10. Boel, E.; Christensen, T. and Woldlike, H. (Novo Nordisk AS) Chem. Abstr. 
1996, 125, 160364.
11. Hemmerle, H. and Gais H. -J. Tetrahedon Lett. 1987, 28, 3471.
12. Ramos Tombo, G. M.; Schar, H. -P.; Fernandez, X.; Busquetes, I. and 
Ghisalba, O. in Biocatalysis in Organic Media; Laane, C., Tramper, J. and 
Lilly, M. D. Eds.; Elsevier; Amsterdam, 1987, p. 43.
13. Ramos Tombo, G. M.; Schar, H. -P.; Fernandez, X.; Busquetes, I. and 
Ghisalba, O. Tetrahedron Lett. 1986, 27, 5707.
14. Zasks, A. and Klibanov, A. M. Science 1984, 224,1249.
15. Ion Exchange Chromatography: Principles and Methods; Amersham 
Pharmacia Biotech. Ed.; APB; Uppsala, 1999.
16. Hydrophibic Interaction Chromatography. Principles and Methods; 
Amersham Pharmacia Biotech. Ed.; APB; Uppsala, 1999.
17. Gel Filtration Chromatography: Principles and Methods; Amersham 
Pharmacia Biotech. Ed.; APB; Uppsala, 1999.
18. Reversed Phase Chromatography: Principles and Methods-, Amersham 
Pharmacia Biotech. Ed.; APB; Uppsala, 1999.
23
Claudia Neri - University of Bath Lipase as Biocatalysts in Organic Synthesis
Chapter 1
19. Affinity Chromatography: Principles and Methods; Amersham Pharmacia 
Biotech. Ed.; APB; Uppsala, 1999.
20. Sarda, L. and Dasnuelle, P. Biochim. Biophys. Acta 1958, 30, 513.
21. Wrinkler, F. K.; D’Arcy, A. and Hunziker, W. Nature 1990, 343, 771.
22. Brady, L.; Brzowzosky, A. M.; Derewenda, Z. S.; Dodson, E.; Dodson, G.; 
Tolley, S.; Turkenburg, J. P.; Christiansen, L.; Huge-Hensen, B.; Norskov, L.; 
Thim, L. and Menge, U. Nature, 1990, 343, 767.
23. Brzowzosky, A. M.; Derewenda. U; Derewenda, Z. S.; Dodson, G.; Lawson, 
D. M.; Turkenburg, J. P.; Bjorkling, F.; Huge-Hensen, B.; Patkar, S. A. and 
Thim, L. U. Nature, 1991, 351, 491.
24. Uppenberg, J. ; Patkar, M. T.; Hansen, S. and Jones, A. Structure 1994, 2, 
293.
25. van Tilbeurgh, H.: Egloff, M. -P.;Martinez, C.; Rugani, N. ;Verger, R. and 
Cambillau, C. Nature, 1993, 362, 814.
26. Thirstrup, K.: Verger, R. and Carriere F. Biochemistry 1994, 33, 2748.
27. Derewenda, U. and Sharp, A. M. TIBS 1993, 18, 20.
28. Derewenda, U. and Derewenda, Z. S. Biochem. Cell. Biol. 1991, 69, 842.
29. Buchholz, K. and Klein, J. Methods Enzymol. 1987, 135, 3.
30. Anderson, A. M.; Larsson, K. M. and Kirk, O. Biocat. Biotrans. 1998, 16, 181.
31. Secundo, F.; Spadaro, S.; Carrea, G. and Overbeeke, P. L. A. Biotechnol. 
Bioeng. 1999, 62, 554.
32. St. Clair, N. and Navia, M. J. Am. Chem. Soc. 1992, 114, 7314.
33. Reetz, M. T.; Simpelkamp, J. and Zonta, A. Angew. Chem. Ed. Int. 1995, 34,
301.
34. Ellerby, L. M.; Nishida, C. R.; Nishida, F.; Yamanaka, S. A.; Dunn, B.; 
Valentine, J. S. and Zink, J. I. Science 1992, 255,1113.
35. Braun, S.; Shtelzer, S.; Rappoport, S. and Avnir, D. J. Non-Cryst. Solids 
1992, 147, 739.
36. Laane, Tramper VEDI PRIMA. Laane, C.; Boeren, S.; Vos, K. and Veeger, C. 
Biotechnol. Bioeng. 1987, 30, 81.
37. Valivety, R. H. and Hailing, P. J. Biochim Biophys. Acta 1992, 1118, 218.
38. Adlerkreutz, P. Biocatal. Biotrans. 1996, 14,1.
39. Zaks, A. and Klibanov, A. M. J. Biol. Chem. 1988, 263, 8017.
40. Faber, K. J. Mol. Catal. 1991, 65, L49.
41. Nakamura, K. Tibtech 1990, 8, 288.
42. Harris, J. M. Poly(Ethylene Glycol) Chemistry, Plenum Press; New York, 
1992.
24
Claudia Neri - University of Bath Lipase as Biocatalysts in Organic Synthesis
Chapter 1
43. Luisi, P. L. and Laane, C. Trends Biotechnol. 1986, 4,153.
44. Orlich, B. and Schomacker, R. Biotechnol. Bioeng. 1999, 65, 357.
45. Wasserscheid, P. and Keim, W. Angew. Chem. Ed. Int. 2000, 112, 3926.
46. Welton, T. Chem. Rev. 1999, 99, 2071.
47. Madeira Lau, R.; van Rantwijk, F.; Seddon, K. R. and Sheldon, R. A. Org. 
Lett. 2000, 2, 4189.
48. Scohfer, S. H.; Kaftzik, N.; Wasserscheid, P. and Kragl, U. Chem. Commun. 
2001, 425.
49. Kim, K. -W.; Song, B.; Choi, M. Y. and Kim, M. -J. Org. Lett. 2001, 3 ,1507.
50. Faber, K. Biotransformation in Organic Chemistry, Springer; Heidelberg, 
1995.
51. Kazlauskas, R. and Bornscheuer, U. T. in Biotechnology, Vol. 8a; Rehm, H. 
J.; Reed, G.; Puler, A.; Stadler, P. J. W. and Kelly, D. R.; VCH; Weinheim, 
1998, pp.37-191.
52. Enzymatic Reactions in Organic Media Koskined, A. M. P. and Klibanov, A. 
M.; Blackie; London, 1996.
53. Gutman, A. L. and Shapira, L. Synthetic Applications of Enzymatic Reactions 
in Organic Solvents, Adv. Biochem. Eng. Biotechnol.; Vol. 52; Fiechter, A. 
Ed.; Springer; Heidelberg, 1995; pp. 87-128.
54. Borgstrom, B. and Brockman, H. L.; Lipases:, Elsevier,; Amsterdam, 1984.
55. Alberghina, L.; Schidt, R. D. and Verger, R. ED.; Lipases: Structure, 
Mechanism and Genetic Engineering] VCH; Weinheim, 1990.
56. Wooley, P. and Petersen, S. B.; Lipases: Their Structure, Biochemistry and 
Application; Cambridge University Press; Cambridge, 1994.
57. Bornscheuer, U. T. and Kaslauskas, R. J. Hydrolases in Organic Synthesis; 
VCH, Weinheim, 1999.
58. Baumann, R.; Sturmer, R. and Bornscheuer, U. T Angew. Chem. Ed. Int. 
2001, 40,4201.
59. Powell, K. A.; Ramer, S. W.; de Cardayre, S. B.; Stemmer, W. P. C.; Topin, 
M, B.; Longchamp, P. F. and Huisman, G. W. Angew. Chem. Ed. Int. 2001, 
40, 3948.
60. Hemmerle, H. and Gais, H. -J. Tetrahedron Lett. 1987, 28, 3471.
61. Itoh, T.; Ohara, H.; Takagi, Y.; Kanda, N. and Uneyama, K. Tetrahedron Lett. 
1993, 34, 4215.
62. Seu, Y. -B. and Kho, Y. -K. Tetrahedron Lett. 1992, 33, 7015.
25
Claudia Neri - University of Bath Lipase as Biocatalysts in Organic Synthesis
Chapter 1
63. Atsumi, S.; Nakano, M.; Koike, Y.; Tanaka, S.; Ohkubo, M.; Yonezawa, T.; 
Funabashi, H.; Hashimoto, J. and Morishima, H. Tetrahedron Lett. 1990, 31, 
1601.
64. Guanti, G.; Banfi, L. and Narisano, E. Tetrahedron: Asymmetry 1990, 1, 721.
65. Wang, Y. -F.; Lalonde, J.; Momogan, M.; Bergbreiter, D.E. and Wong, C. -Y. 
J. Am. Chem. Soc. 1988, 110, 7200.
66. Terao, Y.; Murata, M.; Achiwa, K.; Nishio, T.; Akamtsu, M. and Kimimura, M. 
Tetrahedron Lett. 1990, 31,1601.
67. Hoenke, C.; Kluver, P.; Hugger, U.; Krieger, R. and Prinzbach, H. 
Tetrahedron Lett. 1993, 34, 4761.
68. Nagao, I.; Kume, M.; Wakabayashi, R. C.; Nakamura, T. and Ochiai, M. 
Chem. Lett. 1989, 239.
69. Bestmann, H. J. and Philipp, U. C. Angew. Chem. Ed. Int. 1991, 30, 86.
70. Kalaritis, P.; Regenye, R. W.; Partridge, J. J. and Coffen, D. L. J. Org. Chem. 
1990, 55, 812.
71. Shioji, K.; Matsuo, A.; Okuma, K.; Nakamura, K. and Ohno, A. Tetrahedron 
Lett. 2000, 11, 8799.
72. Pottie, M.; Van der Eycken, J.; Vandewalle, M.; Dewanckele, J. M. and 
Roper, H. Tetrahedron Lett. 1989, 30, 5319.
73. Sugai, T.; Kakeya, H. and Ohta, H. J. Org. Chem. 1990, 55, 4643.
74. Gu, Q. -M.; Reddy, D. R. and Sih, C. J. Tetrahedron Lett. 1986, 27, 5203.
75. Pitacco, G.; Sessanta, A. and Valentin, E. Tetrahedron: Asymmetry 2000, 
11, 3263.
76. Ng-Youn-Chen, M. C.; Serraqi, A. N.; Huang, Q. and Kazlauskas, R. J. J. 
Org. Chem. 1994, 59, 2075.
77. Wirtz, B. and Walter, W. Tetrahedron: Asymmetry, 1992, 3 ,1049.
78. Ha, H.-J.; Yoon, K. -N.; Lee, S. -%J.; Park, Y. -S.; Lim, M. -S. and Yim, Y. G. 
J. Org. Chem. 1998, 63, 8062.
79. Laumen, K. and Schneider, M. P. J. Chem. Soc., Chem. Comm. 1988, 598.
80. van Almsieck, A.; Buddrus, J.; Honicke-Schmidt, P.; Laumen, K. and 
Schneider, M. P. J. Chem. Soc., Chem. Comm. 1989, 1391.
81. Xie, Z. -F.; Nakamura, I . ; Suemune, H. and Sakai, K. J. Chem. Soc., Chem. 
Comm. 1988, 966.
82. Gotor, V. Bioorg. Med. Chem. 1999, 7,2189.
83. Gotor, V.; Brieva, R. and Rebolledo, F. Tetrahedron Lett. 1988, 29, 6973.
84. Gonzales-Sabin, J.; Gotor, V. and Rebolledo, F. Tetrahedron: Asymmetry 
2002, 13, 1315.
26
Claudia Neri - University of Bath Lipase as Biocatalysts in Organic Synthesis
Chapter 1
85. Sanchez, V.; Rebolledo, F. and Gotor, V. Synlett 1994, 529.
86. Bianchi, D. and Cesti, P. J. Org. Chem. 1990, 55, 5657.
87. Degueil-Castaing, M.; De Jeso, B.; Drouillard, S. and Maillard, B. 
Tetrahedron Lett. 1987, 28, 953.
88. Kawasaki, M.; Goto, M.; Kawabata, S. and Kometani, T. Tetrahedron: 
Asymmetry 2QM, 12, 585.
89. Yang, H.; Henke, E. and Bornscheuer, U. T. J. Org. Chem. 1999, 64,1709.
90. Williams, J. M. J.; Parker, R. J. and Neri, C, in Enzyme Catalysis in Organic 
Synthesis; Drauz, K. and Waldman, H. Eds.; VCH: Weinheim, 2002; Vol. II, 
pp. 287-312.
91. Inagaki, M; Hiratake, J.; Nishioda, T. and Oda, J. J. Am. Chem. Soc. 1991, 
113, 9360.
92. Inagaki, M; Hiratake, J.; Nishioda, T. and Oda, J. J. Org. Chem. 1992, 57, 
5643.
93. Van der Heuvel, M.; Cuiper, A. D.; van der Deen, H.; Kellogg, R. M. and 
Feringa, B. L. Tetrahedron Lett. 1997, 38,1655.
94. van der Deen, H.; Cuiper, A. D.;Hof, R. P.; van Oeveren, A.; Kellogg, R. M. 
and Feringa, B. L. J. Am. Chem. Soc. 1996, 118, 3801.
95. Allen, J. V. and Williams, J. M. J. Tetrahedron Lett. 1996, 37, 1859.
96. Persson, B. A.; Larsson, A. L. E.; Ray, M. L. and Backvall, J. -E. J. Am. 
Chem. Soc. 1999, 121,1645.
97. Persson, B. A.; Huerta, F. F. and Backvall, J. -E. J. Org. Chem. 1999, 64, 
5327.
98. Huerta, F. F.; Laxmi, Y. R. S. and Backvall, J. -E. Org. Lett. 2000, 2 ,1037.
99. Runmo, A. -B. L.; Pamies, O.; Faber, K. and Backvall, J. -E. Tetrahedron 
Lett. 2002, 43, 2983.
27
Claudia Neri - University of Bath Evans Auxiliaries. Features and Main Applications
Chapter 2
2. Evans’ Auxiliaries. Features and General Applications
2.1 Introduction
Compounds that occur in Nature are enantiomerically pure because living organisms 
tend to produce only a single enantiomer of a given molecule. The asymmetry of 
these molecules arises from the inherent chirality of the enzymes that are 
responsible for their production.
Reception sites in biological systems, which are also enantiomerically enriched, have 
the ability to differentiate between two enantiomers of a specified molecule. If a 
pharmaceutical, or any biologically active compound, is chiral then the enantiomers 
are likely to interact differently with the natural biomolecule. The enantiomers will 
probably possess different levels of biological activity and could also exhibit quite 
different types of activity. In effect, the two enantiomers should be viewed as two 
distinct compounds. It follows that using racemate of a particular biologically active 
compound is equivalent to using a mixture of two different compounds.
Usually the reactivity of two enantiomers is different. This being the case, it is clearly 
undesiderable to use a racemic biologically active compound. Only one of the 
enantiomers possesses the desired beneficial activity, but both enantiomers carry the 
risk of unwanted activity (side effects). In the previous chapter we have described the 
utility of lipase-catalysed reactions in organic synthesis to obtain enantiomerically 
enriched alcohols, carboxylic acids, lactones and amines by kinetic resolution of 
racemic mixtures. Other enzymes than lipases are widely used to obtain a wide 
range of enantiomerically enriched compounds.1,2
However, the technique of resolving enantiomers has been used for well over a 
century before the introduction of enzymatic catalysis. In 1848 Louis Pasteur 
mechanically separated crystals of each optical isomer of sodium ammonium tartrate. 
Obviously this method is not suitable for a general resolution technique; 
nevertheless, selective crystallisation of one enantiomer is still used today as a 
method of resolution. Other methods of resolution involve the formation of a covalent 
bond between a racemate substrate and an enantiomerically pure molecule. The
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resulting pair of diastereoisomers, in many instances, can be separated by 
chromatographic techniques. Advances have recently been made in resolution 
techniques by chromatography of racemates on chiral stationary phases.3 
Each of the methods of resolution described above suffer from the major 
disadvantage that half of the mixture is the wrong enantiomer. A quantitative 
separation in the resolution step at best allows for the recovery of only half of the 
synthesized material. Moreover, thus far, we have considered the separation of only 
one pair of enantiomers. As additional centres of asymmetry are added to the 
molecule, the number of stereoisomers increases exponentially by a factor 2". 
Therefore the separation of one particular stereoisomer from the mixture by 
resolution techniques is impractical, if not impossible, to achieve.
The solution to the aforementioned problems is asymmetric synthesis. Strategically, 
this can be accomplished by two basic approaches. First, the synthesis of a target 
molecule can be designed so as to incorporate a chiral fragment whose absolute 
stereochemistry is already established. In this respect Nature’s “chiral pool” can be 
used to one’s advantage. Second, the asymmetry in the target molecule can be 
induced by means of an external chiral auxiliary reagent that, under ideal conditions, 
is recoverable and recyclable. Again, Nature furnishes the source of chirality inherent 
in these auxiliaries.
Amino acids fulfil the criteria for both approaches to asymmetric synthesis.4,5 Of all 
the classes of compounds of the “chiral pool”, the amino acids as a family are the 
most versatile. Nearly all of the 19 common a-amino acids are available (many 
commercially) in two enantiomeric forms. Therefore synthetic routes can be planned 
to produce either enantiomer of a specified molecule. L-amino acids, which are 
commonly found in Nature, are the more abundant and hence less expensive of the 
two forms.
In 1969 Yamada and co-workers6 reported the first stereoselective transformation of 
an amino acid derived enantiomerically pure enamine. In contrast to the modest 
chemical yields obtained, considerable selectivities were observed for the reaction of 
proline derivative 2.1 with a,p-unsaturated nitriles and esters (Scheme 2.1). The 
ketones, obtained after hydrolysis, were isolated with 43-59% enantiomeric excess.
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R = Me, Et, feu X = CN, COzMe
43-59% e.e.
Scheme 2.1. Asymmetric synthesis of ketones from amino-acid derived 
enantiomerically pure enamine 2.1
To perform useful chemical transformations using amino acids, it its often necessary 
to protect either or both reactive functionalities of the molecule, the amine and the 
carboxylic acid groups. In 1981 Evans and co-workers found a way to use 
intramolecularly protected a-amino acids as chiral auxiliary reagents.7,8 An amino 
acid, usually valine, terf-leucine, phenylalanine or phenylglycine is reduced to the 
corresponding amino alcohol, which is then cyclised to the enantiomerically pure 




*   -  1------ NH2 -----------► I NHNH,
R
V u n  NH2 ---------- ..
R
a-amino acid p-amino alcohol 2-oxazolidinone
Scheme 2.2. Preparation of Evans’ chiral auxiliaries
The introduction of enantiomerically pure 2-oxazolidinones (Evans” chiral auxiliaries) 
can be considered a milestone in the history of asymmetric synthesis using 
covalently bound auxiliaries. Following the introduction of Evans” auxiliaries, other 
chiral auxiliaries such as Oppolzer’s camphor derivatives (e.g. compound 2.3)9'11 
carbohydrates,12'14 ureas such as compound 2.4,15 the Schollkopf chiral auxiliary 
2.5,16'18 2,5-diketopiperazine 2.6,19 (/^-piperidin-S-ol 2.7,20 chiral auxiliaries derived 
from (-)-p-pinene like compound 2.821 (Scheme 2.3), and many others22'25 have been 
designed and employed to achieve asymmetric syntheses.
30










Scheme 2.3. Chiral auxiliaries used in synthesis
2.2 Chiral Evans’ auxiliaries
2.2.1 Chiral auxiliary approach to asymmetric synthesis
Practical enantioselective transformations using chiral auxiliaries must be either 
catalytic, or the chiral auxiliary must be efficiently recycled. A general reaction cycle 
in a chiral auxiliary-based asymmetric synthesis is illustrated in Scheme 2.4. The 
achiral substrate is covalently bond to the chiral auxiliary. The acylated auxiliary then 
undergoes a diastereoselective reaction, which introduces a chiral centre in the 
achiral substrate. Finally, cleavage of the auxiliary affords enantiomerically enriched 
product.
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chiral auxiliary










M Diastereos elective 
reaction
R R
Scheme 2.4. Chiral auxiliary approach to asymmetric synthesis
An ideal chiral auxiliary has to fulfil several criteria in this overall reaction cycle. It 
should be inexpensive and both enantiomers should be readily available. Attachment 
and cleavage should proceed in high yield by simple methods. And, most importantly, 
it should provide a high degree of diastereoselection, being stable under the 
conditions of the diastereoselective reaction. If a chiral auxiliary fulfils all these 
criteria, at the end reaction cycle will afford enantiomerically enriched product and 
recyclable chiral auxiliary.
2.2.2 Evans’ auxiliaries’ stability: attachment and cleavage
Despite the number of chiral auxiliaries today available, the strength of Evans’ 
auxiliaries remains their close similarity to an ideal chiral auxiliary. In fact, as 
required, chiral 2-oxazolidinones are quite stable molecules. The strong base 
conditions usually required for the attachment of the achiral substrate to the auxiliary 
7,26,27 don’t affect the auxiliary (Scheme 2.5).
o
ii) acyl chloride 
or anhydride
2.9 2.10
Scheme 2.5. Attachment of the auxiliary
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In addition, cleavage of the auxiliary can be performed under mild reaction conditions 
affording the intact 2-oxazolidinone and a range of different classes of compounds, 
as identified in Scheme 2.628'30
o
Ri Ri
i) LiOH, H20 2 ii) NaOEt iii) NH3 iv) LiBH4, H20  v) UAIH4
Scheme 2.6. Cleavage of the auxiliary
2.2.3 Evans’ auxiliaries’ main applications
Evans’ auxiliaries also provide good diastereocontrol in different types of reaction 
widely used in asymmetric synthesis for the construction of C-C bonds.4,28,31'33
2.2.3.1 Stereoselective alkylation of chiral enolates
Substitution at the a position of chiral enolates is a large and important area of 
asymmetric synthesis. Several conditions are required for the alkylation of an enolate 
with high and predictable stereochemical control. First, the enolate has to be formed 
in only one of the two possible geometries. Considering the result of a non-selective 
enolate formation, illustrated in Scheme 2.7, reveals the importance of this. Even if 
the chiral auxiliary directs completely to one face of the enolate, the 
diastereoselectivity of the reaction will depend upon the preferred geometry in the 
enolate formation.
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i l *  AuA -" E =  A
R, "i
enolate 2
E+ = Electrophile 
Aux = auxiliary
Ri E
Scheme 2.7. Non-selective enolate formation in a chiral auxiliary based reaction
Thus, given that in Scheme 2.7 the chiral auxiliary directs reaction completely to the 
“upper” face of the enolate, two diastereomeric products are likely to be formed. If the 
selectivity is low, the asymmetric synthesis is unsuccessful.
Factors that can influence the stereoselectivity of enolate formation include choice of 
base, solvent, temperature, counter-ion and most importantly, the structure of the 
chiral auxiliary. Ideally, a given chiral auxiliary should also produce the same enolate 
geometry, exclusively enolate 1 or 2 in Scheme 2.7, irrespective of the nature of Ri.
A representative example of the high level of diastereoselectivity induced by Evans’ 
auxiliaries is reported in Scheme 2.8. Treatment of acylated oxazolidinone 2.11 with 
base, usually LDA, produces chelated enolate 2.12 with 98% diastereomeric excess, 
to give almost exclusively product 2.13 as the major diastereomer.34
A A  LDA . A V .
P 'u"o
PhCH2E
\ / \ /
/  V  THF, 0 °C






Scheme 2.8. Oxazolidinones in stereoselective alkylations
Stereoselective alkylations have also been performed with an Evans-type supported 
oxazolidinone attached to a Merrifield polystyrene resin, for use in solid phase
34
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synthesis (Scheme 2.9).35 After hydrolysis, the polymer bound auxiliary can be 
recovered by simple filtration.
o o o o oAA- A-V A, j
\ __ /  i) LDA, THF, 0 °C \  /  I Hi) NH4CI \  /  II
\     \  V Ph    \  + HOI  H) PhCH2 Br /  iv) LiOH, THF/HzO /  I
2.14 2.15 2.16 2.17
42% yield, 
96% e.e.
Scheme 2.9. Polymer supported Evans’ oxazolidinones in stereoselective
alkylation reactions
2.2.3.2 Stereoselective aldol reactions
The development of chiral enolates that participate in stereoregulated aldol 
condensations has been a challenging undertaking. Oxazolidinones have been able 
to fulfill most of the requirements (see Chapter 5). The utility of Z-enolates derived 
from /V-acyl oxazolidinones has been shown through the aldol condensation reaction 
with aldehydes to give enantiomerically enriched a-substituted-p-hydroxy A/-acyl-2- 
oxazolidinones in high yields. An example7,26 is illustrated in Scheme 2.10.
o  o  o h
i) Bu2BOTf, 'Pr2NEt, -78 °C
2.10 2.17
99.4% "Evans" syn
Scheme 2.10. Oxazolidinones in stereoselective aldol reactions
One of the problem of using acylated oxazolidinones in aldol reactions is that acetate 
enolates usually react relatively unselectively, when compared to the corresponding 
propionate enolates. This is illustrated in Scheme 2.11.32
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O o
nBuLi, ('PrO)3TiCI A A A ,  A M  
A M  V K
Ph 7 Ph 7








P  O OH
Ph
Ph




Scheme 2.11. Comparison between diastereoselectivity of aldol reactions with 
acetate enolate and propionate enolate
To overcome this problem, a-bromoacetyl Evans’ auxiliary 2.22 has been used in a 
chromium-Reformatsky reaction, affording product 2.23 with good diastereoselectivity 
(Scheme 2.12).36
2.2.3.3 Stereoselective conjugate additions and Diels-Alder reactions
Additions to C-C double bonds represent another important area in asymmetric 
synthesis, because several chiral centres can be formed in a single reaction. The 
most studied classes of reactions of this type are conjugate additions and Diels-Alder 
reactions.
The conjugate addition of organometallic reagents to crotonyl derivatives of a variety 
of chiral auxiliaries has been extensively studied. For example, conjugate additions of 






Scheme 2.12. Chromium-Reformatsky reaction using 
a-bromoacetyl Evans’ auxiliary
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diastereoselectivity and allow access to p-branched carboxylic acids, as reported in 
Scheme 2.13.37
o o 
o '  'Na
K








Scheme 2.13. Evans’ auxiliaries in stereoselective conjugate additions
Allylated products such as compound 2.26 can also be prepared by the conjugate 
addition of allyltrimethylsilane, as shown in Scheme 2.14.38
A  1  .
 ___________ ^  88% yield
\ / 84% d.e.





Scheme 2.14. Oxazolidinones in stereoselective allylations
The asymmetric Diels-Alder cycloaddition reaction can also be realized by use of 
chiral Evans’ auxiliaries. The use of a dienophile attached to a chiral auxiliary has 
been the most intensively studied type of asymmetric Diels-Alder reaction. In the 
presence of dimethylaluminium chloride (DMAC), a,p-unsaturated /V-acyl derivatives 
of enantiomerically pure oxazolidinones undergo endo-cycloaddition with high 
diastereoselectivity.
As previously discussed in relation to diastereoselective alkylations, chelation is 
important in understanding these reactions. The study of the reaction of 
oxazolidinone 2.27 with cyclopentadiene to give compound 2.31 (Scheme 2.15) as a 
function of the amount of added Lewis acid, shows that there is a dramatic increase 
in both the endoiexo ratio and in the diastereoselectivity of the endo-cycloaddition 
when one equivalent (or more) Lewis acid is present.39 Furthermore, it also increases 
the reaction rate. This remarkable behaviour is interpreted in terms of initial formation 
of the complex followed by reversible ionisation promoted by the addition of more 
Lewis acid. This is illustrated in Scheme 2.15. The positively charged intermediate
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2.29 formed on ionisation would be expected to be more conformationally 
constrained than the intermediate 2.28, and would provide more stereocontrol in 
Diels-Alder reactions. A transition state resembling intermediate 2.30 seems to be 























Scheme 2.15. Asymmetric Diels-Alder reactions with Evans’ auxiliaries
Finally, some applications of chiral Evans’ auxiliaries in stereoselective radical 
reactions are also reported.42
2.3 Towards the ideal chiral auxiliary. Chemically designed chiral Evans’ 
auxiliaries
The ability to induce high stereocontrol in asymmetric synthesis is in practice the 
main reason why a specified chiral auxiliary is chosen to achieve asymmetric 
synthesis. That explains why since 1981 much work has been published about the 
use of novel Evans-type chiral auxiliaries, chemically designed and from other source 
than natural a-amino acids. Moreover, structural modifications often provide better 
stability under chiral auxiliary removal conditions.
3 8
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One of the drawbacks of the Evans’ methodology involves the removal of the 
auxiliary, which has to be done under mild and selective conditions, without 
racemisation of the stereogenic centres present in the system. The position of 
nucleophilic cleavage in /V-acyl oxazolidinones is dependent upon steric and 
electronic requirements (Scheme 2.16),43 The nucleophilic cleavage of unhindered 
systems is subject to electronic factors and exocyclic cleavage occurs to give the 
required products. If the AZ-acyl group is sterically demanding or a-branched, then 
the unwanted endocyclic hydrolysis can predominate. This problem can be overcome 
by using lithium hydroperoxide as a nucleophile, since it is apparently less 
susceptible to steric hindrance.43
In 1995 Davies and co-workers44 developed an elegant solution in the form of 
“SuperQuat “ chiral auxiliaries, which are 4-substitued-5,5-dimethyl-2-oxazolidinones 
such as compound 2.32 (Scheme 2.17). These auxiliaries do not suffer from the 
undesired endocyclic cleavage and give very good diastereoselectivities in alkylation 





Scheme 2.16. Cleavage of the auxiliary
i) LHMDS
94% yield 
97% d.e.ii) BnBr 
THF, -78 °C
2.32 2.33
Scheme 2.17. Stereoselective alkylation with a “SuperQuat” auxiliary
39
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Other A/-acylated oxazolidinones, with different substituents than methyl groups in 5 
position, such as oxazolidinones 2.34 (Scheme 2.18), have been studied and tested 
for their ability to promote diastereoselective reactions.48
~ LDA, 0 °C, PhCHoBrQ o
NaHMDS, -78 °C, Mel 52-69% yield
j j 82- 97% d.e. 
Ar* J ' 1 1
At 'Pr Ar' 'Pr
2.34 2.35
Ar = Ph, 2-naphthyl or 4-tolyl D, . .  D.
R = M Z c ^ P h  R = Me, CH2Ph
Scheme 2.18. Other “SuperQuat” auxiliaries
Another important class of Evans’-like chiral auxiliaries is that of amino indanol 
derivatives.49,50 The amino indanol derived auxiliary 2.37, prepared by treatment of 
amino indanol with disuccinimidyl carbonate in the presence of triethylamine, 
promotes aldol reactions with complete diastereofacial selectivity (>99% d.e.)51 An 
example of application of this amino indanol derived auxiliary in the synthesis of the 
core unit of the HIV protease inhibitor Sequinavir® 2.40 is reported in Scheme 2.19.52
i) Bu2BOTf, 'PrNEt 
Ph BnOCH2CHO
OH
'BuCOCI, THF O' .OBn











Scheme 2.19. Application of the c/s-1-amino indan-2-ol derived auxiliary
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The aminoindanol-derived oxazolidinone 2.41 (Scheme 2.20) has a gem-dimethyl 
group on one face of the alkene and afforded >99:1 selectivity in Diels-Alder 
reactions with both cyclic and acyclic dienes, using Et2AICI as Lewis acid.53
Scheme 2.20. Aminoindanol-derived oxazolidinone2.41 in Diels-Alder reactions
The enantiomerically pure oxazolidinone-derived vinylsulfonamide 2.43 (Scheme 
2.21) has also been employed in asymmetric Diels-Alder reaction with 
cyclopentadiene, again using Et2AICI as Lewis acid, but in this case increasing the 
temperature to up to -40 °C.54
o
0 A nV ^  ^ A IC ! 0 A nV A \  51% yield
\  /  \  /  >99% d.e. (endo)
W  DCM
Ph Me - 40 °C, 5 h Ph Me
2.43 2.44
Scheme 2.21. Oxazolidinone-derived vinylsulfonamide 2.43 in Diels-Alder reactions
C2-symmetric bis(oxazolidinone) 2.47, the first water-soluble chiral auxiliary,55 has 
been synthesized via intramolecular regioselective cyclisation of biscarbamate 2.45. 
The sodium enolate from A/,/V-di(phenylacetyl)bis(oxazolidinone) 2.48 reacts with 
methyl iodide with high facial selectivity (95:5) (Scheme 2.22).
41
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PhCH2C 0 2H Et3N, toluene
pivaloyl chloride 90%
Ph Ph







Scheme 2.22. Application of the water-soluble C^symmetric bis(oxazolidinone) 2.47
Oxazolidinone-type chiral auxiliaries have also been synthesized from carbohydrates. 
Chiral A/-acylated 2-oxazolidinones readily available from D-xylose have been 
demonstrated to undergo highly diastereoselective acylation reactions.56 The glyco-2- 
oxazolidinones 2.50, illustrated in Scheme 2.23, can also be used in 
diastereoselective halogenation reactions via their boron-enolate to get a- 
halogenated products.
Other glyco-2-oxazolidinones based on D-glucose 2.53 have been used in 
dialkylboron-mediated aldol reactions (Scheme 2.24).57
- 78 °C 
ii) R'COX





Scheme 2.23. Applications of D-xylose derived 2-oxazolidinones
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RiO
T l  OR.
RiO
RiO—: i) nBu2BOTf, 'Pr2NEt R1 °  
- 78 °C
ii) R2CHO
Z  \ OR.
2.53 2.54
Scheme 2.24. D-glucose derived 2-oxazolidinones mediated aldol reactions
Enantiomerically pure [4+2]cycloadduct-based-2-oxazolidinones 2.57 and 2.58 
(Scheme 2.25) were used as excellent chiral auxiliaries in the Evans’ asymmetric 
strategy, providing very high diastereoselectivity in alkylations and Diels-Alder 
reactions, when compared with traditional Evans’ auxiliaries.58'59 An example59 of 
cycloaddition reaction is reported in Scheme 2.25.
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HXN* T (°C) Yield (%) exo.endo endo(S)-2.56:(/?)-2.56
Scheme 2.25. [4+2]Cycloadduct-based-2-oxazolidinones as 
Excellent chiral auxiliaries
2.4 Other uses of enantiomerically pure 2-oxazolidinones
The above paragraphs described the use of chiral 2-oxazolidinones in different 
efficient and elegant asymmetric syntheses. In conclusion, it should be mentioned 
that in the last few years enantiomerically pure 2-oxazolidinones have also received 
wide attention for their high biological activity. Some significant examples of drugs, 
which incorporate the oxazolidinone ring in their active structures, are displayed in 
Scheme 2.26.
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cytotaxone 2.60 pilocarpine analogue 2.61
c
HN-
AR-R17779 2.62 linezolid 2.63
Scheme 2.26. Synthetic biologically active 2-oxazolidinones
An example is cytotaxone 2.60, an alkaloid isolated from Streptomyces sp. This 
oxazolidinone is an immunomodular that inhibits intercellular communication between 
macrophages.60 An oxazolidinone analogue of the muscarinic agonist pilocarpine 
(compound 2.61) is equipotent to pilocarpine andused for the treatment of glaucoma. 
This means that the oxazolidinone analogue has the flexibility to adopt the necessary 
receptor-active configuration.61
Another series of oxazolidinones receiving a lot of interest are the 
spirooxazolidinones. AR-R17779 2.62 has been found to be a strong antagonist of 
the rat a7 nicotinic receptor. Such antagonists have been used in the treatment of 
neurodegenerative diseases such as Alzheimer’s disease.62 
The oxazolidinones are also a new chemical class of synthetic antimicrobial agents 
with a unique mechanism of inhibiting bacterial protein synthesis. Their activity 
against multi-drug resistant gram-positive pathogenic bacteria has been used to 
develop a new class of potent antibiotics. Linezolid 2.6363,64 is shown in Scheme 
2.26.
45
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3. Preparation of 2-Oxazolidinones by Enzymatic 
Desymmetrisation
3.1 Introduction
Desymmetrisation of meso-configured or prochiral substrates to obtain 
enantiomerically enriched products is a powerful synthetic tool. The advantage of 
desymmetrisation over conventional kinetic resolution reactions being the potential 
ability to achieve high enantiomeric excess even at 100% conversion.1 
In general, the desymmetrisation of two enantiotopic functional groups can be 
achieved using a chiral reagent or catalyst.
The ready availability of meso-diols by the c/s-dihydroxylation of suitable alkenes and 
their utility for the preparation of chiral building blocks make them popular substrates 
for enantioselective desymmetrisation studies.2'5 Desymmetrisation of achiral diols 
using enzymes is a well known process for the formation of enantiomerically enriched 
mono-esters.6'9
This chapter focuses upon the enzymatic desymmetrisation strategy, which has been 
successful in the preparation of enantiomerically enriched oxazolidinones.
Our overall desymmetrisation strategy involved the use of A/-Boc-protected serinol
3.1 to give a mono-acetate 3.2, followed by appropriate chemical transformation to 





Achiral diol Enantiomerically enriched oxazolidinone
Scheme 3.1. General approach to preparation of oxazolidinones by 
enzymatic desymmetrisation
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3.2 Background. Enzymatic desymmetrisation of diols
The mono-functionalisation of diols is an important challenge in organic synthesis.1 
Whilst sterically or electronically different hydroxyls may be selectively modified, 
chemical methods for the mono-functionalisation of similar hydroxyls groups are not 
so many. The problem is that both hydroxyls groups react at a similar, if not the 
same, rate and thus even with one equivalent of reagent, a statistical mixture of 
starting diol and mono-/bis functionalised products are formed (Scheme 3.2).
OH OH OH OAc OAc OAc
Scheme 3.2. Desymmetrisation of diols
Enzyme-catalysed acetylation of diols in organic solvent has rapidly become one of 
the best methods to achieve desymmetrysation of meso-diols.
Porcine pancreas lipase (PPL) represents the cheapest commercially available 
lipase. Although it is a complex mixture of different hydrolases and is mainly used in 
the hydrolysis of esters, many successful applications of this crude preparation for 
the desymmetrisation of prochiral diols by selective mono-acetylation in organic 
solvent have been achieved. Other lipases of microbial origin, like those from 
Pseudomonas sp. and Candida sp. strains have shown synthetic utility in the 
acylation of diols in organic solvent.10
Lipase-catalysed acetylation is a widely applied method for the desymmetrisation of 
2-substituted-1,3- diols. For example, Guanti and co-workers11 reported the 
desymmetrisation of a series of 2-substitued-1,3-propanediols and of a cis- 
cyclohexene diol through monoacetylation with crude PPL supported on celite. Vinyl 
acetate acted as both the solvent and acylating agent (Scheme 3.3).
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0H nn, /OAc
PPL on celite f  96% e.e., R = Ph,
OH ^OH 970/0 e e ’ R = (CH3)2CH=CH-
3.4 3.5
OH PPL on celite n ir OH
94% e.e.
0H ^ O A c  ' ^ V ' 0AC 
3.6 3 .7
Scheme 3.3. Enzymatic desymmetrisation of propanediols 3.4 
and cis-cyclohexene diol 3.6
Meso-1,3-diols disubstituted with an alkoxymethyl or a thiophenyl group in the 2 
position have been converted into the corresponding monoacetate through an 
enzyme-catalysed acylation with Pseudomonas fluorescens lipase (Scheme 3.4).12
< y — OH p p l X y — OAc a: X=OMe, R=H
X  ---------------------- X  b: X=OfBu, r =h
1 OH ^ OAc ft' OH c: X=SPh, R=H
3.8a-c 2 - 2 4  h 3.9a-c
79-91 %e.e.
Scheme 3.4. Enzymatic desymmetrisation of 2-disubstituted-1,3-diols
Phosphorylated tyrosine analogues can be obtained by Pseudomonas sp. catalysed 
desymmetrisation of 2-benzyl-1,3-propanediols 3.10 possessing different 
functionalities at the para- or mefa-position (Scheme 3.5).13









a: Z=CH2, para-substitued 
b: Z=CF2, para-substitued 
c: Z=CH2, mefa-substitued
Scheme 3.5.Preparation of tyrosine analogues by desymmetrisation of
2-benzyl-1,3-propanediols 3.10
51
Claudia Neri- University of Bath Preparation of 2-Oxazolidinones by Enzymatic Desymmetrisation
Chapter 3
Meso-cisA ,2-cycloalkanediols 3.12 were efficiently desymmetrised with 82-97% e.e. 
without racemisation by lipase from Candida rugosa (Scheme 3.6).14
J J > Q  "
Q t oh crl




Scheme 3.6. Desymmetrisation of meso-c/s-1,2-cycloalkanediols
Several other examples of application of lipases in the desymmetrisation of diols 
have been reported.15'19
Serinol derivatives have only received limited attention in desymmetrisation 
reactions. A literature search reveals few examples in which serinol has been used 
as starting material in desymmetrisation-based syntheses.
Enantiomerically pure 3-0-acetyl-2-/V-(benzyloxycarbonyl)serinol 3.15, an important 
building block for the preparation of biologically active molecules such as 
phospholipids, phospholipase A2 inhibitors and sphingoglycolipids20 can be 
prepared by PPL-catalysed desymmetrisation of 2-O-benzyl 2-N- 
(benzyloxycarbonyl)serinol 3.14 (Scheme 3.7).21
o
° J
J i  Bn pPI-.11h H N ^ S o '  60% conv.
O H O . J v s .Ov ?Bu 770/0 y*eld
A . . ,  T
HN O 
HOv. ✓OH
A ^O ^^B u n o
3.14 THF, 28 °C (fl)-3.15
Scheme 3.7. Desymmetrisation of 3-Oacetyl-2-A/-(benzyloxycarbonyl)serinol 3.14
A derivative of serinol possessing an enantiomerically pure a-methyl benzyl nitrogen 
protecting group, compound 3.16, has been used in a chemical/auxiliary based 
diastereoselective synthesis of oxazolidinones. Treatment with chloroformate 
afforded (4S)- and [4R)~3.M with up to 92% d.e. (62% yield) (Scheme 3.8).22
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i) dg-Py, Ph3CH 
CDCI3( rt, 24 h









Scheme 3.8. Asymmetric synthesis of serinol derivatives
One potential problem in the preparation of desymmetrised serinol derivatives is that 
of racemisation by exchange reactions. In one example, racemisation during 
oxazolidinone formation of a mono-silyl ether of /V-Boc-serinol has been reported and 
a 1,3-silyl shift was suggested in this case as a likely cause of racemisation (Scheme 
3.Q).23
o
NHBoc i) NaH, THF X .




Scheme 3.9. Oxazolidinone formation of a mono-silyl ether of A/-Boc-serinol
We decided to focus our attention upon the enzymatic desymmetrisation of serinol as 
potential precursor of enantiomerically enriched oxazolidinones.
3.3 Desymmetrisation of M-Boc-serinol
Desymmetrisation of serinol (1,3-dihydroxy-2-aminopropane) required previous 
protection of the amino group to avoid /V-acylation.24,25 Boc-protection of achiral 
serinol 3.20 was achieved in 90% yield by treatment of serinol with Boc anhydride 
(Scheme 3.10).26
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NH2 (Boc)20  NHBoc
90% yield
H O . ^  .O H  B 0H  rti1h  H O . ^  .O H
3.20 3.1
Scheme 3.10. Boc-protection of achiral serinol 3.20
The desymmetrisation of /V-Boc-serinol was achieved by the selective mono- 
acetylation using PPL (porcine pancreas lipase) and vinyl acetate as the acylating 
agent, in organic solvent (Scheme 3.11). A small amount of di-acetylated material 
was also observed, providing a self-correcting process for the removal of the 
unwanted enantiomer of mono-acetylated product.27
NHBoc
3.1




HO\ ^ \ / OAc + ' Ac° -  .OAc
(/?)-3.2 3.21 (traces)
Scheme 3.11. Desymmetrisation of A/-Boc-serinol by PPL
Only one enantiomer of the mono-acetylated product was detected by chiral HPLC. 
The effects of solvent and temperature variations on the conversion and selectivity of 
the acylation reaction were investigated.
We first examined the effect of solvent on the acylation of protected serinol 3.1 at 30 
°C (Table 3.1).
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Table 3.1. Influence of solvent on conversion, e.e. and mono/di-acetylated 
product ratioa,b for reaction illustrated in Scheme 3.11
Entry Solvent Conversion e.e. Mono/
(%) (%) di-acetylatedc
1 THF/n-hexane 1:1 96 >99 87
2 'Pr20 42 >99 >99
3 Vinyl acetate >99 >99 >99
4 Cyclohexane 28 >99 >99
5 Toluene 29 >99 >99
6 Acetone 72 >99 98
7 Acetonitrile 28 >99 >99
a 140 mgenzyme/mmolsubstrate in 5 mL solvent using 1 mmol of /V-Boc-serinol and 3 mmol vinyl acetate. 
b Conversion, enantiomeric excess and mono/di-acetylated ratio were determined by HPLC analysis.28 
0 Mono/di-acetylated ratio = = [(fl)-3.2/3.21] x 100.
As can be seen (entries 1 and 3), striking differences in reactivity were found, vinyl 
acetate and a mixture of THF/n-hexane being the best reaction solvents. The 
increase in conversion was particularly evident when compared to solvents such as 
cyclohexane, toluene and acetonitrile (entries 4, 5, 7).
The reaction in vinyl acetate was examined at different reaction temperatures. In 
Table 3.2 the relative results after 2 h are displayed.
Table 3.2. Influence of temperature on conversion, e.e. and mono/di-acetylated 
product ratio3, b for reaction illustrated in Scheme 3.11
Entry Temperature Conversion e.e. Mono/
(°C) (%) (%) di-acetylatedc
1 30 >99 >99 >99
2 40 >99 >99 85
3 50 >99 >99 84
a140 mgenzyme/mmolsubstrate in 5 mL vinyl acetate using 1 mmol of /V-Boc-serinol. 
b Conversion, enantiomeric excess and mono/di-acetylated ratio were determined by HPLC analysis.28 
c Mono/di-acetylated ratio = = [{R)~3.2/3.21] x 100.
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Increasing the temperature (entries 2 and 3) had a noticeable effect upon the di- 
acetylated product, which appears after only 2 h.
Although PPL is widely used for the resolution of prochiral diols,29 we also examined 
other enzymes in our desymmetrisation strategy. Lipase from Candida antarctica 
type B (CAL B), lipase from Candida cylindracea (CCL), lipase from Pseudomonas 
cepacia (PCL) and from Pseudomonas fiuorescens (PFL) immobilized on Sol-Gel- 
AK, lipase from Aspergillus niger (ANL) were tested for their activity and selectivity in 
the acylation reaction illustrated in Scheme 3.11. Again vinyl acetate was used as 
both the acylating agent and solvent at 30 °C (Table 3.3).
Table 3.3. Influence of catalyst on conversion, e.e. and mono/di-acetylated product 
ratio3 of reaction illustrated in Scheme 3.11
Entry Lipase Conversion e.e. Mono/
(%) (%) di-acetylatedc
1 PPL >99 >99 >99
2 CAL Bb >99 1 <1
3 CCL 49 >99 94
4 PCL 96 >99 91
5 ANL 16 >99 >99
6 PFL 96 >99 92
3 For reaction conditions see Table 3.1.
b Reaction with CAL B was performed in both vinyl acetate and THF/n-hexane solution. 
c Mono/di-acetylated ratio = [(R)-3.2/3.21] x 100.
The conversion after 2 h was greater than 96% when PPL, CAL B, PCL and PFL 
(entries 1 ,2 ,4 , 6) were used as catalysts. The best selectivity was observed with 
PPL.
No selectivity was observed with CAL B. The di-acetylated product only was formed 
in reactions in both vinyl acetate and THF/n-hexane media (Table 3.3, entry 2).
In summary, the maximum conversion (>99%, after 2 hours) and selectivity (>99% 
e.e. and >99% mono/diacetylated product) were obtained when the reaction was 
performed in vinyl acetate at 30 °C, using porcine pancreas lipase as catalyst. The 
isolated yield of product after chromatographic purification was 69%.
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3.4 Synthesis of enantiomerically enriched oxazolidinones
The next step in our study was to establish the cyclisation of acetate 3.2 to obtain 
enantiomerically enriched oxazolidinone 3.3, as illustrated in Scheme 3.12.
ov
) - N H
0N^ j L ^ xOAe 
enantiomerically enriched 3.3
Scheme 3.12. Cyclisation of acetate 3.2
3.4.1 Synthesis of racemic 4-acetoxymethyl-2-oxazolidinone and kinetic 
resolution by enzymatic hydrolysis
i 0
> uO NH 
H<X JDAc
(fl)- 3.2
The intramolecular reaction was first attempted under basic conditions. Treatment of 
enantiomerically enriched acetate 3.2 with potassium carbonate at 130 °C under 
vacuum30 afforded the racemic oxazolidinone 3.3(Scheme 3.13).






Scheme 3.13. Synthesis of racemic 4-acetoxymethyl-2-oxazolidinone 3.3
Unfortunately, this product was obtained as a racemic mixture. We assume that 
intramolecular acetyl transfer occurs prior to the cyclisation, thereby affording the 
racemic product.
Nevertheless, kinetic resolution of rac-3.3 was achieved by enzymatic hydrolysis in 
phosphate buffer (Scheme 3.14).
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lipase
H20  phosphate buffer (0.1 M) 9 \
________________________/ “'"NH +
OAc 30 °C, 8 h ° \ ^ ^ s ^ ' 0H  ° \ ^ \ / 0Ac
(/?)-3.22 (S)-3.3
Scheme 3.14. Lipase-catalysed kinetic resolution of rac-3.3
Porcine pancreas lipase, lipase from Pseudomonas cepacia and from Candida 
antarctica type B were examined for their activity and selectivity towards the reaction 
studied.
The reactions were stopped after 8 hours by removal of the enzymes by filtration. 
The yields of the reactions catalysed by the different lipases were determined after 
chromatographic purification of the products. The optical purity of hydroxymethyl 
oxazolidinone (R)-3.4 was determined comparing the specific rotation of the obtained 
alcohol with that reported in literature for the corresponding enantiopure form.31,32 
The results are illustrated in Table 3.4.
Table 3.4. Kinetic resolution of rao3.3 with different lipases3
Entry Lipase Yield (%) Optical purity (%)D
1 CALB 33 93
2 PCL 36 90
4 PPL 42 84
8 140 mgenzyme/mmolsubstrate in 1.5 mL phoshate buffer solution (0.1 M, pH 7) using 0.6 mmol of racemic 
4-acetoxymethyl-2-oxazolidinone 3.3.
b optical purity (%) = {[a]°3o of obtained (/?)-4} /  { [a ]D 30 of enantiopure (R)-4} x 100.
The (/^-enantiomer of oxazolidinone 3.3 reacted faster than the (S)-enantiomer. 
After 8 hours, optical purities greater than 84% were detected.
3.4.2 Synthesis of enantiomerically enriched (S)-4-acetoxymethyl-2- 
oxazolidinone
We decided to try another approach to the cyclisation reaction reported in Scheme 
3.13 and to avoid basic conditions.
rac-3.3
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Enantiomerically enriched (S)-oxazolidinone 3.3 was obtained in a one-step reaction 
by cyclisation with thionyl chloride (Scheme 3.15).33,34
>k
9  SOCI2, THF O
5 h, reflux y — NH 72% yield




Scheme 3.15. Synthesis of (S)-4-acetoxymethyl-2-oxazolidinone 3.3
The reaction proceeded with >98% enantiomeric excess and 72% yield.
The absolute stereochemistry of oxazolidinone (S)-3.3 was confirmed by enzymatic 
hydrolysis of the acetate group (Scheme 3.16) and comparison of the specific 
rotation of hydroxy oxazolidinone 3.22 with literature data.31,32
o
y — n H 77% yield
° \ X / ° h > 9 9 % a e '
(Si-3.3 (S)-3.22
CALB
H20  phosphate buffer (0.1 M)
^ — NH
On^ J ^ ^ O A c 30 °C, 24 h
Scheme 3.16. Hydrolysis of 4-acetoxymethyl-2-oxazolidinone
The synthetic utility of 4-hydroxymethyl-2-oxazolidonone 3.22 has previously been 
demonstrated in its straightforward conversion into 4-benzyl and 4-ethyl derivatives.31 
We can note that Candida antarctica lipase type B preferred the (/^-enantiomer 
when it had a choice of the two enantiomers (Scheme 3.14). However, the same 
enzyme hydrolysed the (S)-enantiomer, in the absence of the other enantiomer 
(Scheme 3.16).
3.4.3 Synthesis of enantiomerically enriched (/?)-4-benzyloxymethyl-2- 
oxazolidinone
The acetoxy group of oxazolidinone 3.3 and the hydroxy group of oxazolidinone 3.22 
represent a limitation to the use of these enantiomerically enriched oxazolidinones in 
chiral auxiliary-based chemistry, where strong basic conditions are often required.
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Though they can be easily converted into their 4-alkyl substituted forms,31 we 
envisaged that protection of the oxygen would be an advantage.
In an alternative approach, the enantiomerically enriched mono-acetate 3.2 was 
benzylated using benzyl trichloroacetimidate, in the presence of a catalytic amount of 
triflic acid,35'37 to afford the A/-benzyloxycarbonyl-0-benzyl acylated serinol 3.23 in 
reasonable yield. Traces of the analogue A/-Boc-Obenzyl acylated serinol 3.24 were 




10% mol TFMSA 
Cyclohexane/DCM 1:1 






Scheme 3.17. Protection of the hydroxylic group
Cyclisation with potassium carbonate30 then provided the (/?)-oxazolidinone 3.25 in > 
99% e.e. (Scheme 3.18).
BnO.
k2c o 3
20% mol. HzO 
150 °C, vacuum
BnO. q  63% yield >99% e.e.
3.23 (fl)-3.25
Scheme 3.18. Synthesis of enantiomerically enriched 
4-benzyloxymethyl-2-oxazolidinone
Protection of the hydroxylic group avoided any racemisation during the base- 
catalysed cyclisation reaction. Catalytic water was found to be essential for the 
activation of the acylated hydroxy group as nucleophile.
3.5 Conclusions
Different lipases have been shown to catalyse selectively the mono-acetylation of N- 
Boc-serinol with vinyl acetate in organic solvent. Aspects of the reaction such as 
effect of solvent, temperature and lipase origin were discussed and we can conclude
60
Claudia Neri- University of Bath Preparation of 2-Oxazolidinones by Enzymatic Desymmetrisation
Chapter 3
that the desymmetrisation of A/-Boc-protected serinol can be successfully achieved in 
good yield and high e.e. in 2 hours, by using the inexpensive crude commercial PPL 
in vinyl acetate at 30 °C.
The desymmetrisation of A/-Boc-serinol has been exploited in different ways to 
prepare enantiomerically enriched (4S)- and (4/^-substituted 2-oxazolidinones, as 
illustrated in Scheme 3.19.38
3.2







i) B n O ^ X C I3 
cat. TFMSA 
O-benzylation













Scheme 3.19. Preparation of 2-oxazolidinones by enzymatic desymmetrisation
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4. Enzymatic Kinetic Resolution of Racemic Evans’ Auxiliaries
4.1 Introduction
Since 1981, when Evans introduced the use of enantiomerically pure 2- 
oxazolidinones (Evans’ auxiliaries) to achieve asymmetric syntheses,1 the 
development of chiral auxiliaries and reagents has been a matter of utmost interest. 
Most chiral auxiliaries are derived from naturally occurring homochiral compounds 
and their derivatives,2 but limitations in their structural modifications and lack of 
accessibility to their configurational antipodes are sometimes an obstacle in 
improvement of the selectivity of asymmetric reactions. Therefore, the development 
of new enantiomerically pure compounds, which can be suitably designed for each 
asymmetric process, has recently received considerable attention and some 
successful examples have been reported.3'12
Nevertheless, chiral auxiliaries used in asymmetric transformations need to be 
enantiomerically pure. This makes them expensive and difficult to prepare. 
Especially considering the paradox that the main source of the most efficient chiral 
auxiliaries, 2-oxazolidinones, are chiral a-amino alcohols, and their asymmetric 
synthesis sometimes, in turn, is achieved using chiral auxiliaries.13'15 
This explains why the preparation of chiral auxiliaries by either resolution of the 
racemic precursor or by direct resolution of chemically designed racemic auxiliaries 
has received increasing attention.
4.2 Background
Resolution of suitably designed racemic a-amino alcohols is one of the main 
methods used to synthesise chiral Evans’ auxiliaries.
As an example, resolution of racemic c/s-2-amino-3,3-dimethyl-1-indanol 4.1 by 
selective crystallisation of the diastereoisomeric salts 4.2 with (S)-mandelic acid has 
been reported (Scheme 4.1).16
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35% yield (based on rao-4.1) >99% e.e.
1) 2 M NaOH aq.
2) Ac20 , Py
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Scheme 4.1. Resolution of a racemic indanol derivative
Solid phase parallel synthesis starting from Merrifield resins can be very useful for 






Scheme 4.2. Solid phase synthesis of enantiomerically enriched amino alcohols
However, in the last few years there have been seen several examples of the direct 
design of racemic auxiliaries and their enzymatic resolution.
2,2-Diphenylcyclopentanol 4.6, an efficient chiral auxiliary, and structurally related 
hindered secondary alcohols were resolved by enantioselective hydrolysis of their 
acetate esters with either pig liver or horse liver acetone powder (Scheme 4.3).18
vinyl acetate









Scheme 4.3. Enzymatic resolution of 2,2-diphenylcyclopentanol 4.6
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Enzymatic resolution of the chiral auxiliary 2-methoxy-2-phenylethanol 4.8 has also 





vinyl acetate  ►










Scheme 4.4. Enzymatic resolution of 2-methoxy-2-phenylethanol
Lipase-catalysed resolution of a “pantolactone type” racemic auxiliary 4.10 afforded 
resolved D- and L- pantolactone analogues (/?)-4.10 and (S)-4.11. (Scheme 4.5).20
3. OH 3 OH 3 OAc
y (  vinyl acetate y C
\  ^  \  + .N lipase Amano PS N NI • I I
Ph 'Pr20  Ph Ph
rac-4.10 (fl)-4.10 (S)-4.11
99% e.e. 88% e.e.
Scheme 4.5. Lipase-catalysed resolution of a pantolactone analogue
racemic auxiliary
Moreover, Williams and co-workers have reported recently that racemic pantolactone 
4.12 can be converted into either enantiomerically enriched pantolactone acetate or 


















Scheme 4.6. Lipase-catalysed resolution of pantolactone
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Enantiomerically enriched 2-oxazolidinones have also been prepared by resolution. 
Though chromatographic separation is widely used to resolve enantiomers,22 
chemical and enzymatic resolutions still remain the most used methods. Herein we 
wish to report some examples.
A reductive monodeacetylation, catalysed by oxazaborolidines derived from 
conformationally rigid chiral aminoalcohols is successfully applied to the kinetic 
resolution of racemic 1-acetyl-2-oxazolidinones (Scheme 4.7).23
4.15
aminoalcohol (5-10 mol%) 
BH3 SMe2 (0.65-0.7 eq)
THF, 0 °C -*- rt




Scheme 4.7. Kinetic resolution of oxazolidinones by reductive monodeacetylation
A regiodivergent kinetic resolution of racemic 5-vinyloxazolidinones 4.17 by allylic 
substitution with phthalimide and a palladium catalyst to afford optically enriched 



















Scheme 4.8. Regiodivergent kinetic resolution of racemic 5-vinyloxazolidinones
Enantiomerically pure 4- or 5- substituted 2-oxazolidinones were obtained by lipase- 
catalysed enantioselective hydrolysis of the 3-acyloxymethyl-2-oxazolidinones and 
transesterification of the 3-hydroxymethyl- 2-oxazolidinones with vinyl propionate in 
organic solvent (Scheme 4.9).25
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enantiomerically enriched oxazolidinones
Scheme 4.9.Lipase-catalysed resolution of 3-acyloxymethyl and 3-hydroxymethyl -2-
oxazolidinones
Hydrophobic (fl,S)-5-acyloxymethyl-3-alkyl-2-oxazolidinones were successfully 
hydrolysed stereoselectively with lipoprotein lipase Amano 3 (LPL) adsorbed on 












Rt= tert-butyl, isopropyl 
R2= CsHu , C7H15
>95% e.e. 
(flf>4.21
Scheme 4.10. Enzymatic selective hydrolysis
Asymmetric desymmetrisation of 2-[(af7)-a-methyl benzyl] amino-1, 3-propanediol 
4.22 with 2-chloroformate and DBU gave diastereomerically enriched (4S)-4- 
hydroxymethyl-N- [(aR)-a-methylbenzyl]-2-oxazolidinone (4SJ-4.23 (Scheme 4.11).27
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Scheme 4.11. Desymmetrisation of 2-[(afl)-a-methyl benzyl] amino-1, 3-propanediol
After these examples and the successful enzymatic resolution of racemic 
pantolactone, we envisaged that an enzymatic reaction could also be used to resolve 
racemic Evans’ auxiliary oxazolidinone. Under suitable conditions, we believed that 
the resolution of racemic Evans’ auxiliaries could be accomplished by either an 
enzyme-catalysed transamidation reaction or by hydrolysis of the amide derivative 
(Scheme 4.12).
o o o
transamidation LI 1 1 0
   -  -  O NH + O







Scheme 4.12. General approach to the enzymatic resolution of Evans’ auxiliaries
The same reaction would also be a simple alternative method to accomplish 
attachment/detachment of an achiral substrate to a chiral auxiliary.
4.3 The attempted enzymatic kinetic resolution of chiral Evans’ 
auxiliaries
The main priority was to employ an Evans’ auxiliary previously used in asymmetric 
synthesis and known to activate the substrate toward reaction. For this reason, the 
Evans’ auxiliary 4-benzyl-2-oxazolidinone28 was chosen as the racemic auxiliary for 
the transamidation reaction in organic media. In addition, the commercially available 
acylated form, 4-benzyl-3-propionyl-2-oxazolidinone was tested in the hydrolysis 
reaction (Scheme 4.13).
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The enzymes chosen had proved to be the most selective and active in 
transamidation and amide hydrolysis reactions.29'34 Lipases from Candida antarctica, 
Candida cylindracea, Pseudomonas fluorescens and from Mucor javanicus were 
tested in the kinetic resolution of the 4-benzyl-2-oxazolidinone. Lipases from Candida 
antarctica and from Candida cylindracea, protease from Aspergillus oryzae, 
Penicillum Amidase, proteinase from Bacillus subtilis and esterase from hog liver 
were tested in the kinetic resolution of the acylated 4-benzyl-2-oxazolidinone via the 
hydrolysis reaction.
Vinyl acetate, vinyl propionate and ethyl propionate were employed as acylating 
agents. Vinyl esters are often used as acyl donors, because the resulting vinyl 
alcohols are rapidly converted into the corresponding aldehydes, thus making the 
transesterification or transamidation irreversible.35"38
As the influence of the reaction medium on both catalytic activity and stereoselectivity 
in lipase catalysed kinetic resolutions is well documented in the literature,39"41 the 
same reaction was also performed in different organic solvents or aqueous buffers.
4.3.1 4-Benzyl-2-oxazolidinone enzymatic Al-acylation
The enzymatic resolution of (H/S)-(+/-)-4-benzyl-2-oxazolidinone via A/-acylation was 
studied in organic solution at a standard temperature of 40 °C (Scheme 4.14).
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O O o O
J-l acyl donor J-l I I  J I
O NH - O N R + O NH
lipase
'Ph organic solvent Ph Ph
40 °C
rac-4.24 4.25 R = Et 4.24
4.26 R = Me
O O
acyl donor: ^ QA R ^ A x '
R= Me, vinyl acetate (VA) t
R= Et, vinyl propionate (VP) ethy‘ P«P«nate (EP)
Scheme 4.14. Lipase-catalysed A -^acylation of rao4-benzyl-2-oxazolidinone
Four lipases (lipase from Candida antarctica type B, lipase from Pseudomonas 
fluorescens immobilised in Sol-Gel-AK, lipase from Mucor javanicus and lipase from 
Candida cylindracea) were tested for their activity and selectivity towards the 
acylation reaction.
Three different acylating agents were examined (vinyl acetate, vinyl propionate and 
ethyl propionate), and the substrate/acylating agent ratio was varied from 1:1 up to 
1:100.
The same reaction was also performed in reaction media with different 
hydrophobicity, functionality and structure. Diisopropyl ether, n-hexane, dioxane, 
toluene, vinyl acetate, vinyl propionate, diisopropyl ether/water, n-hexane/water and 
n-hexane/isopropanol were all investigated.
These results are comprehensively tabulated in Table 4.1.
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0.05 0.05 EP 1:1 'Pr20 CCL, 400 48 0
0.02 0.02 EP 1:1 'Pr20 CCL, 400 48 0
0.05 0.05 EP 1:1 'Pr20 CAL B, 400 48 0
0.01 0.01 EP 1:1 'Pr20 CAL B, 400 72 0
0.01 0.01 VP 1:1 'Pr20 CAL B, 400 72 0
0.25 0.05 EP 1:1 'Pr20 CCL, 80 48 0
0.25 0.05 EP 1:1 dioxane CCL, 400 66 0
0.25 0.05 VP 1:1 dioxane CCL, 400 66 0
0.25 0.05 VP 1:1 n- hexane CCL, 400 66 0
0.25 0.05 VA 1:100 dioxane CCL, 400 72 0
0.25 0.05 VP 1:100 dioxane CCL, 400 72 0
0.25 0.05 VP 1:100 n- hexane CCL, 160 66 0
0.1 0.05 EP 1:1 'Pr20/H20
98:2
CCL, 400 72 0
0.1 0.05 VP 1:1 n-hexane PFL, 700 72 0
0.1 0.05 EP 1:1 'Pr20 MJL, 450 72 0
0.2 0.05 VP - VP CCL, 500 96 0
0.2 0.1 EP 1:1 'Pr20 CAL B, 200 72 0
0.2 0.1 VP 1:10 n-hex7IPA
90:10
CAL B, 200 72 0
0.4 0.4 VP - VP CAL B, 38 48 0
0.3 0.3 VA - VA CAL B, 50 48 0
0.4 0.4 VP 1:4 toluene CAL B, 38 48 0
0.3 0.3 EP 1:4 toluene CAL B, 50 48 0
0.1 0.1 VP 1:3 /7-hexane 
(H20  sat.)
CAL B, 200 96 0
0.3 0.3 VA - VA CAL B, 3 24 0
0.3 0.3 VP - VP CAL B, 3 24 0
In all cases, after 2-4 days of reaction time no enzyme activity (the reactions were 
followed by chiral HPLC analysis) was observed.
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Rationalising these results, it was conceivable that the substrate chosen was too 
sterically demanding. Therefore, a more hindered example such as 4-isopropyl-2- 
oxazolidinone and less hindered examples such 4-methyl-2-oxazolidinone and 2- 
oxazolidinone were also investigated (Scheme 4.15).
II 0
A m h  A







Scheme 4.15. Less hindered racemic auxiliaries
4-lsopropyl-2-oxazolidinone rao-4.27, 4-methyl-2-oxazolidinone rao4.28 and 2- 
oxazolidinone 4.29 were examined in the A/-acylation reaction catalysed by Candida 
antarctica lipase B. These reactions were performed in vinyl acetate at 40 °C 
(Scheme 4.16).
U U (1 u
X  O^Ac X  A. A
O NH . O N ^  + O NH
\  /  CAL B \__ */ \  «/
R 40 °C R
rao4.27 R = 'Pr 4.30 R = 'Pr 4.27 R = 'Pr
rao-4.28 R = Me 4.31 R = Me 4.28 R = Me
4.29 R = H 4.32 R = H 4.29 R = H
Scheme 4.16. Lipase-catalysed /V-acylation of 
rao4-isopropyl/methyl-2-oxazolidinone
Every reaction was carried out at 0.3 M concentration in vinyl acetate solution and 
followed for 24 h. Different enzyme concentrations were tested (Table 4.2). Still no 
reaction was observed after 24 hours reaction time.
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4-isopropyl-2-oxazolidinone 0.3 VA, 1 ml 33 24 0
4-isopropyl-2-oxazo!idinone 0.3 VA, 1 ml 67 24 0
4-isopropyl-2-oxazolidinone 0.3 VA, 1 ml 100 24 0
4-methyl-2-oxazolidinone 0.3 VA, 1 ml 33 24 0
2-oxazolidinone 0.3 VA, 1 ml 167 24 0
4.3.2 3-Propionyl-4-benzyl-2-oxazolidinone enzymatic hydrolysis
The next stage of our investigation concerned the enzymatic resolution of racemic 4- 
benzyl-3-propionyl-2-oxazolidinone 4.25. Hydrolysis in an aqueous buffer, at 40 °C 
was performed as indicated in Scheme 4.17.
o o o o o
II II HzO buffer II II II
O     O NH +  O'
lipase \ _________________ \ __J
-Ph 40° C \ — ph \ — Ph
rac-4.25 4.24 4.25
Scheme 4.17. Lipase-catalysed hydrolysis of rao-4-benzyl-
3-propionyl-2-oxazolidinone
The lipase from Candida antarctica type B and the lipase from Candida cylindracea 
were tested for their activity and selectivity in two different aqueous buffers, both at 
pH 7.2 (Table 4.3).
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0.02 tris/HCI buffer, 2 ml CCL 72 0
5 mM, pH 7.2 1.5 g/mmolsub
0.02 hepes/HCI, 2 ml CALB 72 0
10mM, pH 7.2 1.5 g/mmolsub
0.02 tris/HCI buffer, 2 ml CCL 72 0
5 mM, pH 7.2 1.5 g/mmolsub
0.02 hepes/HCI, 2 ml CALB 72 0
10mM, pH 7.2 1.5 g/mmolsub
No enzymatic reaction was observed. After 72 h, the same extent of conversion, 
followed by HPLC analysis, was observed in absence (control) or presence of the 
catalyst.
In the absence of success with lipase enzymes, we then turned our attention to 
hydrolases. Protease from Aspergillus oryzae, proteinase from Bacillus subtilis, 
Penicillum amidase from Escherichia coli, esterase from hog liver (immobilised on 
Eupergit C) were investigated for their activity and selectivity in phosphate buffer 
(Table 4.4).
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Table 4.4. 3-Propionyl-4-benzyl-2-oxazolidinone hydrolysis 









0.3 phosphate buffer Protease from Aspergillus o. 48 0
0.01 M, pH 7,1 ml 150 mg/mmolsub
0.3 phosphate buffer Penicillum Amidase 48 0
0.01 M, pH 7, 1 ml 133 mg/mmolsub
0.3 phosphate buffer Proteinase from Bacillus s. 48 0
0.01 M, pH 7.5,1 ml 67 mg/mmolsub
0.3 phosphate buffer Proteinase from Bacillus s. 48 0
0.01 M, pH 7.5, 1 ml var. Biotech. A, 67 mg/mmolSUb
0.3 phosphate buffer Esterase from hog liver 48 0
0.01 M, pH 8, 1 ml imm. on Eupergit, 67 mg/mmolSUb
Despite these attempts, no reaction was observed after 48 h using different enzymes 
as catalysts.
4.4 Conclusions
We attempted the enzymatic kinetic resolution of different 4-substituted 2- 
oxazolidinones, by either A/-acylation of hydrolysis of the substrate. Though we 
tested a range of enzymes in different reaction conditions, no enzymatic reaction was 
observed.
From these results detailed here, it seemed to be evident that the screened enzymes 
were not active towards the desired reactions.
Lipases are known to have a very selective catalytic reaction site,42-44 and though the 
utility of lipases in /V-acylation reactions for the preparation of chiral amides from 
primary amines has been demonstrated demonstrated,45'55 the resolution of 
secondary amines/amides via enzyme-catalysed acylation/hydrolysis is a relative 
rare process.56'58 In this respect, the observed results are perhaps unsurprising.
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5. Racemic Auxiliaries: Applications to Asymmetric Synthesis
5.1 Introduction
For a selective catalyst to be generally useful, it must combine two opposing 
qualities. It must accept a broad range of substrates; yet also retain a high selectivity 
for each one. Lipases are among the few catalysts that fulfil both criteria1 and that is 
the reason why they are so widely used in stereoselective catalysis.
Nevertheless, lipase and enzyme reactivity in general can hardly be improved. Either 
they are active towards the studied reaction, with general high activity and 
stereoselectivity, or they are not active at all. That was actually what we experienced 
in our attempt of enzyme-catalysed kinetic resolution of racemic Evans’ auxiliaries 
(see previous chapter).
However, the proposal for the use of racemic auxiliaries to achieve asymmetric 
synthesis still seemed to be a valid idea.
We decided to attempt an unusual approach to asymmetric synthesis, using racemic 
aldol adduct from a diastereoselective aldol reaction and an enzymatic resolution. In 
order to achieve this goal, the auxiliary has to relay its stereochemistry to the 
substrate, which can then be resolved by the enzyme (Scheme 5.1).





Racemic Racemic Enantiomerically Enantiomerically enriched enriched product Evans auxiliary
Aux = auxiliary
Scheme 5.1. General approach to asymmetric synthesis with a racemic auxiliary
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We envisaged that through the application of this methodology we could eventually 
obtain enantiomerically enriched auxiliary and enantiomerically enriched product.
The main objective of the overall process was to find a good stereoselective aldol 
reaction, which could afford only two enantiomers, separable by an enzyme- 
catalysed resolution.
To understand the difficulty of achieving this goal, it has to be considered that eight 
possible stereoisomers can be obtained in the aldol reaction between a racemic 
acylated oxazolidinone and an aldehyde. This is illustrated in Scheme 5.2.
o  o  OH o  o  OH o  o  OH O O OH
A V »  A A A  A - . \  A M ,
\  /  D  \  /  Q  \  /  rj \____ /  QV n i v  rll v  “ 1
o o OH o o OH o o OH O O OH
AAA. AAA. A A A  A A A
K  I  M  T  K  *. M  *.
R R R R
Scheme 5.2. Possible isomers from an aldol reaction with racemic auxiliary
The actual number of isomers formed depends upon the stereoselectivity of the aldol 
reaction used.
5.2 Background. Asymmetric aldol reactions with Evans’ chiral 
auxiliaries
The literature on stereocontrolled aldol reactions using chiral auxiliaries was very 
useful to our investigation. Evans’ chiral auxiliaries provide good stereocontrol in 
aldol reactions. Much of the work on asymmetric aldol reactions has actually 
concentrated on the development of chiral auxiliaries, which control the 
diastereoselectivity and the enantioselectivity of the enolates.2 The stereochemistry 
of the enolate has an important bearing on the stereoselectivity of the subsequent 
aldol reactions, along with several other variables including the nature of the 
aldehyde, the metal, the solvent and the precise reaction conditions.
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Given all these variables it might be expected that "rules" could be elaborated for the 
prediction of the outcome of an aldol reaction. Fortunately, a great body of work 
already exists and from this it is often possible to make a reasonable prediction in 
most cases.
The stereochemical outcome of the aldol reaction can be discussed by using the 
chair-like Zimmerman-Traxler transition-state model.3 In this model, the aldehyde 
associates with the enolate-metal complex, and the aldol reaction proceeds via a six- 
membered transition state.
For many enolates it is found that the E-isomer gives an anti aldol product, and the Z- 
isomer a syn aldol product (Scheme 5.3).
(£)-Enolate











Bonding from the upper face of the enolate
R "equatorial" 
R' "equatorial" (2S,3R)-anti
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(2)-Enolate





















R '^ ^ ^ - A u x
(2R,3R)-syn
Scheme 5.3. Stereochemistry of a chiral auxiliary-based aldol reaction
Which of the two possible anti or syn aldol products is obtained will depend on which 
face of the enolate reacts preferentially, which in turn usually depends on the chiral 
auxiliary (Aux).
Chiral auxiliaries are likely to be sterically demanding and favour the formation of Z- 
enolates, and therefore it is not difficult to understand why syn selective asymmetric 
aldol reactions are much more common than those leading to anti aldol products. 
This means that among the four possible isomers from an aldol reaction with a chiral 
Evans’ auxiliary, the two syn “Evans” and “non-Evans” aldol adducts are likely to be 
preferentially formed. Sometimes the anti 1 is also formed; no formation of the other 
anti has ever been reported (Scheme 5.4).
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"ncxi-Evans' syn anti 1
R
"Evans" syn |_ anti 2
Scheme 5.4. Possible isomers from an aldol reaction with chiral auxiliary
Through these general “rules”, the attributes of the aldol reaction can be improved by 
the introduction of architecturally refined enolate metal centres. Herein a few 
examples essential to our study are reported (vide supra).
The most frequently used procedure utilises boron-enolates. The /V-propionyl- 
oxazolidinone 5.1 undergoes a highly stereoselective enolisation with di-n-butylboron 
triflate (Scheme 5.5).4 The observed diastereomer ratio “Evans” syn/other 
diastereomers is 99.4:0.6, in favour of the “Evans” syn aldol product 5.2.
n-Bi^BOTf, 1.1 eq 
'PrgNEt, 1.2 eq




Scheme 5.5. The aldol reaction via B-enolate
When the same Evans’ reagent is reacted with isobutyraldehyde under Lewis acid 
catalysis, the major product is either the “non-Evans” syn aldol 5.2 or anti 1 aldol 5.2, 
depending on the Lewis acid used (Scheme 5.6).5




















17% with TiCI4 
95% with SnCI4
Scheme 5.6. The aldol reaction via B-enolate under Lewis-acid catalysis
The Li-enolate of /V-propyl-oxazolidinone 5.3 undergoes a moderately stereoselective 









p h -  1 '  1 '
Ph
(S)-5.3
Scheme 5.7. The aldol reaction via Li-enolate
The tetrachlorotitanium-enolate of 3-propionyl-4-benzyl-2-oxazolidinone 5.5 gave the 
same diastereoselection reported for the analogous boron-mediated processes, 
when reacted with isobutyraldehyde in the presence of tetramethylethylenediamine 
(Scheme 5.8).7
1 , 1 ^
Q N v  ----------------► 98%
'PrCHO 





Scheme 5.8. The aldol reaction via TiCI4-enolate
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Whereas ('PrO)3TiCI-mediated aldol reactions give a reversal of diastereofacial 
selectivity, being the “non-Evans” syn aldol 5.2 the major product (Scheme 5.9).8




Et20 , -78 °C
OH
“non-Evans" syn-5.2(S)-5.1
Scheme 5.9. The aldol reaction via Ti -enolate from ('PrCHO)3TiCI
The stereochemical outcome of the aldol reactions using different metal-enolates can 
be rationalised by considering the chair-like transition-state model. Thus, boron- 
enolate derivatives produce “Evans” syn aldols via intermediate A, and lithium- or 
titanium-enolates are thought to use an additional co-ordination site, to give “non- 








"Evans" syn "non-Evans" syn "non-Evans" syn "Evans* syn
favored disfavored favored disfavored
Scheme 5.10. Stereochemical outcome of B- and Ti-enolate mediated aldol reaction
Use of a titanium enolate would enable chelation control, while at the same time the 
presence of ligands on the Ti would enhance the selectivity.9'10 Boron has given high 
levels of stereocontrol in aldol reactions, where the presence of added ligands is 
believed to be the controlling factor. However boron is incapable of chelation 
because it cannot complex with additional groups beyond the aldehyde component of 
the aldol reaction.11'12
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Besides the metal-enolate, the choice of the aldehyde is also crucial. Stereocontrol in 
the aldol reaction with chiral auxiliaries strongly depends upon the aldehyde 
structure.4,5,8,13 Aldehydes such as benzaldehyde and isobutyraldehyde usually 
provide good diastereocontrol, while aldehydes with small substituents (Me, Et) 
usually do not.
The following paragraphs describe our studies towards the aldol reaction with a 
racemic auxiliary. Though the exhaustive literature about stereocontrolled aldol 
reactions with chiral auxiliaries, no example is reported to date about the use of a 
racemic auxiliary.
Remember that starting from a racemic 2-oxazolidinone, we wished to obtain only 
two enantiomeric aldol adducts. If a stereoselective aldol reaction with a chiral 
auxiliary can afford four possible isomers, the matter is even more complicated when 
a racemic auxiliary is used and so eight possible isomers can be obtained.
With this main issue to solve, we focused our attention upon the search of the ideal 
stereoselective reaction. Therefore, we tested different enolates and base systems 
for this reaction. Whilst, looking for a compromise between a good diastereocontrol in 
the aldol reaction and a suitable substrate for the enzymatic resolution (Scheme
5.1 ),14'16 we also considered the possibility of a less hindered aldehyde such as 
acetaldehyde.
5.3 Approaching the synthesis of the racemic aldol adduct
5.3.1 Synthesis of aldol adducts via Li-enolate and their enzymatic resolution
In the initial screening of reaction diastereoselectivity we decided to use a Li-enolate. 
The chosen oxazolidinone was the synthetically useful racemic 4-benzyl-2- 
oxazolidinone auxiliary.17
The reaction studied was the aldol reaction of racemic 3-propionyl-4-benzyl-2- 
oxazolidinone 5.5 with benzaldehyde using LDA as base, at -78 °C in tetrahydrofuran 
solution (Scheme 5.11).18
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Scheme 5.11. The synthesis of aldol adducts via Li-enolate
Though a reasonable yield was obtained, the reaction stereoselectivity was very 
poor, giving different and uncharacterised diastereomers and enantiomers, according 
to TLC, HPLC and NMR analysis.
To examine the enzymatic activity towards any obtained aldol product, the crude 
aldol adducts 5.7 were stirred with CAL B under standard conditions,19 using vinyl 
acetate as acylating agent in either n-hexane or in vinyl acetate (Scheme 5.12).
Scheme 5.12. The enzymatic resolution of Li-enolate aldol adducts
After 3 days, no reaction or kinetic resolution of the aldol adducts from benzaldehyde 
was detected by chromatographic and spectroscopic analyses.
The inadequacy of the Li-mediated aldol reaction was obvious. Because of the poor 
diastereoselectivity, we began to think about a more diastereoselective reaction to 
use, changing the metal of the enolate complex.
Since no enzymatic reaction was detected, we also considered the idea of a less 
hindered aldehyde substrate.
5.3.2 Synthesis of aldol adducts WaTiCl/Pr^NEt-enolate
As a consequence of the poor diastereoselectivity of the Li-enolate mediated aldol 
reaction, our second attempt focused upon titanium enolates. Given the high
no reaction
Bn organic solvent 
40 °C, 72 h
5.7
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diastereomeric excess obtained in aldol reactions with TiCI47 and CITi(0'Pr)38t we 
decided to investigate the use of Ti-enolates, particularly a tetrachlorotitanium- 
enolate generated by diisopropylethylamine.
Instead of using the racemic auxiliary directly, as we had done in the case of the Li- 
enolate mediated aldol reaction, we simplified the matter. The stereochemical 
outcome of the aldol reaction was determined by reacting (fl)-3-propionyl-4-benzyl-2- 
oxazolidinone (fl)-5.5 and (S)-3-propionyl-4-benzyl-2-oxazolidinone (S)-5.5 
separately. Considering the effect of lipase specificity towards the steric bulk of the 
substituents,14'16 acetaldehyde was selected instead of benzaldehyde.
First, we examined the aldol reaction between oxazolidinone (fl)- 5.5 and 
acetaldehyde in the presence of titaniumtetrachloride and diisopropylethylamine 
(Scheme 5.13).
Q o
\ -----£  MeCHO










1:1 product ratio 
50% total yield
Scheme 5.13. The synthesis of the (4fl)-aldol adducts via TiCL/'P^NEt-enolate
Of the four possible isomers that could be obtained, we got only the “non-Evans” syn 
and the anti 1 aldol adducts, in a 1:1 ratio.
The “non-Evans” syn and the anti relative configurations for aldol adducts 5.8 were 
established from the observed 1H NMR coupling constants for the vicinal protons at 
the newly created stereogenic centres,8,20,21 by comparison with analogous 
compounds synthesised by us in subsequent studies and by enzymatic resolution of 
the diastereomeric product (see below).
Given that the reaction with the (R)- enantiomer proceeded diastereoselectively, we 
wanted then to ensure that the same diastereoselectivity could be observed when the 
other enantiomer was used. Oxazolidinone (S)-5.5 was reacted in the same reaction 
conditions, as shown in Scheme 5.14.
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1:1 product ratio 
54% total yield
Scheme 5.14. The synthesis of the (4S)-aldol adducts waTiCI/P^NEt-enolate
Again, only the “non-Evans” syn and the anti 1 aldol adducts were formed in 1:1 ratio.
In summary, each enantiomer of the acylated oxazolidinone 5.5 gave as the major 
products two of the four possible diastereomers of aldol adduct 5.8, according to 
chiral HPLC and NMR analysis. The given yield is the total yield of the aldol mixture, 
calculated after chromatographic purification.
5.3.3 Enzymatic kinetic resolution of the diastereomeric aldol adducts from 
TiCiyP^NEt-enolate mediated aldol reaction
Each pair of aldol adducts was tested in the enzymatic resolution. Lipase from 
Candida antarctica type B was again used as catalyst for its general high activity, 
selectivity and versatility in transesterification reactions in organic solvent.22'25
5.3.3.1 Enzymatic resolution of aldols (4/?,2’S,3’/J)- and (4/7,2’S,3’S)-5.8
The enzymatic resolution of aldols (4/7,2’S,3’R)- and (4/?,2’S,3’S)-5.8 from 
oxazolidinone (fl)-5.5 was carried out using vinyl acetate in different organic 
solvents at 40 °C, catalysed by lipase from Candida antarctica type B (Scheme 5.15).
90
Claudia Neri -  University of Bath______ Racemic Auxiliaries: Applications to Asymmetric Synthesis
Chapter 5
O O OH O O OH < ^ O A c  O O OAc O O OH
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*Bn 'Bn 40 °C "Bn 'Bn
(4/?,2'S,3'fl)-5.8 (4/?,2'S,3,S)-5.8 (4/7,2'S,3,R)-5.9 (4fl,2,S,3'S)-5.8
“non-Evans" syn anti 1
Scheme 5.15. The enzymatic resolution of aldol adducts
The enzymatic resolution was successful. The (3’R) diastereomer reacted faster than 
the (3’S) one.
The progress and the diastereomeric excess of the reaction were monitored by chiral 
HPLC analysis after removal of the enzyme by filtration.
In Table 5.1, the transesterification rate and diastereoselectivity of the enzymatic 
reaction in vinyl acetate are illustrated.
Table 5.1. Time course and diastereoselectivity of the enzymatic reaction in vinyl 
acetate8 illustrated in Scheme 5.15
t(h) %conv. %d.e.p %d.e.8c D
0 0 - 0 -
1 0 - 0 -
4 6 >99 6 >210
24 34 >99 51 >330
48 43 >99 75 >440
8 50 mgenzyme/mmolsubstrate in 5 mL vinyl acetate using 1 mmol of diastereomeric aldo.l 
b diastereomeric excess of the product. 
c diastereomeric excess of the remaining substrate.
d D = ln[(1-c(1+d.e.p)]/!n[(1-c(1-d.e.p)] = ln[(1-c)(1-d.e.s)]/ ln[(1-c)(1+d.e.s)]; c= conversion.26,27
The extent of conversion of the diastereomeric starting material and the optical purity 
expressed as the diastereomeric excess was calculated according to the equation 
previously described in literature.26,27 The diastereomeric ratio D was calculated from 
the extent of conversion and the d.e. of the product according to the equation 
generally used to calculate E (enantiomeric ratio).27
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Table 5.1 shows that the conversion increased up to 43% after 48 h when vinyl 
acetate was used as both solvent and acylating agent. Only one diastereomer was 
acylated during the course of the reaction; this explains why a diastereomeric excess 
>99% for the product was always observed. On the other hand, the diastereomeric 
excess of the substrate increased with time from 0 up to 75%: the percentage of the 
slower reacting aldol adduct increased as the other one was acylated to the 
corresponding acyl ester 5.9.
The relationship between the conversion and the diastereomeric excess of the 
product (or the remaining substrate) is expressed by D, the diastereomeric ratio. D 
gives a value of the discrimination of two competing diastereomers by the enzyme. 
26,27 In our case, the diastereoselectivity of the reaction, expressed as D, increased 
with reaction time: the enzyme preferred the (3’R) diastereomer as substrate, even 
when its percentage in the diastereomeric substrate [(3’f?) + (3’S)] decreased.
The same experiment was repeated in solvents with different hydrophobicity, as 
illustrated in Table 5.2.
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Table 5.2. Time course and diastereoselectivity of the enzymatic reaction illustrated 
in Scheme 5.15 in different solvents3
DCM n-Hexane
t(h) %conv. %d.e.pD %d.e.8c Dd t(h) %conv. %d.e.p %d.e.s D
0 0 - 0 - 0 0 - 0 -
1 0 - 0 - 3 30 >99 42 >300
4 2 >99 2 >200 6 46 >99 84 >530
24 6 >99 6 >210 24 50 >99 >99 >1050
48 12 >99 13 >220 48 56 88 >99 -
Toluene Diisopropyl ether
t(h) %conv. %d.e.p %d.e.s D t(h) %conv. %d.e.p %d.e.s D
0 0 - 0 - 0 0 - 0 -
1 0 - 0 - 1 0 - 0 -
4 12 >99 13 >220 4 16 >99 19 >230
24 42 >99 71 >420 24 45 >99 81 >500
48 45 >99 81 >500 48 45 >99 81 >500
3 50 mgenzyme/mmolsubstrate in 5 mL solvent using 1 mmol of diastereomeric aldol and 2 mmol vinyl 
acetate.
b diastereomeric excess of the product. 
c diastereomeric excess of the remaining substrate.
d D = ln[(1-c(1+d.e.p)]/ln[(1-c(1-d.e.p)] = ln[(1-c)(1-d.e.s)]/ ln[(1-c)(1+d.e.s)]; c= conversion.26,27
The kinetics of the reactions in different solvents was reported in graphs.
Fig. 5.1 displays the conversion (%) versus the reaction time.
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Fig. 5.1. Rate of transesterification in different solvents: ♦ n-hexane, • toluene,
♦ isopropyl ether, ■ vinyl acetate, * DCM
The reaction rate of the lipase-catalysed transesterification was faster in non-polar 
solvents such as n-hexane and toluene, and slower in polar solvents such as DCM.28'
30
The d.e.p values reported in Table 5.2 show that after 48 hours, only one of the two 
diastereomers was converted into the corresponding ester (4/?,2’S,3’fl)-5.9 in vinyl 
acetate, DCM, isopropyl ether and toluene (d.e. >99%). The other ester (4/?,2’S,3’S)- 
5.9 appeared only in n-hexane after 24 hours and the diastereomeric excess of the 
product decreased as the reaction progressed.
In Fig. 5.2, the diastereomeric excess of the substrate in the different solvents is 





0 10 20 30 40 50
Time (h)
Fig. 5.2. Time course of the d.e. of the substrate in different solvents: ♦ n-hexane, 
• toluene, + isopropyl ether, ■ vinyl acetate, * DCM
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The increase in diastereomeric excess of the substrate (Fig. 5.2) was faster in n- 
hexane and considerably slower in DCM. The results achieved in toluene, diisopropyl 
ether and vinyl acetate solution were comparable.
A common trend could be detected when the d.e. of the substrate was plotted 
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Conversion (%)
Fig. 5.3. Diastereoselectivity vs. conversion: ♦ n-hexane, • toluene,
+ isopropyl ether, ■ vinyl acetate, * DCM
As the conversion increased, the d.e. of the remaining substrate increased, because 
one of the two diastereomers was preferentially acetylated. The other diastereomer 
reacted only when the preferred one was completely consumed.
5.3.3.2 Enzymatic resolution of aldols (4S,2’/?,3’S)- and (4S,2’fl,3’fl)-5.8
The enzymatic resolution of the two aldol adducts from oxazolidinone (/?)-5.5 was a 
success, with the enzyme preferring the (3’R) diastereomer in the acylation reaction. 
Our next step was to find out if the same diastereoselectivity could be observed when 
the aldol adducts from oxazolidinone (S)-5.5 were reacted with vinyl acetate in the 
presence of CAL B.
The enzymatic resolution of aldols (4S,2’/?,3’S)- and (4S,2’A?,3’/?)-5.8 from 
oxazolidinone (S)-5.5 was carried out as described above for aldols from (R)-5.5 
(Scheme 5.16).
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(4S,2'/?,3'S)-5.8 (4S,2'/?,3,fl)-5.8 (4S,2'/?,3'S)-5.8 (4S,277,377)-5.9
"non-Evans" syn anti 1
Scheme 5.16. The enzymatic resolution of the adducts from 
TiCU/'P^NEt aldol reaction
As we expected, the (3’R) diastereomer reacted faster than the (3’S) diastereomer. 
Conversion and enantiomeric excess were similar to those obtained when the aldol 
adducts from (Ffy-5.5 were enzymatically resolved.
The progress and the diastereomeric excess of the reaction were monitored by chiral 
HPLC analysis after removal of the enzyme by filtration.
In Table 5.3 the time course and diastereoselectivity of the enzymatic reaction in 
vinyl acetate are reported.
Table 5.3. Time course and diastereoselectivity of the enzymatic reaction illustrated
in Scheme 5.16 in vinyl acetate3
t(h) %conv. %d.e.pD %d.e.sc D
0 0 - 0 -
1 0 - 0 -
4 3 >99 3 >200
8 9 >99 10 >210
24 29 >99 40 >290
48 47 >99 88 >580
3 50 mgenzyme/mmolsubstrate in 5 mL vinyl acetate using 1 mmol of diastereomeric aldol. 
b diastereomeric excess of the product. 
c diastereomeric excess of the remaining substrate.
d D = ln[(1-c(1+d.e.p)]/ln[(1-c(1-d.e.p)] = ln[(1-c)(1-d.e.s)]/ ln[(1-c)(1+d.e.s)]; c= conversion.26,27
The conversion increased up to 47% with reaction time. After 48 h only one 
diastereomer was acylated (d.e.p >99%). Whilst the diastereomeric excess of the
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substrate increased from 0 up to 88%; the percentage of the slower reaction 
diastereomer increased as the other one was acylated. Diastereoselectivity (D) of the 
reaction increased with the reaction time.
The reaction was repeated in a range of solvents with different hydrophobicity (Table 
5.4). Traces of the other acylated diastereomer were detected in n-hexane, toluene 
and diisopropyl ether.
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Table 5.4. Time course and diastereoselectivity of the enzymatic reaction illustrated 
in Scheme 5.16 in different solvents3
Toluene Diisopropyl ether
t(h) %conv. %d.e.pD %d.e.,° D 1(h) %eonv. %d.e.p %a.e.t D
0 0 - 0 - 0 0 - 0 -
2 0 - 0 - 2 5 >99 5 >200
4 3 >99 3 >200 4 7 >99 7 >210
6 5 >99 5 >200 6 11 >99 12 >220
24 28 90 35 >20 24 49 92 88 >70
48 44 88 69 >30 48 56 88 >99 -
DCM Dioxane
t(h) %conv. %d.e.p %d.e.. D t(h) %conv. %d.e.p %d.e.s D
0 0 0 - - 0 0 - 0 -
1 0 0 - - 2 0 - 0 -
4 0 0 - - 4 0 - 0 -
8 3 >99 3 >200 6 0 - 0 -
24 7 >99 7 >210 24 5 >99 5 >200
48 21 >99 26 >250 48 8 >99 9 >216
/i-Hexane
t(h) %conv. %d.e.p %d.e.s D
0 0 - 0 -
1 3 >99 3 >200
4 18 >99 22 >240
8 39 >99 63 >380
24 51 89 >99 >50
48 60 80 >99 -
3 50 mgenzyme/mmolsubstraie in 5 mL solvent using 1 mmol of diastereomeric aldol and 2 mmol vinyl 
acetate.
b diastereomeric excess of the product. 
c diastereomeric excess of the remaining substrate.
d D = ln[(1-c(1+d.e.p)]/ln[(1-c(1-d.e.p)] = ln[(1-c)(1-d.e.s)]/ ln[(1-c)(1+d.e.s)]; c= conversion.26,27
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We studied the kinetics of the reactions performed in the different solvents.
In Fig. 5.4 the conversion (%) is displayed against the reaction time. Again the 
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Fig. 5.4. Rate of transesterification in different solvent: ♦ n-hexane, • toluene,
♦ isopropyl ether, ■ vinyl acetate, * DCM, - dioxane
In Fig. 5.5 and Fig. 5.6 the diastereomeric excess of the product and the 
diastereomeric excess of the substrate in the different solvents are respectively 
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Fig. 5.5. Time course of d.e. of the product in different solvents: ♦ n-hexane,
• toluene, ♦ isopropyl ether
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Fig. 5.6. Time course of d.e. of the substrate in different solvents: ♦ n-hexane,
• toluene, + isopropyl ether, ■ vinyl acetate, * DCM, - dioxane
After 48 hours, only aldol adduct (4S,2’/?,3’f?)-5.8 was converted into the 
corresponding acetate in vinyl acetate, DCM and dioxane. The acetate from aldol 
(4S,2’A?,3’S)-5.8 appeared in n-hexane, toluene and isopropyl ether after 24 hours 
and the diastereomeric excess of the product in these solvents decreased as the 
reaction progressed (Fig. 5.5).
The increase in diastereomeric excess of the substrate (Fig. 5.6) was observed to be 
faster in n-hexane and slower in the other solvents screened.
In Fig. 5.7 the diastereomeric excess of the substrate is reported against the 
conversion for the solvents examined.
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Fig. 5.7. Diastereoselectivity vs. conversion
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Again a common trend can be noted. One of the two diastereomers reacts 
selectively, and the other starts to react only when the first one has been completely 
consumed.
We had found a diastereoselective aldoi reaction, which employed TiCI/P^NEt- 
enolate. Only two of the four possible diastereomers were formed from each 
enantiomer of the acylated oxazolidinone 5.5 in a 1:1 mixture.
The use of CAL B as catalyst was found to be a valid method for the resolution of 
diastereomers of aldol adducts from acetaldehyde. The reaction was relatively fast 
when n-hexane was used as solvent (> 40% conversion in 8 h) and proceeded with 
high diastereoselectivity (>99% d.e.). Moreover, the (3’R) diastereomers were 
preferentially acylated by the enzyme, as reported in Table 5.5.
Table 5.5. Chiral preference of CAL B in the acylation reaction

















These results were very promising. We had demonstrated the validity of our 
approach of coupling a diastereoselective aldol reaction to an enzymatic resolution. 
We wanted a diastereoselective aldol reaction and we found one able to give a 1:1
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mixture. We wanted to see if enzymes could react selectively with only one 
diastereomer. They did.
We would expect that by means of an aldol reaction with better stereoselectivity, we 
might be able to obtain only one diastereomer from each enantiomer of A/-propionyl 
oxazolidinone 5.5, i.e. two enantiomers, separable upon the chiral preference of the 
lipase towards (3’R) stereocentres.
5.3.4 Synthesis of aldol adducts via TiCI^-sparteine/NMP-enolate and their 
enzymatic resolution
We still needed to improve the stereoselectivity of the aldol reaction with 
acetaldehyde. Our aim was always to obtain only one isomer from each enantiomer 
of oxazolidinones (fl)-5.5 and (S)-5.5, in order to get closer to the use of racemic 
auxiliaries (Scheme 5.1).
The desired stereoselectivity for the aldol reaction was obtained when we used the 
same reaction conditions reported by Crimmins and co-workers for an analogous 
asymmetric aldol reaction.31
The acylated oxazolidinones (/?)-5.5 and (S)-5.5 were separately reacted with 
acetaldehyde via a TiCU-enolate using a combination of (-)-sparteine and AJ-methyl- 
2-pyrrolidinone (1:1) as base.
The acylated oxazolidinones (/?)-5.5 afforded the “Evans” syn aldol adduct 5.8 in 
reasonable yield and >99% diastereomeric excess (Scheme 5.17).




\ ___/  MeCHO \ ___/
\ n  DCM, -78 °C \ n
"Evans" syn
(fl)- 5.5 (4/7,2'/7,3lS)-5.8
Scheme 5.17. Synthesis of aldol adducts via TiCI4 /(-)-sparteine/NMP-enolate from
acylated oxazolidinone (/7)-5.5
Using the same reaction, the acylated oxazolidinones (S)-5.5 also afforded the 
“Evans” syn aldol adduct 5.8 in reasonable yield and >99% diastereomeric excess 
(Scheme 5.18).
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Scheme 5.18. Synthesis of aldol adducts via TiCl4/(-)-sparteine/NMP-enolate from
acylated oxazolidinone (S)-5.5
Each enantiomer gave only the “Evans” syn aldol in 99% diastereomeric excess, 
according to chiral HPLC analysis. The “Evans” syn relative configurations of aldols 
(4/?,2’/?,3’S)-5.8 and (4S,2’S,3’f?)-5.8 were established by comparison of the specific 
rotations and 1H NMR spectra with those reported in the literature.32
After purification by chomatography, the enantiomers were examined for their 
reactivity towards acylation, using Candida antarctica type B as the catalyst.
“Evans” syn aldol adduct (3’S)-5.8 was not acylated by the enzyme (Scheme 5.19).
Scheme 5.19. Enzymatic resolution of “Evans” syn aldol adduct (3’S)-5.8 from the 
TiCI/P^NEt-enolate aldol reaction
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Scheme 5.20. Enzymatic resolution of “Evans” syn aldol adduct (3’ fl)-5.8 from the 
TiCI/Pr2NEt-enolate aldol reaction
No enzymatic reaction of aldol (4/?,2’/?,3’S)-5.8 was detected by TLC and chiral 
HPLC analysis. However, aldol adduct (4S,2’S,3’/?)-5.8 was converted into ester 
(4S,2’S,3’/3)-5.9 in 87% conversion after 72 hours.
The time course of the enzymatic reaction is illustrated in Table 5.6 and Fig. 5.8. 
Table 5.6. Time course of the enzymatic reaction illustrated in Scheme 5.20a








a 30 mgenzyme/mmolsubstrate in 5 mL vinyl acetate using 1 mmol of aldol (4S,2’S,3’R)-5.8.
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Fig. 5.8. Rate of transesterification
These results were compared with those previously obtained in the lipase-catalysed 
resolution of analogous isomers of aldol adduct 5.8 (Table 5.7).
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Table 5.7. Chiral preference of CAL B in the acylation reaction
Aldol 5.8 Configuration Enzyme substrate
O o  OH.V A
'"Bn
14R.2'S.3'R)
0  O OHA A A
'"Bn
(4R.2,S.3'S) no
O O OHA J y .
Bn
(4S.2’ R,3' S) no
O O OHA A ^
Bn
(4S.2’R.3’R\





H n  *
(4S,2’S,377) ✓
From these results, the chiral preference of Candida antarctica lipase B towards 
(3’fl)-stereocentres in the acetylation reaction was obvious.16,33
5.4 Synthesis of the racemic aldol adduct and its enzymatic resolution
At this point of our investigation we had two powerful tools to work with:
A) We had found a highly stereoselective and reliable aldol reaction able to afford 
only one diastereomer from each enantiomer of the acylated chiral auxiliary. These 
aldols were therefore also enantiomeric, as illustrated in Scheme 5.21:
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B) We had established that CAL B promoted the kinetic resolution of our aldol 




Research next focused upon the combination of these results, using a racemic 
starting material. We wanted to see if the highly diastereoselective aldol reaction via 
TiCl4/(-)-sparteine/NMP-enolate was efficient when a racemic mixture of 
oxazolidinone 5.10 was used instead of the two individual enantiomers. We wished to 
obtain a racemic mixture of diastereomerically pure aldol adducts, where one 
enantiomer would undergo enzyme-catalysed acylation faster (Scheme 5.23).
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Successful completion of the reaction illustrated in this scheme would equate to 
successful completion of the project’s initial aims.
5.4.1 Synthesis of racemic A/-(3-acetoxy-2-methylbutanoyl)-4-benzyl-2- 
oxazolidinone and its enzymatic resolution
Racemic 4-benzyl-2-oxazolidinone 5.10 was prepared from the corresponding 
racemic amino acid phenylalanine 5.11, following the procedure reported by Wu and 
Shen.34
The racemic amino alcohol 5.12 (from reduction of amino acid 5.11 with 
NaBH4/H2S0435) was treated directly with Me02CCI to give the carbamate 5.13, 
which was cyclised in the presence of traces of K2C03 at 125-130 °C under vacuum, 
to afford the racemic 2-oxazolidinone 5.10 in 72% total yield (Scheme 5.24).
NH,
HO. D. NaBH4/H2S 0 4 NH2 Me02CCI/Na2C03 J L----------------------------   I D.    MeO NH  —HO^ ^  ^Ph I 125-130 °C
k2c o 3 ^








Scheme 5.24. Synthesis of the racemic 4-benzyl-2-oxazolidinone 5.10
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The racemic oxazolidinone 5.10 was then acylated to obtain the racemic 3-propionyl- 
4- benzyl-2-oxazolidinone 5.S.36 The subsequent diastereoselective aldol reaction 
with acetaldehyde in the presence of TiCI4, (-)-sparteine and /V-methyl-2- 
pyrrolidinone31 provided racemic syn-5.8 in 99% diastereomeric excess (Scheme 
5.25).
Scheme 5.25. Acylation and aldol reaction of rao4-benzyl-2-oxazolidinone 5.10
Sparteine was used as a convenient base and did not, as expected, exert any 
observable stereocontrol upon the aldol reaction.
Enzymatic resolution of the enantiomers of aldol adduct 5.8 via transesterification 
catalysed by Candida antarctica lipase type B, afforded the (3’F?)-acylated aldol 
adduct 5.9 and the (3’S)-non-acylated aldol adduct 5.8 (Scheme 5.26). The choice of 
solvent was crucial to this process, and the solvent effects are illustrated in Table 5.8.
rao-5.10 rao- 5.5 'Evans" rac-syn- 5.8
(i) "BuLi, EtCOCI/THF, -78 °C (88%); (ii) TiCL, (-)-sparteine, /V-methyl-2-pyrrolidinone, 
CHaCHO/DCM, 0 -» -7 8  °C (54%)
CAL B, 40 °C 
organic solvent, 24 h
(4/?,2'/?,3'S)-5.8 (4S,2'S,3'fl)-5.8 (4/7,2'/7,3S)-5.8 (4S,2'S,3'fl)-5.9
Scheme 5.26. Lipase-catalysed aldol adduct resolution
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1 n-hexane 50 >99 >99 >1050
2 'Pr20 45 81 >99 >500
3 toluene 42 72 >99 >420
4 VA 34 51 >99 >330
5 DCM 6 6 >99 >210
3 30 mQenzyme/mmolsubstrate in 5 mL solvent using 1 mmol of racemic aldol and 2 mmol vinyl acetate. 
b E = ln[(1-c(1+e.e.p)]/ln[(1-c(1-e.e.p)] = ln[(1-c)(1-e.e.s)]/ ln[(1-c)(1+e.e.s)]; e.e.s= enantiomeric excess of 
the remaining substrate; e.e.p= enantiomeric excess of the product; c = conversion.26,27
The reaction rate of the lipase-catalysed transesterification was faster in non-polar 
solvents such as n-hexane and toluene (Entries 1 and 3), whilst it was slower in polar 
solvents such as dichloromethane (Entry 5).28*30
The selectivity of Candida antarctica lipase type B towards the aldol adduct 
enantiomers was in accordance with the reported stereoselectivity of this enzyme 
towards racemic secondary alcohols.37
The enantiomeric excess of the recovered 5.8 and of product 5.9 was monitored 
during the course of the reaction in n-hexane solution (Fig. 5.9). The enantiomeric 
excess of the product was constant and >99% during the reaction. The enantiomeric 
excess of the substrate increased to 99% as the reaction approached 50% 
conversion.
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Fig. 5.9. Kinetic study of enantiomeric excess versus conversion in n-hexane: 
♦acetylated aldol adduct, + non-acetylated aldol adduct
Finally, hydrolysis36 of the enzymatically resolved aldol 5.8 and ester 5.9 afforded the 
enantiomerically enriched 3-hydroxy-2-methylbutanoic acids (2/?,3S)-5.10 and 




LiOH, H20 2 O NH
   w  + h o
p /
(Ft)-5.10 (2fl,3S)-5.14
85% yield, >99% e.e. 60% yield, >99% e.e.
O O OAc O
o  o h




84% yield, >99% e.e. 55% yield, >99% e.e.
Scheme 5.27. Hydrolysis of enzymatic resolution products
The relative configuration of the non-acylated aldol adduct was also confirmed by X- 
ray crystal log raphic analysis of the crystal structure (see Appendices).
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For comparison, the enantiomer of the lipase-acylated oxazolidinone 5.9 was 
synthesised by chemical esterification of (4/?,2’/?,3’S)-5.8 with acetic acid in the 












Scheme 5.28. Chemical esterification of the (3’S)-aldol
The chemical esterification gave, as expected, the ester with opposite specific 
rotation with respect to the ester obtained by the enzymatic reaction.
5.4.2 Synthesis of racemic /V-(3-acetoxy-2-ethylbutanoyl)-4-benzyl-2- 
oxazoiidinone and its enzymatic resolution
To prove the general application of our methodology to obtain enantiomerically 
enriched auxiliary and enantiomerically enriched product, we decided to change the 
acyl moiety of our oxazolidinone.
We intended to see if this structural change could affect the aldol reaction 
diastereoselectivity or/and the enzymatic resolution.
This time, the racemic oxazolidinone 5.10 was acylated using butyryl chloride to 
obtain the A/-butanoyl oxazolidinone 5.15. This underwent the diastereoselective 
aldol reaction with acetaldehyde in the presence of TiCl4/(-)-sparteine/NMP to afford 
the rac-syn-5.16 in 59% yield and 95% d.e., according to 1H NMR20,32 and chiral 
HPLC analysis (Scheme 5.29).
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rao  5.10 rao-5.15 Evans" rac-syn-5.16
(i) "BiiLi, "PrCOCI/THF, -78 °C (88%); (ii) TiCU, (-)-sparteine, /V-methyl-2-pyrrolidinone, CHaCHO/DCM,
0 -► -78 °C (59%)
Scheme 5.29. Acylation of (±)-4-benzyl-2-oxazolidinone 5.10 with "PrCOCI and
subsequent aldol reaction
Enzymatic resolution of the enantiomers of aldol adduct 5.16 via transesterification 
catalysed by Candida antarctica lipase type B in n-hexane, afforded the acylated 
aldol adduct 5.17 and the non-acylated aldol adduct 5.1632 with 50% conversion and 
>99% enantiomeric excess of the product after 20 hours (Scheme 5.30).
X-ray analysis of the crystals confirmed the configuration of the non-acylated product
We were very pleased to discover that the aldol reaction was still highly selective 
even when the acyl moiety was changed. The enzymatic resolution was effective 
even when the 2’-methyl substituent was exchanged with an ethyl group.
i t  CAL B, 40 °c
hexane, 20 h
(4/?,2'/?,3'S)-5.16 (4S,2'S,3'fl)-5.16 (4/?,2'/?,3'S)-5.16 (4S,2'S,3'/7)-5.17
>99% e.e. 50% conv., >99% e.e.
Scheme 5.30. Lipase-catalysed aldol adduct resolution
5.16.
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5.5 A general application. Preparation of enantiomerically enriched 4- 
ethyl-2-oxazolidinones
Our methodology proved to be very efficient when the widely used racemic 4-benzyl-
2-oxazolidinone was used as starting material. We were able to obtain 
enantiomerically enriched p-hydroxy acids and, at the same time, enantiomerically 
enriched 4-benzyl-2-oxazolidinones. Our aim was now to prove that our approach 
could be generally exploited to obtain the indirect resolution of chemically designed 
racemic auxiliaries.
For example, racemic 2-amino-1-butanol is readily available at low cost. We 
envisaged that using this inexpensive starting material we could obtain 
enantiomerically enriched 4-ethyl-2-oxazolidinones.
Racemic 2-amino-1-butanol 5.18 was used to synthesise racemic rao-syn-5.22, 




rao- 5.18 5.19 rao-5.20 ra o  5.21 rac-syn-5.22
(i) NaaCOa/EtCfeCCI, H20 ; (ii) KaCOa, 125-130 °C, vacuum (90%); (iii) "BuLi, EtCOCI/THF, -78 °C (64%);
(iv) TiCU, (-)-sparteine, A/-methyl-2-pyrrolidinone, CH3CHO/DCM, 0 -► -78 °C (55%)
Scheme 5.31. The synthesis of the racemic rac-syn-5.22 4-ethyl oxazolidinone
The application of our methodology produced resolved alcohol (4f?,2’/?,3’S)-5.22 
and acetate (4S,2’S,3’/3)-5.23 (Scheme 5.32).
o O pH ^ O A C  O o OH o o OAc
2*iuiv- o ^ n ^ v A  + o A .
\ ^   ^ CAL B, 20 h \ i  \ -----1 i
Et 40 °C, hexane "Et Et
(+/-J-5.22 (4fl,2,/?,3,S)-5.22 (4S,2,S,3,fl)-5.23
>99% e.e. * 50% conv, >99% e.e.
Scheme 5.32. Enzymatic resolution of aldols 5.22
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Oxidative cleavage afforded enantiomerically enriched (2/?,3S)-5.14 and (!2S,3R)-















82% yield, >99% e.e.
HO-
(2/7,3S)-5.14
53% yield, >99% e.e.
O O QAc Q
NHA A A  0A
H _  1 K
Et Et
M S 9>c3 .0 WS 23 (S>-5-20 (2S,3fl)-5.14J J 87o/o yie|di >9g% e.e. 51 % yield, >99% e.e.
Scheme 5.33. Preparation of enantiomerically enriched 4-ethyl-2-oxazolidinones and
3-hydroxy-2-methylbutanoic acids
We were very pleased to find out that, even when a less hindered 4-substituted 
oxazolidinone was used, our approach proved to be successful.
5.6 Conclusions
In summary, after examining a range of experimental conditions and experiencing 
progressive improvements in our methodology, we were able to achieve the aims of 
the project.
Starting from racemic Evans’ auxiliary, by means of a diastereoselective aldol 
reaction coupled with a lipase-catalysed resolution, we proved that we could achieve 
the preparation of enantiomerically enriched p-hydroxy acids and enantiomerically 
enriched 2-oxazolidinones.40
The great achievement of our project was the indirect resolution of racemic Evans’ 
auxiliaries.
The choice of Evans’ auxiliary can be limited by the availability of an appropriate 
enantiomerically pure amino acid or alcohol. Aside from the (S)-substituted 2- 
oxazolidinones readily available from naturally occurring a-amino acids such as L- 
valine and L-phenylalanine,41 their configurational antipodes are less accessible.
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The sterically constrained, designed chiral 2-oxazolidinones, such as 4,5- 
disubstituted-2-oxazolidinones, conformationally fixed by bicyclo [2.2.1] and bicyclo 
[2.2.2] systems,42 are also less easily available.
However, our methodology allows the use of not only racemic amino acids but also 
racemic amino alcohols to access the otherwise difficult to prepare antipodes. It also 
offers, for the first time in chiral auxiliary-based chemistry, the possibility of using 
designed racemic auxiliaries, instead of the difficult to prepare chiral equivalents.
Not only can resolved aldol adducts be obtained using this methodology, but in 
addition the procedure acts as in indirect enzyme-catalysed resolution of Evans’ 
auxiliaries.
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6. Towards the One-Pot Synthesis of /V-acyl Oxazolidinones
6.1 Introduction
This chapter describes research carried out towards the one-pot synthesis of /V-acyl 
oxazolidinones. Despite the high versatility of chiral 2-oxazolidinones through 
numerous elegant syntheses developed by Evans and others,1'5 their broader 
application in asymmetric synthesis is seriously limited by the lack of an easy, safe 
and low-cost synthesis.
We envisaged that the development of a facile one-pot synthesis of racemic /V*acyl 
oxazolidinones could be achieved.
Thereby we would obtain enantiomerically enriched oxazolidinones and be in a 
position to exploit our methodology of coupling a highly asymmetric aldol reaction to 
an enzymatic resolution (for a more detailed description, see previous chapter), as 









Scheme 6.1. General approach to the one-pot synthesis of /V-acyl oxazolidinones
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6.2 Background. Synthesis of Atacylated Evans auxiliaries
The most common method for the preparation of chiral Evans auxiliaries is the 
generation of 2-oxazolidinones from p-amino alcohols, in turn usually prepared by 
reduction of the corresponding amino acids. This procedure provides easy access to 
enantiopure 2-oxazolidinones from a variety of natural a-amino acids such as L- 
phenylalanine, L-valine, and L-phenylglycine. In addition, other amino acid-derived 
starting materials can be employed.6 Some examples are illustrated in Scheme 6.2.
'Pr H BrV SH Pl\  SHV 1 V ' v
H2N ^ S x )2H H2N ^ X 0 2H HgN^XCfeH
L-valine L-phenylalanine L-phenylglycine
X .
H2N C02H H2N'X^ C 0 2H Ph Me
L-tert-leucine L-cyclohexylalanine (1S,2fl)-norephedrine
Scheme 6.2. Oxazolidinone precursor
A large number of reagents have been employed in the synthesis of oxazolidinones 
from amino alcohols. Reactions between amino alcohols and either phosgene or 
diethyl carbamate or chloroformate represent the most direct route to oxazolidinones. 
Early methods tended to employ phosgene.7'10 This method, although a facile one- 
pot synthesis, is quite hazardous (Scheme 6.3).
h2n ‘
o
Ph II? COCfe, NaOH
/O H _____________^  O NH
i  DCM, -5 °C
Ph Pff 'Ph
6.1 6.2
Scheme 6.3. Synthesis of 2-oxazolidinones with phosgene
More recently, without the use of phosgene, efficient and high-yielding syntheses of 
oxazolidinones have been achieved via carbamate intermediates.
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Using this method, a variety of 4-substituted-2-oxazolidinones such as 6.4 may be 
synthesised from the corresponding amino alcohol 6.3 with diethyl carbonate under 
base catalysis (Scheme 6.4)11,12
Ph
NH
,OH 125 °C, 8 h
Ph
6.3 6.4
Scheme 6.4. Synthesis of 2-oxazolidinones with diethyl carbonate
The disadvantages of this method are that the reaction time is around 8 hours and 
the ethanol by-product must be distilled from the reaction mixture.
Methyl or ethyl chloroformates can also be used. These first react with the amino 
group to give the carbamate 6.6, which is then cyclised in the presence of a base to 
give the desired oxazolidinone 6.7 (Scheme 5).5
EtCOCI
Scheme 6.5. Synthesis of 2-oxazolidinones with chloroformate
Other traditional methods include the preparation of enantiomerically pure 2- 
oxazolidinones 6.2 with isocyanate (Scheme 6.6).6
o
KNCO H ,0 + A
O NH
AcOH, A n2,>l i or A
Ph Ph 
6.8 6.2
Scheme 6.6. Preparation of 2-oxazolidinones with isocyanate
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New approaches to an easy, low cost and high yielding synthesis of enantiomerically 
enriched 2-oxazolidinones have been explored in the last few years.
One of these approaches is the oxidative conversion of a carbamate 6.9 to 
disubstituted 2-oxazolidinone 6.10 by a Rh-catalysed C-H insertion reaction (Scheme 
6.7).13 This methodology utilizes catalytic quantities of a Rh (II) carboxylate complex 
and an inexpensive commercial oxidant, Phl(OAc)2.
Me o
5 mol% [Rh2(0 2CR')4] U
T  ------------------   °  ,NH
°  Phl(OAc)2, MgO '— K ^ M e
CH2CI2, 40 °C |J|e /
6.9 6.10
Scheme 6.7. Synthesis of 2-oxazolidinones by a Rh-catalysed C-H insertion reaction
A one-pot preparation of enantiomerically enriched 4,5-disubstituted-2- 
oxazolidinones using a modified Sharpless asymmetric dihydroxylation has also been 
reported (Scheme 6.8).14 This method utilizes an asymmetric aminohydroxylation of 












71% yield, 90-93% e.e.
Scheme 6.8. One-pot preparation of chiral 4,5-disubstituted-2-oxazolidinones via 
modified Sharpless asymmetric aminohydroxylation
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Since the majority of chiral auxiliary-based reactions (alkylations, a-substitution, aldol 
reactions) are performed on A/-acyl oxazolidinones, at least another step has to be 
added to the above-described reactions, for the chiral auxiliary to be synthetically 
useful. A/-Acylation of enantiopure oxazolidinones is usually achieved by 
deprotonation of the auxiliary 6.4 with rr-butyllithium, followed by the addition of acid 
chloride (Scheme 6.9).7,15,16
O 1) nBul_i/THF/ -78 °C 9 O
X  2) EtCOCI X  X ^
0 NH-------------------------------- ► O N
M .  M .
Bn Bn
6.4 6.13
Scheme 6.9. /V-Acylation with nBuLi
More recently, a simplified procedure has been developed. The acylation reaction 
occurs at room temperature in the presence of triethylamine and catalytic quantities 
of 4-(A/,A/-dimethylamino)pyridine, thereby eliminating the requirement for a strong 
base such as n-butyllithium. Acylation occurs with both symmetrical and mixed 
anhydrides, as well as acid chlorides. An example of application is reported in 
Scheme 6.10.17
A
\ -----^  NEt3, cat. DMAP \ -----^
Ph Ph
6.14 6.15
X = OCOEt, OCO'Bu, Cl
Scheme 6.10. A/-Acylation with NEt3 and DMAP
In summary, AkJerivatised-2-oxazolidinones are prepared via a process using not 
less then three steps: amino acid reduction, intermolecular 2-oxazolidinone formation 
and finally /V-derivatisation.
Therefore, considerable research effort has been focused upon the one-pot synthesis 
of A/-derivatized-2-oxazolidinones.
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In 1994 Huwe and Blechert18 reported a one-pot synthesis of enantiomerically 
enriched A/-acyl and A/-vinyl oxazolidinones (6.19) from amino alcohol carbamates 
(6.18), prepared in their enantiopure forms via enzymatic resolution (Scheme 6.11).
H Enzymatic H Reduction OH Na^ h^ E* M
CbzOgC ^ N  OBn resolllll° n | CbzOgC N O B n  L K OBn . 0 A ' E
R O R O I  S
rac-6.16 6.17 6.18 6.19
r = ■ y  E= ^
Scheme 6.11. One-pot synthesis of A/-acyl and A/-vinyl oxazolidinones from amino
alcohol carbamates
A/-methyl-oxazolidinone 6.21 has been prepared by the reaction of a Grignard 
reagent with a /V-alkoxy-carbonyl-a-amino ester, followed by in situ cyclisation 
(Scheme 6.12).19 The reaction is however very dependent on the nature of R’. When 










Scheme 6.12. One-pot synthesis of /V-methyl-oxazolidinone 6.21
A/-acetyl-2-oxazolidinone 6.23 has been prepared from the palladium-catalysed 
carbonylation of A/-acetyl-p-amino alcohol 6.22 under mild conditions (Scheme 
6 .13).20
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Scheme 6.13. Synthesis of A/-acetyl-2-oxazolidinone 6.23 by 
palladium-catalysed carbonylation
The same A/-acetyl-oxazolidinone was obtained in the reaction between acetyl 
chloride and an isocyanate (Scheme 6.14).21
Despite these examples, few of them are of practical use to date.
When we approached this study, our general idea was to find an efficient and easy 
one-pot synthesis of racemic A/-acyl oxazolidinones. The application of our 
methodology described in the previous chapter (the asymmetric aldol reaction 
coupled to the enzyme-catalysed resolution) would hopefully achieve this goal.
A screening of the literature revealed that in some cases heterocycles, mostly 
epoxides, had been used to prepare racemic 2-oxazolidinones.22'28 
We also found an example of one-pot synthesis of 5-substituted A/-acyl oxazolidinone 
6.27 from the reaction of /V-acylurethane 6.26 with the mono-substituted epoxides 
6.25 reported in 1966 (Scheme 6.15).29
o




Scheme 6.14. A/-acetyl-oxazolidinone 6.23 from an isocyanate
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Scheme 6.15. One-pot synthesis of 5-substituted A/-acyl oxazolidinone 6.27
We anticipated that this last example would provide a convenient starting point for 
the development of a one-pot synthesis of 4,5-disubstituted-A/-acyl oxazolidinones 
from /V-acyl urethane 6.26.
6.3 The one-pot synthesis of JV-acyl-5-substituted-2-oxazolidinone
Our study began with the synthesis of a 5-substituted-acyl oxazolidinone previously 
reported in literature.29 A/-acyl urethane 6.28 was prepared from the commercially 
available and inexpensive acyl chloride 6.29 and ethyl carbamate 6.30. Heating the 
two reagents at reflux for 2 hours until HCI evolution ceased gave 6.30 in 58% yield 
(Scheme 6.16).30
ox





Scheme 6.16. Synthesis of carbamic acid ester 6.30
The obtained carbamic ester was then reacted with phenoxymethyl oxirane 6.25, in 
the presence of 1,4-diazabicyclo[2J2,2]octane (DABCO), to afford /V-propionyl-5- 
phenoxymethyl-2-oxazolidinone 6.31 (Scheme 6.17).
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Scheme 6.17. One-pot synthesis of /V-propionyl-5-phenoxymethyl- 
2-oxazoiidinone 6.31
Disappointingly however, the reaction proceeded in low yield (32% isolated product). 
The authors noted the same problem. The poor yield was attributed to N->0 
migration of the acyl group during the course of the reaction.29 
Despite the disappointing yield, we continued our investigation to examine the 
subsequent diastereoselective aldol reaction. Reaction with acetaldehyde in the 
presence of TiCI4, (-)-sparteine and A/-methyl-2-pyrrolidone31 provided racemic syn- 
6.32 aldol adducts in 31% yield and in low diastereoselectivity (47% d.e.). The 
formation of other aldol adducts during the reaction was also observed (Scheme 
6.18).
o 1)TiCI4 «  sparteine o o  OH O O QH
A A ^  2) ch3cho A A^A ^> N      ► O N nr + oO v -------------------- =------------ Q N
) -----1 DCM, -78 °C-------------) -----1 .
PhO— '  PhO— ''' PhO— '
6.31 rac-syn-6.32 6.32 (other aldol adducts)
31 % yield, 47% d.e. 17% yield
Scheme 6.18. Aldol reaction of A/-propionyl-5-phenoxymethyl-2-oxazolidinone 6.31
This result was not a surprise. Although high stereoselectivity of the aldol reaction 
with 4-substituted oxazolidinones is easily achieved, lower diastereoselectivity was 
expected when a 5-substituted oxazolidinone was used instead. In this case, the 
controlling stereocentre is too remote from the enolate formed during the reaction to 
provide high diastereoselectivity.
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6.4 The attempted one-pot synthesis of JV-acyl-4,5-disubstituted-2- 
oxazolidinone
The next step was to attempt the synthesis of an alternative acyl oxazolidinone, 
which could provide higher diastereoselectivity in the aldol reaction.
The major issue in the reaction between a carbamic ester and a mono-substituted 
epoxide is that the nucleophile tends to attack the epoxide at less hindered site,32 
giving preferentially 5-substituted-2-oxazolidinones after cyclisation (Scheme 6.19).
With these premises, we couldn’t expect to be able to synthesise a 4-substituted 
oxazolidinone via this methodology. Therefore, we changed approach, examining 
instead the synthesis of the useful A/-acylated 4,5-diphenyl-2-oxazolidinone.33'36
was then allowed to react with carbamic acid ethyl ester 6.30 in the presence of 1,4- 
diazabicyclo[2,2,2]octane (DABCO) as base. Two products were obtained when this 
reaction was performed (Scheme 6.20).
Scheme 6.20. One-pot synthesis of A/-acylated 4,5-diphenyl-2-oxazolidinone 6.34
The reaction between carbamic acid ester 6.30 and trans-stilbene oxide 6.33 was 
more complicated than had been expected. Trans-stilbene oxide turned out to be 
quite unreactive38,39 and attempts to increase the temperature and/or increase
Scheme 6.19
Trans-stilbene oxide 6.33 was synthesised by epoxidation of frans-stilbene.37 This
DABCO
solvent, T
6.30 6.33 rac-cls-6.34 rac-cls- 6.35
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base:substrate ratio, led only to deacylated product 6.35 as a consequence of the 
strong reaction conditions. These results are illustrated in Table 6.1.
Table 6.1. One-pot synthesis of A/-propionyl-4,5-diphenyl-2 oxazolidinone 6.34a
Entry Carb. ester 
6.30 (eq)






1 1 0.0004 (0.2%) DMF 70 7 no reaction
2 1 0.5 (50%) DMF 150 72 rac-cis- 6.35
17%
3 2 0.2 (20%) PhMe 180 72 rac-cis- 6.35
20%
4 2 0.2 (20%) PhMe 180 3 rac-cis- 6.34
22%
5 2 0.2 (20%) PhMe 150 5 no reaction
6 1 0.2 (20%) PhMe 180 7 rac-cis-6.34
19%
(+ traces of 6.35)
7 1 0.2 (20%) DMF 180 7 rac-cis- 6.35
traces
a Reactions were carried out using 1 eq of trans-stilbene oxide 6.32 at 3 M concentration. 
b Yield of the isolated product after flash chromatography.
After several attempts, the best result we could achieve was a 22% yield of racemic 
cis-6.34 in 3 hours, using 2 equivalents of base in toluene at 180 °C (entry 4). The 
use of a lower temperature (entries 1 and 5) gave no reaction in 7 h and the starting 
material was recovered intact. Increase of the reaction time and temperature (entries 
2 and 3) resulted only in deacylation of 6.34 to 6.35, as noted previously.
6.5 Conclusions
Racemic A/-acylated-5-substituted-2-oxazolidinone was synthesised using a one-pot 
synthesis from a carbamic acid ester and a monosubstituted epoxide, but the
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reaction proceeded in low yield. The subsequent aldol reaction gave racemic syn 
aldol adducts as major products, but with low diastereoselectivity.
We then attempted a one-pot synthesis of A/-acyl-4,5-diphenyl-2-oxazolidinone. 
Unfortunately, the reaction we focused upon gave a lower yield than expected. This 
may be attributed to the poor nucleophilicity of the carbamic acid ester substrate 
under the reaction conditions and/or to the poor reactivity of trans-stilbene oxide 
under the same conditions.
Nevertheless, we have demonstrated that there is a scope for successful future 
attempts with some variations at the one-pot synthesis of /V-acylated-4,5- 
disubstituted-2-oxazolidinone.
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Reactions requiring anhydrous conditions were carried out under an atmosphere of 
nitrogen. Apparatus, needles and syringes were oven-dried. General solvents used in 
these reactions were distilled prior to use. Toluene and hexane were distilled from 
sodium wire. Diethyl ether and THF were distilled from the sodium benzophenone 
ketyl anion. DCM was distilled from calcium hydride. Cyclohexane, DMF, methanol 
and ethanol were all purchased in anhydrous form from commercially available 
suppliers. All solvents used were stored in the presence of activated 3 A molecular 
sieves.
Flash chromatography was carried out using Merck Kieselgel 60H and Fisher Matrex 
Silica 60 silica. TLC was performed using commercially available Merck Kieselgel 
G/UV254 neutral silica coated aluminium and glass plates to monitor all reactions. TLC 
plates were visualised by 254 nm light or with KMn04 dip followed by heating.
Organic solvents were dried over anhydrous MgS04 or Na2S04 and evaporated with 
a Buchi rotary evaporator. Further drying was carried out on a high-vacuum line 
when necessary.
Melting points were measured on a Buchi 535 Series instrument and are 
uncorrected.
Optical rotations were measured with a Optical Activity LTD AA-10 automatic 
polarimeter.
IR spectra were recorded as thin films, solutions (CH2CI2, CHCI3 or CDCI3) or KBr 
discs, using a Perkin-Elmer 1600 Series FT-IR spectrophotometer in the range of 
4000-600 cm'1, with internal background scan.
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Proton 1H NMR spectra were run in CDCI3, unless otherwise stated, using either a 
Bruker AM-300 (300 MHz) or a Jeol GX400 (400 MHz) instrument. Chemical shift are 
reported relative to Me4Si ( 8  0.00 ppm) as internal standard. Coupling constants (J) 
are given in Hertz and multiplicities denoted as singlet (s), doublet (d), triplet (t), 
doublet of doublets (dd), doublet of quartets (dq) or multiplet (m). Carbon 13C NMR 
spectra were run in CDCI3, unless otherwise stated, using either a Bruker AM-300 
(75.5 MHz) or a Jeol GX400 (100 MHz) instrument.
Mass spectra, including high-resolution spectra, were recorded on a Fisons NG- 
Micromass Autospec Spectrometer using electron impact (EI+) ionisation, chemical 
impact (CI+) ionisation and/or fast atom bombardment (FAB+) ionisation.
Elemental analyses were performed using a Carlo Erba 1106 Elemental Analyser at 
the University of Bath.
HPLC was performed using a tsp liquid chromatograph (Spectra Series P200 Pump, 
Spectra Series UV100 Lamp, ChromJet SP4400 Integrator). All separations were 
carried out using Chiralcel OD® and AD® columns obtained from Fisher Scientific 
Supplies.
Candida antarctica lipase type B (CAL B, Chirazyme® L-2, carrier-fixed C3, 
lyophilizate) was a gift from Boeringer Mannheim. Porcine pancreas lipase (PPL, 
EC.3.1.1.3. type II) and Aspergillus oryzae protease (type XXII) were from Sigma. 
Pseudomonas cepacia lipase (PCL) and Pseudomonas fluorescens lipase (PFL) 
immobilised in Sol-Gel-AK, Candida cylindracea lipase (CCL), Mucor javanicus (MJL) 
lipase and Aspergillus niger lipase (ANL) were from Fluka. Bacillus subtilis 
proteinase, Escherichia coli Penicillum amidase and hog liver esterase immobilised 
on Eupergit C were also from Fluka.
Unless preparative details are provided, all chemicals were commercially available 
and purchased from Acros, Fluka, Lancaster or Sigma-Aldrich.
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7.2 Experimental for Chapter 3
Preparation of M-(ferf-butoxycarbonyl)-1,3-propanediol (A/-Boc-serinol) 3.11
Di-te/t-butyl dicarbonate (1.31 g, 6.00 mmol) was added slowly to a stirred solution of 
serinol (2-amino-1,3-propanediol) 3.20 (0.456 g, 5.00 mmol) in EtOH (15 mL). After 1 
hour at room temperature, the solvent was removed under reduced pressure. The 
residue was extracted with EtOAc (2 x 15 mL), and the organic extract was dried 
(Na2S04) and concentrated in vacuo. The obtained white solid was recrystallised 
from hexane/EtOAc to give 3.1 (0.908 g, 95%) as white needles; mp 84-85 °C (Lit. 1 
87-88 °C); HPLC (Chiralcel® OD column, n-hexane/isopropanol 95:5, 1 mLmin'1, X = 
2 1 0  nm): tR = 8 . 6  min; IR (CH2CI2): v=  3425, 2965, 2885, 1700, 1500, 1165, 1050 
cm’1; 1H NMR (300 MHz, CDCI3): SH = 5.25 (1 H, br d, J=  5.4 Hz, NH)t 3.82-3.63 (5H, 
m, 2  x C/^OH and CHN), 2.68 (2H, t, J=  5.5 Hz, 2 x CH20 H), 1.45 (9H, s, 3 x CH3); 
13C NMR (75.5 MHz, CDCI3): 5C = 156.8 (CO), 80.3 (C(CH3)3), 63.2 (2 x CH2OH),
53.5 (CHN), 28.7 (3 x CH3); Anal, calcd. for C8 H17N04: C 50.25%, H 8.96%, N 
7.32%; found: C 50.2%, H 8.9%, N 7.2%.
General procedure for the enzymatic desymmetrisation of M-Boc-serinol 3.1
In a typical experiment a solution of A/-Boc-serinol 3.1 (0.688 g, 3.59 mmol) and vinyl 
acetate (2.6 mL, 28.8 mmol), in organic solvent (20 mL) was stirred with the lipase 
(0.500 g, 140 mgenzyme/mmolsub) at different temperatures for 2 hours. Aliquots were 
taken from the different solutions and analysed by chiral HPLC (Chiralcel® OD 
column, n-hexane/isopropanol 95:5, 1 mLmin'1, X = 210 nm). Conversion (%), 
enantiomeric excess (%) and mono/di-acetylated product ratio obtained using 
different solvents, lipases and temperatures are illustrated in Tables 3.1, 3.2 and 3.3. 
The reaction performed in vinyl acetate at 30 °C, using PPL as catalyst was followed 
until completion was reached (2 hours). The reaction was then stopped by filtering 
the solution. The solution was concentrated in vacuo and the residue purified by flash
O
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chromatography (Si02> n-hexane/EtOAc 50:50) to give (fl)-3.2 as a colourless oil 




Desymmetrised serinol (/?)-3.2 was obtained as a colourless oil (0.580 g, 69% 
isolated yield); Rf (n-hexane/EtOAc 50:50) = 0.29; [a] D30 = +3.5 (c 0.56, CHCI3); 
HPLC (Chiralcel® OD column, /7-hexane/isopropanol 95:5, 1 mLmin'1, X = 210 nm): tR 
= 10.8 min; IR (film): v = 3370 (br), 2975, 1710, 1690, 1525, 1370, 1240, 1170, 1040 
cm'1; 1H NMR (300 MHz, CDCI3): 5H = 5.10 (1H, br d, J=  8.4 Hz, NH), 4.19 (2H, d, J 
= 5.7 Hz, CH2OCO), 3.98-3.88 (1H, m, CHN), 3.68 (1H, dd, J = 4.4 and 11.4 Hz, 
CHHOH), 3.62 (1H, dd, J = 5.0 and 11.4 Hz, CHHOH), 3.02 (1H, br s, OH), 2.09 (3H, 
s, COCH3) 1.45 (9H, s, 3 x CCH3); 13C NMR (75.5 MHz, CDCI3): 8 C = 171.8 (OCO),
155.2 (NCO), 80.3 (C(CH3)3), 63.4 (CH2OCO), 62.2 (CH2OH), 51.4 (CHN), 28.7 (3 x 
CCH3), 21.2 (COCH3); MS (CI+): m/z 234 (MH+, 45%), 178 (100), 160 (53), 134 (62), 
118 (60), 1 0 2  (72); Anal, calcd. for C10H19NO5: C 51.49%, H 8 .2 1 %, N 6 .0 0 %; found: 
C 51.1%, H 8.2%, N 5.9%.
Traces of diacetylated serinol 3.21 (0.030 g, 3%) were obtained as a yellow oil; Rf (n- 
hexane/EtOAc 50:50) = 0.70; HPLC (Chiralcel® OD column, n-hexane/isopropanol 
95:5, 1 mLmin'1, X = 210 nm): tR = 9.7 min; IR (CH2CI2): v = 3360 (br), 2975, 1745, 
1715, 1520, 1370, 1230, 1165, 1045 cm'1; 1H NMR (300 MHz, CDCI3): 5H = 4.90 (1H, 
br s, NH), 4.19-4.08 (5H, m, 2  x CH^OCO and CHN), 2.08 (6 H, s, 2  x COCH3) 1.45 
(9H, s, 3 x CCH3); 13C NMR (75.5 MHz, CDCI3): 5C = 168.7 (2 x OOOCH3), 153.3 
(NCO), 80.0 (C(CH3)3), 61.2 (2 x CH20), 46.4 (CHN), 26.3 (3 x CCH3), 18.8 
(COCH3); MS (CI+): m/z 276 (MH\ 29%), 220 (100), 202 (35), 176 (65), 160 (6 6 ), 
1 0 2  (61).
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Preparation of (/yS)-(+/-)-4-acetoxymethyl-2-oxazolidinone rao3.32
o
nh
O ^X^O C O C H g
Powdered K2C03 (0.010 g, 0.07 mmo!) was added to desymmetrised serinol (R)-3.2 
(0.676 g, 2.89 mmol) and the mixture was heated to 130 °C with magnetic stirring 
under vacuum, until the gas evolution stopped (approximately 2 hours). After cooling 
down to room temperature, the mixture was purified by flash chromatography (Si02, 
n-hexane/EtOAc 10:90), to give raoZ.2 as a colourless oil. Recrystallisation from n- 
hexane/isopropanol afforded rao3.3 as a white solid (0.263 g, 57%); mp 77-79 °C; Rf 
(n-hexane/EtOAc 10:90) = 0.41; HPLC (Chiralcel® AD column, n-hexane/isopropanol 
90:10, 1 mLmin'1, X = 210 nm): tR = 16.3 and 18.8 min; IR (film): v = 3435, 2950, 
1720, 1660, 1450, 1370, 995 cm'1; 1H NMR (300 MHz, CDCI3): 8 H = 5.71 (1 H, br s, 
NH), 4.51 (1 H, dd, app. t, J = 8.5 Hz, CHHO), 4.24-4.01 (4H, m, CH/OCOCH3, 
CHHO, CHN), 2.11 (3H, s, COCH3); 13C NMR (75.5 MHz, CDCI3): 8 C = 170.8 (OCO),
159.8 (NCO), 66.9 (CH2OCOCH3), 64.9 (CH2OCON), 51.1 (CHN), 20.7 (COCH3); MS 
(CI+): m/z 160 (MH+, 1 0 0 %), 118 (23), 99 (2 0 ), 8 6  (30); Anal, calcd. for C6H9N04: C 
45.28%, H 5.70%, N 8.80%; found: C 45.3%, H 5.7%, N 8 .6 %.
General procedure for the enzymatic hydrolysis of (/tfS)-(+/-)-4-acetoxymethyl- 
2-oxazolidinone rao  3.3
In a typical experiment a solution of rao3.3 (0.095 g, 0.60 mmol) in aqueous 
phosphate buffer (1 .5 mL, 0.1 M, pH 7) was stirred at 30 °C with the lipase (0.084 g, 
140 mgenzyme/mmolsubstrate)- After 8  hours, the reaction was stopped by filtering off the 
enzyme. The aqueous phase was extracted with ethyl acetate ( 3 x 2  mL) and the 
combined organic extracts were concentrated in vacuo. The residue was purified by 
flash chromatography (EtOAc/MeOH, 90:10) to give (R)-3.22 as a white solid. Yields 
and specific rotations [Lit.3 [a] D30 = +32.2 (c 1.04, MeOH)] of the products obtained 
using different lipases are reported in Table 7.1.
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CALB 0 , 2 0 33 +30.0 93
PCL 0.26 36 +27.0 90
PPL 0.25 42 +29.0 84
a Optical purity= {[a] D30 of obtained (R)-4}/{[a] D30 of enantiopure (fl)-4) x 100 
(fl)-(+)-4-Hydroxymethyl-2-oxazolidinone (fl)-3.223
o
Hydroxymethyl oxazolidinone (R)-3.22 was obtained as a white solid; mp 95-97 °C 
(Lit.3 96-99 °C); Rf (EtOAc/MeOH, 90:10) = 0.38; 1H NMR (300 MHz, D20): 5H = 4.50 
(1 H, dd, app. t, J=  9.0, CHHOCON), 4.23 (1H, dd, J =  9.0, 5.2, CHHOCON), 4.04- 
3.97 (1H, m, CHN), 3.61 (1H, dd, J=  12.0 and 3.7, CHHOH), 3.52 (1H, dd, J=  12.0 
and 4.1 Hz, CHHOH).
Preparation of (S)-(-)-4-acetoxymethyl-2-oxazolidinone (S)-3.345
o
y —nh
< \^ L ^ o c o c h 3
To a stirred solution of (R)-3.2 (0.700 g, 3.00 mmol) in THF (90 mL) was added 
thionyl chloride (1.8 mL, 24.6 mmol) at room temperature under a nitrogen 
atmosphere. After the solution was heated at reflux for 5 hours, the reaction mixture 
was concentrated in vacuo and the residue was purified by flash chromatography 
(EtOAc/hexane 90:10). Recrystallisation from n-hexane/isopropanol afforded (S)-3.3 
as a white solid (0.343 g, 72%); mp 77-79 °C; Rf (n-hexane/EtOAc 10:90) = 0.41; 
HPLC (Chiralcel® AD column, n-hexane/isopropanol 90:10, 1 mLmin'1, X = 210 nm):
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tR = 18.8 min; [a] D30 = -40.7 (c 1.35, CHCI3); IR (CH2CI2): v = 3435, 2950,1720, 1660, 
1450, 1370, 995 cm'1; 1H NMR (300 MHz, CDCI3): 5H = 5.71 (1 H, br s, NH), 4.51 (1 H, 
dd, app. t, J  = 8.5 Hz, CHHOCON), 4.24-4.01 (4H, m, CH^OCOCHg, CHHOCON, 
CHN), 2.11 (3H, s, COCH3)\ 13C NMR (75.5 MHz, CDCI3): 8 C = 170.8 (OCO), 159.8 
(NCO), 66.9 (CH2OCOCH3), 64.9 (CH2OCON), 51.1 (CHN), 20.7 (COCH3); HRMS 
(FAB+): calcd. for C6 H9N04 159.0532, found 159.0535; Anal, calcd. for CeHgNO^ C 
45.28%, H 5.70%, N 8.80%; found: C 45.3%, H 5.7%, N 8 .6 %.
Preparation of (S)-(-)-4-hydroxymethyl-2-oxazolidinone (S)-3.22
A solution of (S)-3.3 (0.033 g, 0.21 mmol) in aqueous phosphate buffer (0.5 mL, 0.1 
M, pH 7) was stirred at 30 °C with CAL B (0.028 g, 140 m g enzyme/nrimolsub) for 24 
hours. The aqueous layer was extracted with EtOAc (3 x 1 mL) and the combined 
organic extracts were concentrated in vacuo. Flash chromatography purification 
(Si02, EtOAc/MeOH, 90:10) afforded (S)-3.22 as a white solid (0.018 g, 77%); [afe30 
= -30.0 (c 0.6, MeOH); spectroscopic data were in accordance with those above 
described for (Ffy-3.22.
Preparation of (fl)-(-)-1-0-benzyl-3-0-acetyl-2-/\/-(benzyloxycarbonyl)serinol (/?)- 
3.236-8
.OCOCH.
To a stirred solution of (Fty3.2 (1.4 g, 6.00 mmol) in cyclohexane/DCM (60 mL, 
50:50) under nitrogen, benzyl-2,2,2,-trichloroacetimidate (3.3 mL, 17.7 mmol) was 
added. The reaction mixture was stirred with trifluoromethansulfonic acid (54 pL, 0.61 
mmol, 10%) at - 1 0  °C for 2  hours, warmed to 0  °C and then left warming to room 
temperature overnight. The reaction mixture was filtered, quenched with saturated 
NaHC03 solution (20 mL), and the aqueous layer was extracted with ethyl acetate (3 
x 50 mL). The combined organic layers were washed with brine (100 mL), dried
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(MgS04), filtered and concentrated in vacuo. The residue was purified by flash 
chromatography (Si02> n-hexane/EtOAc/CHCI3 70:20:10) to give (A3)-3.23 (1 . 2  g, 
55%) as a colourless solid, mp 119-121 °C; Rf (Si02> hexane/EtOAc/CHCI3 70:20:10) 
= 0.31; HPLC (Chiralcel OD® column, n-hexane/isopropanol 90:10, 1 mLmin'1, X = 
254 nm): tR = 8.7 min; [a] 30 = -5.2 (c 3.25, CHCI3); IR (CH2CI2): v = 3365 (br), 1711 
(br), 1525, 1235 cm'1; 1H NMR (400 MHz, CDCI3): 5H = 7.36-7.26 (10H, m, 2 x C6 H5),
5.19 (1H, d, J =  8.2 Hz, NH), 5.10 (2H, s, C02CH2 Ph), 4.52 (1 H, d, J = 12.2 Hz, 
CH2OCHHPh), 4.48 (1H, d, J = 12.1 Hz, CH2OCHHPh), 4.24-4.03 (3H, m, 
CHsOCOCHa, CHN), 3.58 (1H, dd, J=  3.3 and 9.3 Hz, CHHOCH2Ph), 3.50 (1H, dd, J 
= 4.7 and 9.3 Hz, CHHOCH2 Ph), 1.99 (3H, s, COCH3); 13C NMR (100 MHz, CDCI3): 
8 C = 170.8 (OCO), 155.5 (NCO), 137.2, 135.9, 128.2 (2 C), 128.1 (2 C), 127.9, 127.8,
127.5 (2C), 127.4 (2C) (aromatic C), 73.1 (CH2OCH2 Ph), 68.4 (CH2OCH2Ph), 66.7 
(C02 CH2Ph), 63.2 (CH2OCOCH3), 49.5 (CHN), 21.0 (COCH3); MS (CI+): m/z 358 
(MH+, 25%), 314 (31), 181 (42), 161 (73), 91 (100).
Compound 3.24 was obtained in traces (<1%) as a yellow oil; Rf (Si02, n- 
hexane/EtOAc/CHCI3 70:20:10) = 0.44; IR (CH2CI2): v = 3345, 2970, 2930, 1740, 
1711, 1510, 1365, 1235, 1165, 1045 cm*1; 1H NMR (300 MHz, CDCI3): 8 H = 7.37-7.26 
(5H, m, C6 H5), 4.93 (1 H, d, J=  7.9 Hz, NH), 4.53 (1H, d, J=  12.2 Hz, CH2OCHHPh), 
4.49 (1 H, d, J=  1 2 . 1  Hz, CH2OCHHPh), 4.23-4.03 (3H, m, CH£>COCH3, CHN), 3.56 
(1H, dd, J = 3.4 and 9.4 Hz, CHHOCH2Ph), 3.48 (1H, dd, J = 5.2 and 9.4 Hz, 
CHHOCH2Ph), 2.01 (3H, s, COCH3), 1.44 (9H, s, 3 x CCH3); 13C NMR (75.5 MHz, 
CDCI3): 8 c = 171.2 (OCO), 155.7 (NCO), 138.1, 128.9 (2C), 128.5, 128.2 (2C) 
(aromatic C),80.3 (C(CH3)3), 73.6 (CH2OCH2 Ph), 69.1 (CH2OCH2 Ph), 63.9 
(CH2OCOCH3), 49.5 (CHN), 28.7 (C(CH3)3), 21.2 (COCH3); MS (CI+): m/z 324 (MH+, 
29%), 268 (6 8 ), 224 (100), 91 (33).
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Preparation of (fl)-(+)-4-benzyloxymethyl-2-oxazolidinone 3.25
HN
Powdered K2C03 (0.010 g, 0.07 mmol) and water ( 8  pl_, 0.44 mmol, 20%) were 
added to 3.23 (0.725 g, 2.02 mmol). The mixture was heated to 150 °C with magnetic 
stirring under vacuum, until the gas evolution stopped. After cooling down to room 
temperature, the mixture was purified by flash chromatography (Si02, EtOAc/n- 
hexane, 65:35), to afford 3.25 (0.264 g, 63%) as a cream solid; mp 49-51 °C; Rf 
(Si02, EtOAc/n-hexane 65:35) = 0.34; HPLC (Chiralcel OD® column, n- 
hexane/isopropanol 75:25, 1 mLmin'1, X = 254 nm): tR = 22.0 min; [a]D30= +25.0 (c 
0.08, CHCI3); IR (CH2CI2): v = 3450, 2865, 1760, 1400, 1225, 1098 cm1; 1H NMR 
(300 MHz, CDCI3): 8 h = 5.28 (1H, br s, NH), 4.54 (2H, s, CH2OCH2Ph) 4.47 (1H, dd, 
app. t, J=  8.4 Hz, CHHOCO), 4.13-4.02 (2H, m, CHHOCO, CHN), 3.50-3.46 (2 H, m, 
CH^OCHgPh); 13C NMR (100 MHz, CDCI3): 8 C = 160.0 (NCO), 137.3, 128.8 (2C),
128.3, 128.0 (2C) (aromatic C), 73.9 (CH2OCH2 Ph), 72.1 (CH2OCH2 Ph), 67.3 
(CH2OCO), 52.2 (CHN); MS (CI+): m/z 208 (MH\ 100%), 174 (21), 91 (36); HRMS 
(FAB+): calcd. for CnH^NOs 207.0895, found 207.0904; Anal, calcd. for CHH13NO3 : 
C 63.76%, H 6.32%, N 6.76%; found: C 64.1%, H 6.3%, N 6.4%.
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7.3 Experimental for Chapter 4
General procedure for the lipase-catalysed JV-acylation of (fifS)-(+/-)-4-benzyl-2- 
oxazolidinone rao-4.24
In a typical experiment a solution of rao-4.24 in organic solvent (diisopropyl ether, n- 
hexane, dioxane, toluene, vinyl acetate, vinyl propionate, diisopropyl ether/water, n- 
hexane/isopropanol or n-hexane/water) was stirred with the enzyme and the 
acylating agent (vinyl propionate, vinyl acetate, ethyl propionate, substrate/acyl donor 
molar ratio 1:1-1:10) at 40 °C.
Reaction details are illustrated in Table 4.1. All reactions were performed in 
duplicate.
At different times, aliquots of the reaction mixture were taken, worked up by addition 
of n-hexane/isopropanol, filtered and analysed. Conversion and enantiomeric excess 
values were monitored by chiral HPLC (Chiralcel® OD column, n-hexane/isopropanol 
75:25, ImLmin'1, X = 254 nm and Chiralcel® AD column, n-hexane/isopropanol 90:10, 
ImLmin'1, X = 254 nm).
Lipase-catalysed /V-acylation of (ftfS)-(+/-)-4-isopropyl-2-oxazolidinone rac-4.27, 
(fifS)-(+/-)-4-methyl-2-oxazolidinone rac-4.28 and 2-oxazolidinone 4.29
/7ac-4.27, rac-4.28 and 4.29 (0.30 mmol) were separately reacted with vinyl acetate 
in a vinyl acetate solution (1 mL, 3 M), in the presence of Candida antarctica lipase B 
as catalyst (33-167 m g enzyme/mmolSubstrate), for 24 hours at 40 °C.
Reaction details are illustrated in Table 4.2. All reactions were performed in duplicate 
and monitored by TLC.
General procedure for the lipase-catalysed hydrolysis of (fifS)-(+/-)-3-propionyl- 
4-benzyl-2-oxazolidinone rac-4.25
In a typical experiment rac-4.25 (0.005 g, 0.02 mmol, 0.01 M) was dissolved in either 
tris/HCL ( 2  mL, 5 mM, pH 7.2) or hepes/HCI (2 mL, 10 mM, pH 7.2) aqueous buffer 
solutions at 40 °C. The reaction was started by the addition of CAL B or CCL (0.030 
g, 1.5 mgenzyme/mmolsubstrate). Reaction details are illustrated in Table 4.3.
After 72 hours, samples were extracted with ethyl acetate, dried over MgS04, 
concentrated in vacuo and analysed by chiral HPLC (Chiralcel® OD column, n-
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hexane/isopropanol 75:25, ImLmin'1, X = 254 nm and Chiralcel® AD column, n- 
hexane/isopropanol 90:10, ImLmin'1, X = 254 nm).
General procedure for the hydrolysis of (/tfS)-(+/-)-3-propionyl-4-benzyl-2- 
oxazolidinone rao4.25 catalysed by other hydrolases
In a typical experiment rac-4.25 (0.070 g, 0.30 mmol) was dissolved in phosphate 
aqueous buffer (1 mL, 0.01 M, pH 7) at 40 °C. The reaction was started by the 
addition of the enzyme (protease from Aspergillus oryzae, proteinase from Bacillus 
subtilis, Penicillum amidase from Escherichia coli or esterase from hog liver 
immobilised on Eupergit C, 67-133 m g enzyme/rnnriolsubstrate )■ Reaction details are 
illustrated in Table 4.4.
After 48 hours, samples were extracted with ethyl acetate, dried over MgS04, 
concentrated in vacuo and analysed by chiral HPLC (Chiralcel® OD column, n- 
hexane/isopropanol 75:25, ImLmin'1, X = 254 nm and Chiralcel® AD column, n- 
hexane/isopropanol 90:10, ImLmin'1, X = 254 nm).
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7.4 Experimental for Chapter 5





A solution of lithium diisopropylamide was freshly prepared as follows. To a solution 
of diisopropylamine (350 pL, 2.50 mmol) in THF (10 mL) at 0 °C under an 
atmosphere of nitrogen, n-BuLi (1.6 M in n-hexane, 1.6 mL, 2.50 mmol) was added. 
After 10 min the solution was cooled to -78 °C and 4-benzyl-3-propionyl-2- 
oxazolidinone (0.580 g, 2.48 mmol), dissolved in THF (5 mL), was added dropwise 
over 3 min. After addition was complete, the mixture was stirred at -78 °C for 30 min. 
To the solution at -78 °C, benzaldehyde (254 pL, 2.50 mmol) was added. After 3-5 s, 
the reaction mixture was quenched with saturated aqueous NH4CI solution (2 mL) 
and then warmed to room temperature.
The reaction mixture was diluted with water and extracted with diethyl ether ( 2x10  
mL). The organic extracts were washed with 1 M HCI (10 mL), 1 M NaOH (10 mL), 
and saturated NaCI aqueous solution (10 mL), dried over MgS04 and concentrated in 
vacuo. The residual mixture of isomers was purified by flash chromatography (n- 
hexane/Et20  50:50) to give 5.7 as a yellow oil (0.547 g, 65%); 1H NMR (400 MHz, 
CDCI3); §h = 7.46-7.25 (10H, m, 2 x CGH5), 5.16 (1H, t, J=  3.6 Hz, CHOH), 4.70-4.63 
(1 H, m, CHN), 4.19-4.11 (3H, m, C H A  COCHCH3), 3.20-3.10 (1 H, m, CHHPh), 2.87 
(1H, d, J=  3.2 Hz, OH), 2.65-2.55 (1 H, m, CHHPh), 1.17 (3H, d, J =  7 Hz, CH3). 1H 
NMR data were in accordance with those reported in literature. 10
Enzymatic resolution of 5.7
A mixture of 5.7 (0.050 g, 0.15 mmol) and vinyl acetate (30 pL, 0.32 mmol) in organic 
solvent (2 mL, n-hexane or vinyl acetate) was stirred with Candida antarctica lipase 
type B (0.022 g, 150 mgenzyme/mrnolSUbstrate) for 72 hours at 40 °C. Periodically aliquots 
were removed, filtered and diluted in n-hexane/isopropanol 80:20, and analysed by
144
Claudia Neri - University of Bath Experimental
Chapter 7
chiral HPLC (Chiralcel® OD column, n-hexane/isopropanol 80:20, 1 mLmin'1, X = 254 
nm).
Preparation of (4/7,2’S,3’/?)- and (4/?,2’S,3,S)-A/-(3-hydroxy-2-methylbutanoyl)-4- 
benzyl-2-oxazolidinone 5.8s
A solution of TiCL in dichloromethane (1 M, 5.4 mL, 5.40 mmol) was added to a 
stirred solution of 4-benzyl-/V-propionyl-2-oxazolidinone (/7)-5.5 (0.606 g, 2.60 mmol) 
in dichloromethane (20 mL) at -78 °C under an atmosphere of nitrogen. After 10 
minutes, diisopropylethylamine (900 pL, 5.40 mmol) was added, followed 1 hour later 
by freshly distilled acetaldehyde (300 pL, 5.35 mmol). The reaction mixture was 
maintained at -78 °C for 5 hours and allowed to warm to room temperature overnight. 
Saturated NH4CI solution (10 mL) was added and the mixture was extracted with 
DCM (3 x 50 mL). The dichloromethane extracts were washed with water (30 mL), 
dried over MgS04 and concentrated in vacuo. Purification by flash chromatography 
(Si02, n-hexane/EtOAc 50:50) gave a mixture of (4/7,2’S,3’R)r and (4/7,2’S,3’S)-5.8 
as a white solid (0.360 g, 50%, 1:1); mp 89-93 °C; Rf (n-hexane/EtOAc, 50:50) = 
0.63; HPLC (Chiralcel ® OD column, n-hexane/isopropanol, 80:20, 1 mLmin’1, X = 
254 nm): tR = 11.0 and 1 2 . 2  min; 1H NMR (300 MHz, CDCI3): 6 H = 7.36-7.21 (10H, m, 
2 x C6 H5), 4.73-4.65 (2 H, m, 2 x NCH), 4.24-4.18 (5H, m, 2  x CHCH20, CHOH), 
3.99-3.92 (1H, m, CHOH), 3.87-3.77 (2H, m, 2 x COCHCH3), 3.34-3.28 (2 H, m, 2 x 
CHHPh), 2.87 (1H, d, J=  2.8 Hz, OH), 2.82-2.73 (2H, m, 2 x CHHPh), 2.61 (1H, d, J 
= 7.7 Hz, OH), 1.30 (3H, d, J = 6.3 Hz,COCHCH3), 1.24 (3H, d, J  = 6.4 Hz, 
COCHCHg), 1 . 2 1  (3H, d, J = 2.5 Hz, CHOHCH3), 1.19 (3H, d, J = 2.4 Hz, 
CHOHCH3); 13C NMR (75.5 MHz, CDCI3): 5C = 176.6 and 176.7 (2 x CCO), 153.4 
and 153.5 ( 2  x OCON), 135.1, 135.2, 129.5 (2C), 129.4 (2 C), 129.0 (2C), 128.9 (2C),
127.4, 127.3 (2 x aromatic C), 68.1 and 70.6 (2 x CHOH), 66.1 and 66.2 (2 x CH20),
55.4 and 55.6 (2 x C H N ) ,  43.0 and 45.0 (2 x C O C H C H 3 ) ,  37.8 and 38.0 (2 x CH2Ph),
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Hydroxy oxazolidinones (4S,2’/7,3’S)- and (4S,2,/7,3'A?)-5.8 were synthesised using 
the same quantities and following the procedure above described for the synthesis of 
(4/7,2’S,3’/7)- and (4/7,2’S,3’S)-5.8. In this case (S)-5.5 (0.606 g, 2.60 mmol) was 
reacted with acetaldehyde (300 pL, 5.35 mmol). Purification by flash chromatography 
(Si02, n-hexane/EtOAc 50:50) afforded a mixture of (4S,2’/7,3’S)- and (4S,2,/?,3,fl)-
5.8 as a white solid (0.389 g, 54%, 1:1); mp 90-95 °C; Rf (n-hexane/EtOAc, 50:50) = 
0.59; HPLC (Chiralcel® OD column, n-hexane/isopropanol, 80:20, 1 mLmin'1, X = 254 
nm): tR = 11.6 and 12.8 min; 1H NMR (300 MHz, CDCI3): 8 H = 7.36-7.22 (10H, m, 2 x 
C6 H5), 4.72-4.66 (2H, m, 2 x NCH), 4.24-4.16 (5H, m, 2 x CHCH20, CHOH), 4.09- 
3.99 (1 H, m, CHOH), 3.97-3.78 (2H, m, 2  x COCHCH3), 3.34-3.28 (2 H, m, 2  x 
CHHPh), 2.86 (1H, d, app. s, OH), 2.82-2.75 (2H, m, 2 x CHHPh), 2.57 (1H, d, J =
7.4 Hz, OH), 1.31 (3H, d, J = 6 . 6  Hz, COCHCH3), 1.24 (3H, d, J = 6 . 6  Hz, 
COCHCH3), 1.21 (3H, d, J = 2.3 Hz, CHOHCH3), 1.20 (3H, d, J = 2.4 Hz, 
CHOHCH3);13C NMR (100 MHz, CDCI3): 6 C = 177.1 (2 x COO), 152.9 (2 x OOON),
134.8 (2C), 129.2 (4C), 128.8 (4C), 127.3 (2 C) (aromatic C), 67.6 (2 x CHOH), 66.1 
(2 x CH20), 55.1 (2 x CHN), 43.1 (2 x COCHCH3), 37.8 (2 x CH2Ph), 19.6 (2 x 
CHOHCH3), 10.6 ( 2  x COCHCH3).
General procedure for the enzymatic resolution of (4/7,2’S,3’R)- and 
(4/7,2’5,3’S)-5.8
In a typical experiment alcohols (4/7,2’S,3’/7)- and (4/7,2’S,3’S)-5.8 (0.055 g, 0.20 
mmol) and Candida antarctica lipase type B (0.010 g, 50 mgenzyme/mmolSubstrate) in 
organic solvent (vinyl acetate, n-hexane, toluene, dichloromethane or diisopropyl 
ether, 1 ml) were stirred with vinyl acetate (40 pL, 0.40 mmol) at 40 °C. Periodically 
aliquots were removed, filtered, diluted in a n-hexane/isopropanol 80:20 solution, and 
analysed by chiral HPLC (Chiralcel® OD column, n-hexane/isopropanol, 80:20, 1
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mLmin'1, X = 254 nm). Conversions and enantiomeric excesses obtained in the 
different solvents at different reaction times are reported in Tables 5.1 and 5.2.
After 24-48 hours, the reaction was stopped by filtering off the enzyme and ester 
(4/?,2'S,3,f?)-5.9 was separated from unreacted alcohol (4fl,2’S,3’S)-5.8 by flash 
chromatography (Si02, n-hexane/EtOAc 60:40).
(4/?,2'S,3'/7)-A/-(3-acetoxy-2-methylbutanoyl)-4-benzyl-2-oxazolidinone
(4/?,2'S,3,fl)-5.9





Ester (4/?,2'S,3'fl)-5.9 was obtained as a yellow oil (0.025 g, 40% yield for the 
reaction was performed in n-hexane); Rf (n-hexane/EtOAc, 60:40) = 0.64; HPLC 
(Chiralcel® OD column, n-hexane/isopropanol, 80:20, 1 mLmin'1, X = 254 nm): tR 8.7 
min; [ctfe30 = -9.4 (c 1.0, CHCI3); IR (film): v = 1780, 1735, 1695 cm'1; 1H NMR (300 
MHz, CDCI3): 5h = 7.36-7.22 (5H, m, C6 H5), 5.40 (1H, dq, J = 4.2 and 6.4 Hz, 
CHOCOCH3), 4.71-4.63 (1 H, m, NCH), 4.20-4.08 (2 H, m, CHCH20), 3.91 (1 H, dq, J 
= 4.2 and 6.9 Hz, COCHCH3), 3.34 (1 H, dd, J=  3.3 and 13.4 Hz, CHHPh), 2.67 (1 H, 
dd, J=  10.3 and 13.4 Hz, CHHPh), 2.04 (3H, s, OCOCH3), 1.33 (3H, d, J=  6.4 Hz, 
COCHCH3), 1.22 (3H, d, 6.9 Hz, AcOCHCH3); 13C NMR (75.5 MHz, CDCI3): 6 C =
174.3 (CCO), 170.7 (OOOCH3), 153.7 (OCON), 135.9, 129.8 (2 C), 129.3 (2 C), 127.6 
(aromatic C), 70.7 (CHOCOCH3), 6 6 . 6  (CH20), 55.8 (CHN), 42.7 (COCHCH3), 38.1 
(CH2Ph), 21.5 (OCOCH3), 18.4 (AcOCHCH3), 1 1 . 2  (COCHCH3); MS (EI+, 70eV): m/z 
320 (M++1, 77%), 260 (100), 178 (15), 143 (14), 117.1 (10), 83 (69); Anal, calcd. for 
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Unreacted alcohol (4/?,2’S,3’S)-5.8 was obtained as a white solid (0.019 g, 35% yield 
for the reaction was performed in n-hexane); mp 74-76 °C; Rf (n-hexane/EtOAc, 
50:50) = 0.63; HPLC (Chiralcel® OD column, n-hexane/isopropanol, 80:20, 1 mLmin' 
1, A. = 254 nm): tR 1 2 . 2  min; [a]D30= -19.8 (c0.5, CHCI3); IR (CH2CI2): v = 3570 (br), 
1780, 1690 cm'1; 1H NMR (300 MHz, CDCI3): 8 H = 7.37-7.22 (5H, m, C6 H5), 4.73-4.65 
(1H, m, NCH), 4.24-4.16 (2H, m, CHCH20), 3.96 (1H, dq, app. t, J=  6.4 Hz, CHOH), 
3.83 (1H, dq, J =  7.0 and 7.0 Hz, COCHCH3), 3.33 (1H, dd, J =  3.3 and 13.4 Hz, 
CHHPh), 2.79 (1H, dd, J=  9.6 and 13.4 Hz, CHHPh), 2.55 (1H, br s, OH), 1.31 (3H, 
d, J = 6.3 Hz, COCHCH3),1.20 (3H, d, J=  6.9 Hz, CHOHCH3); 13C NMR (75.5 MHz, 
CDCI3): 8 c = 176.6 (CCO), 153.2 (OCON), 135.2, 129.4 (2C), 128.9 (2C), 127.3 
(aromatic Q, 70.7 (CHOH), 66.1 (CH20), 55.6 (CHN), 45.0 (COCHCH3), 37.8 
(CH2Ph), 21.2 (CHOHCH3), 14.6 (COCHCH3).
General procedure for the enzymatic resolution of (4S,2,/7,3’5)- and 
(4S,2'/7,3,fl)-5.8
Enzymatic resolution of (4S,2’/?,3’S)- and (4S,2'/?,3'/3)-5.8 was carried out as above 
described for the enzymatic resolution of (4/?,2’S,3’/3)- and (4/?,2’S,3’S)-5.8. The 
reactions in different solvents were followed by chiral HPLC (Chiralcel® OD column, 
n-hexane/isopropanol, 80:20, 1 mLmin'1, X = 254 nm). Conversions and enantiomeric 
excesses obtained in the different solvents at different reaction times are reported in 
Tables 5.3 and 5.4.
After 24-48 hours, the reaction was stopped by filtering off the enzyme and the 
acylated oxazolidinone (4S,2'/?,3'fl)-5.9 was separated from unreacted alcohol 
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Acylated oxazolidinone (4S,2l/7,3,/7)-5.9 was obtained as a white solid (0.024 g, 38% 
yield for the reaction performed in vinyl acetate); mp 89-91 °C; Rf (n-hexane/EtOAc, 
60:40) = 0.58; HPLC (Chiralcel® OD column, n-hexane/isopropanol, 80:20, 1 mLmin' 
1, X = 254 nm): tR 14.1 min; [a]D30= +40.0 (c 1 .0 , CHCI3); IR (CH2CI2) v= 1790, 1740, 
1690 cm'1; 1H NMR (400 MHz, CDCI3): 6 H = 7.37-7.21 (5H, m, C6H5), 5.22 (1 H, dq, J 
= 6.3 and 8 . 8  Hz, CHOCOCH3), 4.74-4.66 (1H, m, NCH), 4.23-4.13 (2H, m, CH20),
4.07 (1H, dq, J = 7.0 and 8 . 8  Hz, COCHCH3), 3.24 (1H, dd, J = 3.2 and 13.2 Hz, 
CHHPh), 2.74 (1H, dd, J =  9.5 and 13.2 Hz, CHHPh), 2.00 (3H, s, OCOCH3), 1.31 
(3H, d, J=  6.3 Hz, COCHCH3), 1.20 (3H, d, J=  7.0 Hz, AcOCHCH3); 13C NMR (100 
MHz, CDCI3): 6 c = 174.5 (CCO), 170.0 (OCOCH3), 153.0 (OCON),135.0, 129.4 (2C),
129.0 (2C), 127.4 (aromatic C), 72.1 (CHOCOCH3), 65.8 (CH20), 55.2 (CHN), 42.7 
(COCHCH3), 37.7 (CH2Ph), 21.1 (OCOCH3), 17.2 (AcOCHCH3), 13.7 (COCHCH3); 
MS (EI+, 70 eV): m/z 319 (M +, 70%), 303 (40), 286 (26); 259 (34), 143 (32), 117 
(25), 83 (100), 55 (30), 43 (60); Anal.calc. for Ci7H21N05: C 63.93%, H 6.62%, N 





Unreacted alcohol (4S,2’/?,3’S)-5.8 was obtained as a white solid (0.017 g, 30% yield 
for the reaction performed in vinyl acetate); mp 112-114 °C; Rf (n-hexane/EtOAc, 
50:50) = 0.59; HPLC (Chiralcel ® OD column, n-hexane/isopropanol, 80:20, 1 mLmin' 
\ X  = 254 nm) tR = 12.8 min; [ajo30 = +42.0 (c 0.50, CHCI3); IR (CH2CI2): v = 3575 
(br), 1775, 1690 cm'1; 1H NMR (300 MHz, CDCI3): SH = 7.37-7.21 (5H, m, C6 H5), 4.73- 
4.65 (1 H, m, NC/-/), 4.24-4.15 (3H, m, CHCH20, CHOH), 3.84 (1H, dq, J=  3.0 and
7.0 Hz, COCHCH3), 3.31 (1H, dd, J=  3.4 and 13.4 Hz, CHHPh), 2.86 (1H, d, J=  2.5 
Hz, OH), 2.77 (1H, dd, J = 9.6 and 13.4 Hz, CHHPh), 1.23 (3H, d, J = 6.4 Hz, 
COCHCH3), 1.21 (3H, d, J=  7.0 Hz, CHOHCH3); 13C NMR (75.5 MHz, CDCI3): 8 C =
176.7 (CCO), 153.4 (OCON), 135.1, 129.4 (2C), 128.9 (2C), 127.4 (aromatic C), 68.1
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(CHOH), 66.1 (CH20), 55.4 (CHN), 43.0 (COCHCH3), 38.0 (CH2Ph), 19.5 
(CHOHCH3), 10.6 (COCHCH3).




TiCI4 (1M solution in DCM, 2.6 mL, 2.58 mmol) was added to a solution of N- 
propionyl-2-oxazolidinone (fl)-5.5 (0.576 g, 2.46 mmol) in dichloromethane (20 mL) 
at 0 °C under an atmosphere of nitrogen. The mixture was stirred for 5 min and (-)- 
sparteine (560 pL, 2.46 mmol) was added dropwise slowly. After complete addition 
and 20 min at 0 °C, the mixture was cooled to -78 °C and A/-methyl-2-pyrrolidinone 
(240 pL, 2.46 mmol) was added. The reaction mixture was stirred for 10 min, 
followed by addition of freshly distilled acetaldehyde (240 pL, 4.28 mmol) dropwise. 
The mixture was allowed to react for 1 h at -78 °C, gradually warmed to 0 °C, and 
stirred for 1 h. The reaction was quenched with half-saturated NH4CI (10 mL) and 
warmed to room temperature. The layers were separated and the aqueous layer was 
extracted twice with DCM ( 2x10  mL), dried over Na2S04, filtered and concentrated 
in vacuo. Purification via flash chromatography (Si02, n-hexane/EtOAc, 50:50) 
afforded (4/7,2’/7,3’S)-5.8 (0.348 g, 51%) as colourless crystals; mp 114-115 °C; Rf 
(n-hexane/EtOAc, 50:50) = 0.37; HPLC (Chiralcel® OD column, n-
hexane/isopropanol, 80:20, 1 mLmin'1, X = 254 nm): tR = 10.0 min; [a]D30= -54.5 (c 
0.99, CHCI3); 1H NMR (400 MHz, CDCI3): 6 H = 7.36-7.20 (5H, m, C6 H5), 4.74-4.67 
(1H, m, NCH), 4.26-4.10 (3H, m, CHCH20, CHOH), 3.74 (1H, dq, J = 2.7 and 7.0 Hz, 
COCHCH3), 3.25 (1H, dd, 3.5 and 13.2 Hz, CHHPh), 2.91 (1H, d, J = 2.7 Hz, 
OH), 2.79 (1H, dd, J = 9.7 and 13.4 Hz, CHHPh), 1.27 (3H, d, J = 7.0 Hz, 
COCHCH3), 1.21 (3H, d, J=  6.2 Hz, CHOHCH3); 13C NMR (75.5 MHz, CDCI3): 8 C =
178.0 (CCO), 153.7 (OCON), 135.6, 130.0 (2C), 129.6 (2C), 128.0 (aromatic C), 68.2 
(CHOH), 6 6 . 8  (CH20), 55.7 (CHN), 43.7 (COCHCH3), 38.4 (CH2 Ph), 20.1 
(CHOHCH3), 11.1 (COCHCH3); MS (FAB+): m/z 278 (MH+, 100%); HRMS (FAB+) 
calcd. for C15H19N04: 277.1314, found 277.1314; Anal, calcd. for Ci5Hi9N04: C
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64.97%, H 6.91%, N 5.05%; found: C 64.3%, H 6.9%, N 5.1%. See Appendices for 
crystal structure.
Preparation of (4S,2’S,3’fl)-/V-(3-hydroxy-2-methylbutanoyl)-4-benzyl-2- 
oxazolidinone (4S,2’S,3’/7)-5.812
Hydroxy oxazolidinone (4S,2’S,3,/3)-5.8 was synthesized following the procedure 
above described for the synthesis of (4/?,2’/?,3’S)-5.8. W-Propionyl-2-oxazolidinone 
(S)-5.5 (0.576 g, 2.46 mmol) was reacted with acetaldehyde (240 pL, 4.28 mmol) in 
the presence of TiCU (1M solution in DCM, 2.6 mL, 2.58 mmol), (-)-sparteine (560 pL,
2.46 mmol) and A/-methyl-2-pyrrolidinone (240 pL, 2.46 mmol). Purification via flash 
chromatography (Si02, hexane/EtOAc, 50:50) afforded (4S,2’S,3’/7)-5.8 as 
colourless crystals (0.355 g, 52%); mp 113-114 °C; Rf (n-hexane/EtOAc, 50:50) = 
0.37; HPLC (Chiralcel® OD column, n-hexane/isopropanol, 80:20, 1 mLmin'1, X = 254 
nm) tR = 16.7 min; [afe30 = +56.5 (c 0.99, CHCI3) [Lit. 10 +60.9 (c 0.99, CHCI3)]; 1H 
NMR (400 MHz, CDCI3): 8 H = 7.36-7.20 (5H, m, C6 H5), 4.74-4.68 (1 H, m, NCH), 4.26- 
4.16 (3H, m, CHCHA CHOH), 3.74 (1H, dq, J = 2.7 and 7.0 Hz, COCHCH3), 3.25 
(1H, dd, J=  3.1 and 13.2 Hz, CHHPh), 2.93 (1H, d, J=  2.3 Hz, OH), 2.78 (1H, dd, J =
9.3 and 13.2 Hz, CHHPh), 1.28 (3H, d, J=  7.0 Hz, COCHCH3), 1.22 (3H, d, J=  6 . 6  
Hz, CHOHCH3); 13C NMR (75.5 MHz, CDCI3): 8 C 174.4 (CCO), 153.1 (OCON),
135.0, 129.4 (2 C), 129.0 (2C), 127.5 (aromatic C), 67.6 (COH), 66.2 (CH20), 55.1 
(CHN), 43.1 (COCHCH3), 37.8 (CH2 Ph), 19.6 (CHOHCH3),10.1 (COCHCH3); MS 
(FAB+): m/z 278 (MH+, 100%); Anal, calcd. for C15H19N04: C 64.97%, H 6.91%, N 
5.05%; found: C 65.0%, H 6.9%, N 5.1%.
Lipase-catalysed acetylation of alcohol (4S,2’S,3’R)-5.8
Alcohol (4S,2’S,3’fl)-5.8 (0.100 g, 0.36 mmol) and Candida antarctica lipase type B 
(0.010 g, 30 mgenzyme/mmolsubstrate) were stirred with vinyl acetate (1.7 mL) at 40 °C. 
Periodically aliquots were removed, filtered, diluted in a n-hexane/isopropanol 80:20,
Ph
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and analysed by chiral HPLC. Time course of the enzymatic reaction are reported in 
Table 5.6.
After 72 hours, the reaction was stopped by filtering off the enzyme and acylated 







Acylated oxazolidinone (4S,2’S,3’fl)-5.9 was obtained as yellow needles (0.086 g, 
75%); mp 79-80 °C; Rf (n-hexane/EtOAc, 60:40) = 0.66; HPLC (Chiralcel® OD 
column, n-hexane/isopropanol 80:20, 1 mLmin'1, X = 254 nm): tR = 8.2 min; [a] D30 = 
+77.7 (c 0.99, CHCI3); IR (CH2CI2): v = 2975, 1780, 1735, 1695, 1450, 1370, 1225, 
1110 cm*1; 1H NMR (300 MHz, CDCI3): 5H = 7.36-7.19 (5H, m, C6 H5), 5.30 (1 H, dq, J 
= 4.3 and 6.4 Hz, CHOCOCH3), 4.64-4.56 (1 H, m, NCH), 4.28-4.08 (2 H, m, CMO), 
3.95 (1 H, dq, J = 4.3 and 6.9 Hz, COCHCH3), 3.27 (1 H, dd, J =3.1 and 13.2 Hz, 
CHHPh), 2.76 (1H, dd, J=  9.7 and 13.3 Hz, CHHPh), 2.05 (3H, s, OCOCH3), 1.28 
(3H, d, J=  6.5 Hz, COCHCH3),1.22 (3H, d, J=  6.9 Hz, AcOCHCH3); 13C NMR (75.5 
MHz, CDCI3): 6 C = 172.2 (CCO), 151.7 (OCON), 168.8 (OCOCH3), 133.5, 127.6 (2C),
127.1 (2C), 125.5 (aromatic C), 68.4 (CHOCOCH3), 64.5 (CH20), 54.0 (NCH), 40.5 
(COCHCH3), 36.1 (CH2Ph), 19.3 (OCOCH3), 16.2 (AcOCHCH3), 8.9 (COCHCH3); MS 
(EI+, 70eV): m/z 319 (M+, 10%), 259 (57), 244 (46), 178 (30), 83 (95), 43 (100); 
HRMS (EI+) calcd. for C17H21N05: 319.1420, found 319.1417; Anal, calcd. for 
C17H21N05: C 63.93%, H 6.62%, N 4.38%; found: C 63.5%, H 6 .6 %, N 4.2%.
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To a stirred suspension of NaBH4 (5.0 g, 125 mmol) in tetrahydrofuran (50 mL) 
racemic phenylalanine 5.11 (8.2 g, 49.6 mmol) was added. The flask was immersed 
in an ice-water bath and a solution of conc. H2S04 (3.3 mL, 61.9 mmol) in diethyl 
ether (total volume of 10 mL) was added dropwise at such a rate to maintain the 
reaction temperature below 20 °C. Stirring of the reaction mixture was continued at 
room temperature overnight. 5 N NaOH (50 mL) was then added and, after removing 
the solvent that distilled below 100 °C, the mixture was heated at reflux for 3 hours. 
The turbid aqueous mixture was cooled to room temperature with stirring before 
introducing NaHC03 (21.0 g, 250 mmol) in H20  (40 mL), followed by Me02CCI (4.7 
mL, 52.5 mmol, cooling with 5 °C bath).
After stirring at room temperature for another 1.5 hours, the mixture was filtered and 
extracted with EtOAc (4 x 30mL). The combined organic extracts were washed with 
H20  (15 mL) and brine (15 mL) and dried over MgS04. Removal of the solvent gave 
5.13 as a white solid. Powdered K2C03 (0.035 g, 0.25 mmol) was added and the 
mixture was heated to 125 °C with magnetic stirring under vacuum until the gas 
evolution stopped (approximately 2 hours). The product was dissolved in EtOAc (75 
mL) and the organic layer was washed with H20  (25 mL), dried (MgS04) and 
concentrated in vacuo. Recrystallysation from /7-hexane/EtOAc afforded rao-5.10 as 
a white solid (6.4 g, 72% overall yield); mp 88-90 °C (Lit.2 90-91 °C); [a] D30 = 0.0 (c
1.0, CHCI3); IR (CH2CI2): v  = 3450, 2920, 1760, 1400, 1250, 1025 cm'1; 1H NMR (300 
MHz, CDCI3): 8 H = 7.37-7.16 (5H, m, C6 H5), 5.18 (1H, s, NH), 4.48 (1H, app. t, J =
8.2 Hz, OCHH), 4.15 (1 H, dd, J=  5.6 and 8.4 Hz, OCHH), 4.11-4.04 (1H, m, CHN), 
2.93-2.81 (2H, m, CH2 Ph).
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Preparation of (/yS)-(+/-)-3-propionyl-4-benzyl-2-oxazolidinone rac-5.514
A solution of n-BuLi in n-hexane (1.6 M, 5.0 mL, 7.96 mmol) was added dropwise, 
over a period of 10 min, to a stirred solution of rac-5.10 (1.4 g, 7.96 mmol) in 
anhydrous THF (30 mL) at -78 °C under an inert atmosphere of nitrogen. The mixture 
was stirred at this temperature for 15 min and EtCOCI (0.7 mL, 7.96 mmol) was then 
added dropwise over 5 min. After 30 min the reaction quenched with sat. NH4CI 
solution (20 mL) and allowed to warm to room temperature over a 2 hour period. The 
mixture was extracted with EtOAc (3 x 20 mL) and the organic extracts were 
combined and washed with brine ( 2 0  mL). The dried solution (MgS04) was 
concentrated in vacuo and the residue was purified by recrystallisation (n- 
hexane/EtOAc) to give rao5.5 as a colourless crystalline solid (1.7 g, 91%); mp 43- 
45°C (Lit. 11 44-46°C); IR (CH2CI2): v = 2930, 1780, 1700, 1450, 1380, 1215, 1070 cm' 
1 1 ; H NMR (300 MHz, CDCI3): 8 H= 7.37-7.20 (5H, m, C6 H5), 4.71-4.63 (1 H, m, CHN), 
4.23-4.14 (2H, m, CH^O), 3.31 (1H, dd, J=  3.3 and 13.3 Hz, CHHPh), 3.04-2.88 (2H, 
dq app m, CH^CHa), 2.76 (1H, dd, J=  9.7 and 13.3 Hz, CHHPh), 1.20 (3H, t, J=  7.3 
Hz, CH3); 13C NMR (75.5 MHz, CDCI3): 5C= 175.2 (CCO), 154.6 (OCON), 136.4,
130.5 (2C), 130.0 (2 C), 128.4 (aromatic C), 67.3 (CH20), 56.3 (CHN), 39.0 (CH2Ph),
30.3 (CH2CH3), 9.4 (CH3). 1H and 13C NMR data were in accordance with those 
reported in literature. 15
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Synthesis of rac-syn-5.8 was carried out following the procedure previously 
described for the synthesis of (4/?,2’/?,3’S)-5.8. A/-Propionyl-2-oxazolidinone rac-5.5 
(0.576 g, 2.46 mmol) was reacted with acetaldehyde (240 pL, 4.28 mmol) in the 
presence of TiCI4 (1M solution in DCM, 2.6 mL, 2.58 mmol), (-)-sparteine (560 pL,
2.46 mmol) and A/-methyl-2-pyrrolidinone (240 pL, 2.46 mmol). Purification via flash 
chromatography (Si02, hexane/EtOAc, 50:50) afforded rac-syn-5.8 as a white 
crystalline solid (0.368 g, 54%, >99% d.e.); mp 113-114 °C; Rf (n-hexane/EtOAc, 
50:50) = 0.37; HPLC (Chiralcel® OD column, n-hexane/isopropanol, 80:20, 1 mLmin' 
1, X = 254 nm): tR= 1 0 . 0  and 16.7 min; [a]D30= 0 . 0  (c0.99, CHCI3); 1H NMR (300 MHz, 
CDCI3): 8 h = 7.37-7.19 (5H, m, C6 H5), 4.75-4.67 (1H, m, NCH), 4.26-4.08 (3H, m, 
CHCH20, C/OH), 3.75 (1 H, dq, J=  2.9 and 7.0 Hz, COCHCH3), 3.25 (1 H, dd, J =
3.3 and 13.4 Hz, CHHPh), 2.91 (1H, d, J =  2.7 Hz, OH), 2.79 (1 H, dd, J =  9.4 and
13.4 Hz, CHHPh), 1.27 (3H, d, J = 7.1 Hz, COCHCH3), 1.21 (3H, d, J = 6.4 Hz, 
CHOHCH3).
General procedure for the enzymatic resolution of rac-syn-5.8
In a typical experiment racemic alcohol rac-syn-5.8 (0.050 g, 0.18 mmol) and 
Candida antarctica lipase type B (0.006 g, 30 mgenzyme/mmolSubstrate) in organic solvent 
(vinyl acetate, n-hexane, toluene, dichloromethane or diisopropyl ether, 0 . 8  ml) were 
stirred with vinyl acetate (33 pL, 0.36 mmol) at 40 °C. After 24 hours, the reaction 
was stopped by filtering off the enzyme. Conversions and enantiomeric excesses 
obtained in the different solvents are reported in Table 5.8. Ester (4S,2'S,3,fl)-5.9 
(0.025 g, 43% yield for the reaction performed in n-hexane) was separated from 
unreacted alcohol (4/7,2’/7,3’S)-5.8 (0.019 g, 39% yield for the reaction performed in 
n-hexane) by flash chromatography (Si02, n-hexane/EtOAc 60:40). Spectroscopic, 
chromatographic and physical-chemical data were in accordance with those 
previously reported (vide infra).
Hydrolysis of alcohol (4/?,2’/?,3’S)-5.814
To a solution of alcohol (4/?,2’/?,3’S)-5.8 (0.332 g, 1.20 mmol) in THF/H20  (5 mL, 
80:20) at 0 °C, 30% aqueous hydrogen peroxide (400 pL) was added slowly. LiOH 
(0.038 g, 1.58 mmol) in water (2 mL) was then added and the mixture was allowed to 
stir at 0 °C for 2 hours. The reaction was quenched with a solution of Na2S03 in water 
(1.5 M, 3 mL) and stirred until peroxides were no longer detectable. The bulk of THF
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was removed in vacuo and the resulting mixture (pH 12-13) was extracted with DCM 
( 3 x 5  mL) to remove the chiral auxiliary. The aqueous layer was cooled in an ice 
bath and acidified to pH 1 by addition of 6  M HCI. The resulting cloudy solution 
containing the p-hydroxy acid (2/7,3S)-5.14 was then extracted with EtOAc ( 4 x 5  
mL). The combined EtOAc extracts were dried over MgS04, filtered and concentrated 
in vacuo to give a yellow oil, which was dissolved in 5% aqueous NaHC03 (2 mL). 
This solution was extracted with DCM, acidified with 6  M HCI and extracted with 
EtOAc as before. The combined ethyl acetate exracts were dried (MgS04), filtered 
and concentrated in vacuo to afford p-hydroxy acid (2/7,3S)-5.14 as a yellow oil 
(0.085 g, 60%).
The combined DCM extracts were dried (MgS04), filtered and concentrated in vacuo 





Yellow oil (0.085 g, 60%); [cc]D 30=  +6.9 (c 1 .0 2 , CHCI3); 1H NMR (400 MHz, CDCI3): 
8 h = 5.8 (2H, br s, 2 x OH), 4.15-4.05 (1H, dq, app. m, CHOH), 2.59 (1H, dq, J=  3.7 
and 7.2 Hz, COCHCH3), 1.23 (3H, d,J =  3.9 Hz, COCHCH3), 1 . 2 2  (3H, d, J=  3.1 Hz, 
CHOHCH3); 13C NMR (100 MHz, CDCI3): 5C= 180.5 (COOH), 67.9 (COCHCH3), 45.2 
(CHOH), 19.7 (CHOHCH3), 10.9 (COCHCH3). 1H and 13C NMR data were in 
accordance with those reported in literature. 10
Hydrolysis of ester (4S,2'S,3,fl)-5.914
Hydrolysis of ester (4S,2'S,3'R)-5.9 was carried out following the same procedure 
above described for hydrolysis of alcohol (4/?,2’/?,3’S)-5.8. Ester (4S,2'S,3'fl)-5.9 
(0.160 g, 0.50 mmol) was hydrolysed with LiOH (0.016 g, 0.66 mmol) in H20 2 to 
afford 4-benzyl-2-oxazolidinone (S)-5.10 (commercially available compound) as a 
white solid (0.074 g, 84%) and p-hydroxy acid (2S,3R)-5.14 (0.032 g, 55%) as a 
yellow oil.
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Yellow oil (0.032 g, 55%); [a]D30= -6 . 8  (c 1.0 2 , CHC!3); 1H and 13C NMR data were in 
accordance with those reported in literature. 10
Preparation of (4/?,2’/?,3’S)-A/-(3-acetoxy-2-methylbutanoyl)-4-benzyl-2- 
oxazolidinone (4/?,2’/?,3’S)-5.913
Acetic acid (20 pL, 0.35 mmol) and DMAP (4-dimethylaminopyridine) (0.035 g, 0.28 
mmol) were added to a solution of alcohol (4/?,2’/7,3’S)-5.8 (0.296 g, 1.07 mmol) in 
anhydrous dichloromethane (5 mL). The solution was stirred, cooled in an ice bath to 
0 °C and DCC (dicyclohexylcarbodiimide) (0.080 g, 0.39 mmol) was added over a 
period of 5 min. After a further 5 min at 0 °C, the ice bath was removed and the 
mixture was allowed to react for 3 hours at room temperature. Precipitated 
dicyclohexylurea was removed by filtration and the filtrate was washed with 5 M HCI 
( 2 x 3  mL) and sat. NaHC03 solution ( 2 x 3  mL). During this procedure some 
additional dicyclohexylurea was precipitated, which was removed by filtration of both 
layers to facilitate their separation. The organic phase was dried over Na2S04 and 
concentrated in vacuo. Purification via flash chromatography (n-hexane/EtOAc, 
60:40) afforded acylated aldol adduct (4/?,2’/?,3’S)-5.9 as yellow needles (0 . 2 2 0  g, 
65%); mp 81-82 °C; Rf (n-hexane/EtOAc, 60:40) = 0.65; HPLC (Chiralcel® OD 
column, n-hexane/isopropanol 80:20, 1 mLmin'1, X= 254 nm): tR= 7.6 min; [a]D30= -
75.5 (c 0.96, CHCI3); IR (CHCI3): v = 3520, 2980, 1780, 1735, 1700, 1450, 1380, 
1235, 1110 cm'1; 1H NMR (300 MHz, CDCI3): 6 H = 7.36-7.19 (5H, m, C6 H5), 5.30 (1H, 
dq, J = 4.3 and 6.4 Hz, CHOCOCH3), 4.64-4.56 (1H, m, NCH), 4.28-4.08 (2H, m, 
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Hz, CHHPh), 2.76 (1H, dd, J =  9.7 and 13.3 Hz, CHHPh), 2.05 (3H, s, OCOCH3), 
1.28 (3H, d, J=  6.4 Hz, COCHCH3), 1.23 (3H, d, J=  6.9 Hz, AcOCHCH3); 13C NMR 
(75.5 MHz, CDCI3): 5C = 172.2 (CCO), 168.8 (OCOCH3), 151.7 (OCON), 135.8,
129.9 (2C), 129.4 (2C), 127.8 (aromatic C), 70.8 (CHOCOCH3), 6 6 . 8  (CH20), 56.2 
(NCH), 42.8 (COCHCH3), 38.4 (CH2Ph), 2 1 . 6  (OCOCH3), 18.5 (AcOCHCH3), 11.3 
(COCHCH3); MS (FAB+): m/z 320 (MH+, 8 8 %); Anal, calcd. for C17 H21N05: C 
63.93%, H 6.62%, N 4.38%; found: C 64.4%, H 6 .8 %, N 4.0%.
Preparation of (/VS)-(+/-)-3-butyryl-4-benzyl-2-oxazolidinone rac-5.1514
A solution of n-BuLi in n-hexane (2.5 M, 5.3 mL, 13.2 mmol) was added dropwise, 
over a period of 10 min, to a stirred solution of rac-5.10 (2.0 g, 13.2 mmol) in 
anhydrous THF (60 mL) at -78 °C under an atmosphere of nitrogen. The mixture was 
stirred at this temperature for 15 min and n-PrCOCI (1.6 mL, 15.4 mmol) was then 
added dropwise over 5 min. After 30 min the reaction quenched with sat. NH4CI 
solution (40 mL) and allowed to warm to room temperature over 2 hour period. The 
mixture was extracted with EtOAc (3 x 40 mL); the organic extracts were combined 
and washed with brine (40 mL). The dried solution (MgS04) was concentrated in 
vacuo and the residue was purified by recrystallisation (n-hexane) to give rao-5.15 as 
a colourless crystalline solid (2.5 g, 76%); mp 31-33°C; HPLC (Chiralcel® OD column, 
n-hexane/isopropanol 93:7, 1 mLmin'1, X= 254 nm): tR=15.4 and 15.8 min; IR 
(CH2CI2): v = 2965, 1780, 1700, 1385, 1355, 1215,1090 cm'1; 1H NMR (300 MHz, 
CDCI3): 8 h = 7.37-7.20 (5H, m, C6 H5), 4.71-4.63 (1H, m, CHN), 4.23-4.14 (2H, m, 
CH2O), 3.30 (1H, dd, J=  3.2 and 13.3 Hz, CHHPh), 2.89-2.82 (2H, m, CH^CH2CH3), 
2.76 (1H, dd, J=  9.7 and 13.3 Hz, CHHPh), 1.79-1.62 (2H, m, CH2CH3), 1.01 (3H, t, 
J = 7.4 Hz, CH3); 13C NMR (75.5 MHz, CDCI3): 5C= 173.6 (CCO), 153.8 (OCON), 
135.7, 129.8 (2C), 129.3 (2C), 127.7 (aromatic C), 66.5 (CH20), 55.5 (CHN), 38.3 
(CH2 Ph), 37.7 (CH2CH2CH3), 18.1 (CH2CH3), 14.1 (CH3); MS (EI+, 70 eV): m/z 247 
(M +, 10%), 177 (9), 156 (15), 143 (31), 129 (55), 119 (14), 101 (8 ), 91 (16), 71 (100), 
55 (17), 43 (45); Anal, calcd. for Ci4H17N03: C 6 8 .0 0 %, H 6.93%, N 5.66%; found: C
158
Claudia Neri - University of Bath_________________________________________________ Experimental
Chapter 7
67.9%, H 7.1%, N 5.3%. 1H and 13C NMR data were in accordance with those 
reported in literature. 17







TiCI4 (1M solution in DCM, 6.5 mL, 6.45 mmol) was added to a solution of A/-butyryl- 
2-oxazolidinone rao-5.15 (1.5 g, 6.15 mmol) in dichloromethane (50 mL) at 0 °C 
under an atmosphere of nitrogen. The mixture was stirred for 5 min and (-)-sparteine 
(1.4 mL, 6.15 mmol) was then added dropwise slowly. After complete addition and 20 
min at 0 °C, the mixture was cooled to -78 °C and A/-methyl-2-pyrrolidinone (600 pL, 
6.15 mmol) was added. The reaction mixture was stirred for 10 min, followed by 
addition of freshly distilled acetaldehyde (1.3 mL, 30.7 mmol) dropwise. The mixture 
was allowed to react for 1 h at -78 °C, gradually warmed to 0 °C, and stirred for 1 h. 
The reaction was quenched with half-saturated NH4CI (30 mL) and warmed to 25 °C. 
The layers were separated and the aqueous layer was extracted twice with DCM (2 x 
30 mL), dried over Na2S04, filtered and concentrated in vacuo. Purification via flash 
chromatography (Si02, n-hexane/EtOAc, 50:50) afforded rao-syn-5.16 (1.0 g, 59%, 
95% d.e.) as a cream solid; mp 72-74 °C (Lit. 10 74-76 °C); Rf (n-hexane/EtOAc, 
50:50) = 0.55; HPLC (Chiralcel® OD column, n-hexane/isopropanol 90:10,1 mLmin’1, 
X= 254 nm: tR=14.6 and 20.4 min; [a]D30= 0 . 0  (c0.99, CHCI3); IR (CH2CI2): v = 3570, 
2975, 1775, 1690, 1385, 1355, 1215, 1105 cm’1; 1H NMR (300 MHz, CDCI3): 8 H = 
7.37- 7.22 (5H, m, C6H5), 4.77-4.70 (1H, m, NC/-/), 4.22-4.09 (3H, m, CH2Of CHOH), 
4.03-3.97 (1H, m, CHCH2CH3), 3.36 (1H, dd, J=  3.2 and 13.2 Hz, CHHPh), 2.71 (1H, 
dd, J =  10.1 and 13.2 Hz, CHHPh), 2.53 (1H, s, OH), 1.91-1.83 (1H, m, CHHCH3), 
1.74-1.66 (1H, m, CHHCH3), 1.23 (3H, d, J=  6.4 Hz, CHCH3), 0.98 (3H, t, J=  7.4 Hz, 
CH2CH3); 13C NMR (75.5 MHz, CDCI3): 8 C = 175.9 (CCO), 154.3 (OCON), 135.6,
129.7 (2C), 129.3 (2C), 127.7 (aromatic C), 69.0 (CHOH), 66.4 (CH20), 55.9 (CHN),
50.4 (CHCH2CH3), 38.4 (CH2 Ph), 21.1 (CH2CH3), 19.9 (CHCH3), 12.3 (CH2 CH3); MS 
(EI+, 70 eV): m/z 291 (M \  23%), 273 (27), 258 (53), 247 (50), 115 (25), 97 (21), 8 6
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(65), 71 (100), 43 (56); Anal, calcd. for C16H2 iN04: C 65.96%, H 7.27%, N 4.81%; 
found: C 65.6%, H 7.2%, N 4.5%.
Enzymatic resolution of rac-syn-5A6
Racemic alcohol rac-syn-5.16 (0.932 g, 3.20 mmol) and Candida antarctica lipase 
type B (0.324 g, 100 m g enzyme/nimolsUbstrate) in n-hexane (16 mL) were stirred with vinyl 
acetate (590 pL, 6.40 mmol) at 40 °C. After 20 hours, the reaction was stopped by 
filtering off the enzyme. Ester (4S,2'Sf3'/3)-5.17 (0.373 g, 35%) was separated from 
unreacted alcohol (4fl,2’/?,3’S)-5.16 (0.265 g, 30%) by flash chromatography (Si02, 
n-hexane/EtOAc 50:50) and recrystallised from n-hexane/EtOAc.
(4S,2,S,3'R)-yV-(3-Acetoxy-2-ethylbutanoyl)-4-benzyl-2-oxazolidinone
(4S,2lS,3,/?)-5.17
o  o  o c o c h 3
o
Ph
Ester (4S,2'S,3'/3)-5.17 was isolated as a cream solid; mp 61-63 °C; Rf (n- 
hexane/EtOAc, 50:50) = 0.85; HPLC (Chiralcel® OD column, n-hexane/isopropanol 
90:10, 1 mLmin'1, X= 254 nm): tR=11.5 min; [a] D30 = +57.1 (c 1.05, CHCI3); IR 
(CH2CI2): v = 2965, 1780, 1730, 1695, 1380, 1235, 1110 cm'1; 1H NMR (300 MHz, 
CDCI3): 8 h = 7.36-7.21 (5H, m, C6H5), 5.30-5.22 (1 H, m, CHCH3), 4.72-4.64 (1 H, m, 
NC/-/), 4.24-4.10 (2 H, m, CH20), 4.04-3.98 (1 H, m, CHCH2CH3), 3.32 (1 H, dd, J=  3.2 
and 13.2 Hz, CHHPh), 2.73 (1H, dd, J = 9.9 and 13.2 Hz, CHHPh), 2.01 (3H, s, 
OCOCH3), 1.91-1.83 (1 H, m, CHHCH3), 1.74-1.66 (1 H, m, CHHCH3), 1.27 (3H, d, J =
6.7 Hz, CHCH3), 0.95 (3H, t, J=  7.4 Hz, CH2CH3); 13C NMR (75.5 MHz, CDCI3): 8 C =
173.3 (CCO), 170.4 OCOCH3), 153.4 (OCON), 135.3, 129.4 (2 C), 128.9 (2 C), 127.3 
(aromatic C), 70.1 (CHCH3), 6 6 . 1  (CH20), 55.7 (CHN), 48.6 (CHCH2CH3), 38.1 
(CH2 Ph), 2 1 . 1  (OCOCH3), 2 0 . 0  (CH2CH3), 17.7 (CHCH3), 11.7 (CH2 CH3); MS (EI+, 
70 eV): m/z 333 (M+, 30%), 258 (20), 157 (32), 97 (100), 69 (29), 43 (50); Anal, 
calcd. for C18H23N05: C 64.85%, H 6.95%, N 4.20%; found: C 64.7%, H 7.0%, N 
4.0%.
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Alcohol (4/7,2’/7,3’S)-5.16 was isolated as a cream solid; mp 73-74 °C (Lit.7 74-76 
°C); Rf (n-hexane/EtOAc, 50:50) = 0.55; HPLC (Chiralcel® OD column, n- 
hexane/isopropanol 90:10, 1 mLmin'1, h= 254 nm): tR=14.6 min; [a]D30= -15.8 (c 1.2, 
CHCI3); IR (CH2CI2): v = 3590, 2980, 1780, 1690, 1385, 1350, 1215, 1 1 1 0  cm'1; 1H 
NMR (300 MHz, CDCI3): 8 H = 7.37-7.22 (5H, m, C6 H5), 4.78-4.70 (1 H, m, NCH), 4.22-
4.07 (3H, m, CH20, CHOH), 4.03-3.97 (1 H, m, CHCH2CH3), 3.36 (1H, dd, J=  3.2 and
13.2 Hz, CHHPh), 2.70 (1H, dd, J =  10.0 and 13.2 Hz, CHHPh), 2.54 (1H, s, OH), 
1.91-1.83 (1 H, m, CHHCH3), 1.74-1.66 (1 H, m, CHHCH3), 1.24 (3H, d, J = 7.0 Hz, 
CHCH3), 0.98 (3H, t, J =  7.4 Hz, CH2CH3); 13C NMR (75.5 MHz, CDCI3): 8 C= 175.5 
(CCO), 153.9 (OOON), 135.2, 129.4 (2 C), 129.0 (2C), 127.4 (aromatic C), 6 8 . 6  
(CHOH), 6 6 . 0  (CH20), 55.6 (CHN), 50.1 (CHCH2CH3), 38.1 (CH2Ph), 20.7 (CH2CH3),
19.5 (CHCH3), 11.9 (CH2 CH3); MS (EI+, 70 eV): m/z 291 (M +, 1 1 %), 158 (26), 128 
(27), 99 (1 0 0 ), 8 6  (67), 71 (77), 53 (33), 43 (90); Anal, calcd. for C16H2 iN04: C 
65.96%, H 7.27%, N 4.81%; found: C 65.6%, H 7.2%, N 4.6%. See Appendices for 
crystal structure.
Preparation of AA-[seo(1-hydroxybutyl)]carbamic acid ethyl ester 5.192
2-Amino-1-butanol rac-5.18 (12.6 mL, 133 mmol) was dissolved in a solution of 
Na2C03 (50.0 g, 472 mmol) in H20  (100 mL). The mixture was cooled to 5 °C and 
Et02CCI (14.0 mL, 134 mmol) was added. After stirring at room temperature for 
another 1.5 hours, the mixture was filtered and extracted with EtOAc (70 x 4 mL).
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The combined organic extracts were washed with H20  (30 mL) and brine (30 mL) 
and dried over MgS04. Removal of the solvent gave rac-5.19 as a white solid; 1H
13C NMR (75.5 MHz, CDCI3): 8 C = 157.6 (NCO), 65.4 (CH2OH), 61.3 (COOCH2CH3),
54.9 (CHN), 24.7 (CHCH2CH3), 14.9 (OCH2 CH3), 10.8 (CHCH2 CH3).
Preparation of (/VS)-(+/-)-4-ethyl-2-oxazolidinone rao-5.202
Powdered K2C03 (0.093 g, 0.14 mmol) was added to carbamic acid ethyl ester rac-
5.19 and the mixture was heated to 125 °C with magnetic stirring under vacuum until 
the gas evolution stopped (approximately 2 hours). The mixture was dissolved H20  
(50 mL) and extracted with EtOAc (3 x 50 mL). The combined organic extracts were 
washed with brine (50 mL), dried (MgS04), run through silica to eliminate K2C03 in 
excess, and concentrated in vacuo to afford rac-5.20 as a yellow oil (10.6 g, 70% 
overall yield from rac-5.18); Rf (n-hexane/EtOAc, 66:34) = 0.11; IR (film): v = 3290, 
2965, 2935, 1745, 1405, 1235, 1050 cm'1; [a]D30= 0.0 (c0.63, CHCI3); 1H NMR (300 
MHz, CDCI3): 8 h = 7.0 (1H, br s, NH), 4.48 (1 H, app. t, J=  8.5 Hz, CHHO), 4.02 (1H, 
dd, J=  6.0 and 8.4 Hz, CHHO), 3.84-3.78 (1H, m, CHN), 1.65-1.55 (2H, m, CH^CH3), 
0.95 (3H, t, J=  7.6 Hz, CH2CH3); 13C NMR (75.5 MHz, CDCI3): 8 C= 160.9 (OCON),
70.4 (CH20), 54.2 (CHN), 28.5 (CH2CH3), 9.6 (CH3). 1H NMR data were in 
accordance with those reported in literature. 18
Preparation of (/VS)-(+/-)-3-propionyl-4-ethyl-2-oxazolidinone rao-5.2114
NMR (300 MHz, CDCI3): 8 H = 5.03 (1H, br s, NH), 4.10 (2H, q, J = 7.1 Hz, 
COOCH^CHa), 3.69-3.54 (3H, m, CH£>H, CHN), 3.03 (1H, s, OH), 1.61-1.41 (2H, m, 
CHCH2CH3), 1.24 (3H, t, J=  7.1 Hz, OCH2CH3), 0.95 (3H, t, J=  7.4 Hz, CHCH2CH3);
O
162
Claudia Neri - University of Bath
Chapter 7
Experimental
A solution of n-BuLi in n-hexane (1.6 M, 5.0 mL, 7.96 mmol) was added dropwise, 
over a period of 10 min, to a stirred solution of rao-5.20 (916 mg, 7.96 mmol) in 
anhydrous THF (30 mL) at -78 °C under an atmosphere of nitrogen. The mixture was 
stirred at this temperature for 15 min and EtCOCI (690 pL, 7.96 mmol) was then 
added dropwise over 5 min. After 30 min the reaction quenched with sat. NH4CI 
solution (20 mL) and allowed to warm to room temperature over 2 hour period. The 
mixture was extracted with EtOAc (3 x 20 mL); the organic extracts were combined 
and washed with brine (20 mL). The dried solution (MgS04) was concentrated in 
vacuo and the residue was purified via flash chromatography (Si02, n-hexane/EtOAc 
66:34) to give rao-5.21 as a colourless oil (0.875 g, 64%); Rf (n-hexane/EtOAc, 
66:34) = 0.61; HPLC: (Chiralcel® AD column, n-hexane/isopropanol 90:10, 1 mLmin'1, 
X = 254): tR= 8.3 and 10.2 min; IR (film): 2970, 2940, 2885, 1780, 1705, 1390, 1375, 
1250, 1210, 1070, 1020 cm'1; 1H NMR (300 MHz, CDCI3): 8 H = 4.45-4.36 (2H, m, 
OCH2), 4.15-4.11 (1H, m, CHN), 2.96-2.86 (2 H, m, COCH^CHa), 1.87-1.69 (2 H, m, 
CHC/-/2CH3), 1.16 (3H, t, J = 7.3 Hz, COCH2CH3), 0.92 (3H, t, J = 7.5 Hz, 
CHCH2CH3); 13C NMR (75.5 MHz, CDCI3): 8 C = 173.9 (CCO), 153.9 (OCON), 6 6 . 8  
(CH20), 55.0 (CHN), 29.1 (COCH2CH3), 25.1 (CHCH2CH3), 8.3 (CHCH2 CH3), 8.1 
(COCH2 CH3); MS (EI+, 70 eV): m/z 171 (M+, 15%), 142 (16), 116 (18), 8 6  (8 ), 57 
(1 0 0 ), 28 (52); Anal, calcd. for C8H13N03: C 56.13%, H 7.65%, N 8.18%; found: C 
56.0%, H 7.6%, N 7.9%.
Preparation of (4/?,2'/?,3'S)- and (4S,2lS,3lR)-/V-(3-hydroxy-2-methylbutanoyl)-4- 
ethyl-2-oxazolidinone rac-syn-5.2212
TiCI4 (1M solution in DCM, 2.6 mL, 2.58 mmol) was added to a solution of N- 
propionyl-2-oxazolidinone rac-5.21 (0.421 g, 2.46 mmol) in dichloromethane (20 mL) 
at 0  °C. The mixture was stirred for 5 min and (-)-sparteine (560 pL, 2.46 mmol) was 
then added dropwise. After complete addition and 20 min at 0 °C, the mixture was 
cooled to -78 °C and A/-methyl-2-pyrrolidinone (240 pL, 2.46 mmol) was added. The
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reaction mixture was stirred for 1 0  min, followed by addition of freshly distilled 
acetaldehyde (0.5 mL, 12.3 mmol) dropwise. The mixture was allowed to react for 1 h 
at -78 °C, gradually warmed to 0 °C, and stirred for 1 h. The reaction was quenched 
with half-saturated NH4CI (20 mL) and warmed to 25 °C. The layers were separated 
and the aqueous layer was extracted twice with DCM (2 x 20 mL), dried over 
Na2S04f filtered and concentrated in vacuo. Purification via flash chromatography 
(Si02> n-hexane/EtOAc, 40:60) afforded rac-syn-5.22 (0.293 g, 55%, >99% d.e.) as 
a colourless oil; Rf (n-hexane/EtOAc, 40:60) = 0.53; HPLC (Chiralcel® OD column, n- 
hexane/isopropanol 80:20, 1 mLmin'1, X = 254): tR= 7.3 and 11.3 min; [a]D30= 0.0 (c 
0.63, CCI3); IR (film): v = 3465, 2970, 2940, 2885, 1775, 1690, 1385, 1230, 1205 cm' 
1; 1H NMR (300 MHz, CDCI3): 6 H = 4.50-4.45 (1H, m, CHN); 4.40 (1H, app. t, J=  8.2, 
OCHH), 4.15-4.11 (2H, m, J = 2.7 Hz, CHOH, OCHH), 3.72 (1H, dq, J=  2.9 and 7.0 
Hz, COCHCH3), 3.02 (1H, s, OH), 1.83-1.72 (2H, m, CH2CH3), 1.24 (3H, d, J =  7.0 
Hz, COCHCH3), 1.19 (3H, d, J = 6.4 Hz, CHOHCH3), 0.93 (3H, t, J = 7.5 Hz, 
CH2CH3); 13C NMR (75.5 MHz, CDCI3): 6 C = 177.5 (CCO), 153.4 (OCON), 67.5 
(CHOH), 66.7 (CH20), 54.9 (CHN), 43.0 (COCHCH3), 24.9 (CH2CH3), 19.5 
(CHOHCH3), 10.6 (COCHCH3), 8.0 (CH2 CH3); MS (CI+): m/z 216 (M+, 80%), 198 
(100), 171 (35), 156 (14), 142 (18), 116 (64), 83 (20); Anal, calcd. for C10H17NO4: C 
55.80%, H 7.96%, N 6.51%; found: C 55.4%, H 8.0%, N 6.3%.
Enzymatic resolution of rac-syn-5.22
Racemic alcohol rac-syn-5.22 (0.250 g, 1.16 mmol) and Candida antarctica lipase 
type B (0.116 g, 100 m g enzyme/mmolsubstrate) 'n ^-hexane (5 mL) were stirred with vinyl 
acetate (214 pL, 2.32 mmol) at 40 °C. After 20 hours, the reaction was stopped by 
filtering off the enzyme. Ester (4S,2'S,3'/3)-5.23 (0.098 g , 33%) was separated from 
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Ester (4S,2'S,3'fl)-5.23 was isolated as a yellow oil; HPLC (Chiralcel® OD column, n - 
exane/isopropanol 80:20, 1 mLmin'1, X = 254): tR= 6.0; [a]D30= -8 6 . 6  (c0.30, CHCI3); 
IR (film): v = 2985, 2940, 1780, 1735, 1385, 1370, 1700, 1240, 1210 cm"1; 1H NMR 
(300 MHz, CDCI3): 8h = 5.27 (1H, dq, J =  3.2 and 6.4 Hz, CHOCOCH3), 4.44-4.35 
(2H, m, CHN, OCHH), 4.13 (1H, dd, J=  1.8 and 8.0 Hz, OCHH), 3.96 (1H, dq, J =
3.4 and 6.9 Hz, COCHCH3), 2 . 0 2  (3H, s, OCOCH3), 1.82-1.72 (2 H, m, CH2CH3), 1.26 
(3H, d, J=  6.4 Hz, COCHCH3), 1.19 (3H, d, J=  6.9 Hz, AcOCHCH3), 0.92 (3H, t, J =
7.5 Hz, CH2CH3); 13C NMR (75.5 MHz, CDCI3): 8 C= 174.0 (CCO), 170.6 (OCOCH3), 
153.8 (OCON), 70.3 (CHOCOCH3), 6 6 . 8  (CH20), 55.6 (CHN), 42.1 (COCHCH3), 25.1 
(CH2CH3), 2 1 . 1  (OCOCH3), 18.1 (AcOCHCH3), 1 1 . 0  (COCHCH3), 8 . 2  (CH2 CH3); MS 
(CI+): m/z 258 (MH+, 55%), 198 (100), 171 (12), 143 (21), 83 (40); Anal, calcd. for 




U n re a c te d  a lco h o l (4fl,2’/?,3’S)-5.22 w a s  o b ta in e d  a s  a  c o lo u r le s s  o il; Rf (n- 
h e xa n e /E tO A c , 40:60) = 0.53; H P LC  (C h ira lce l®  O D  c o lu m n , n -h e x a n e /is o p ro p a n o l 
80:20, 1 m Lm in *1, A, = 254): tR=  7.3 m in; [a]D30= -40.0 (c0.35, C H C I3); 1H NMR (300 
MHz, CDCI3): 8h = 4.50-4.45 (1H, m , C H N ), 4.40 (1H, app . t, J = 8.5 Hz, O C H H ), 
4.17-4.10 (2H, m , O C H H , C H O H ), 3.71 (1H, dq, J=  3.5 a n d  7.1 Hz, C O C H C H 3), 2.98 
(1 H, s, O H ), 1.82-1.72 (2H, m , CH2CH3), 1.24 (3H, d, J =  7.0 Hz, C O C H C H3), 1.19 
(3H, d, J = 6.4 Hz, C H O H C H3), 0.93 (3H, t, J = 7.5 Hz, C H 2C H 3); 13C NMR (75.5 
MHz, CDCI3): 8C = 177.9 (C C O ), 153.8 (O C O N ), 67.8 (C H O H ), 67.1 (C H 20), 55.3 
(C H N ), 43.4 (C O C H C H 3), 25.3 (C H 2C H 3), 19.9 (C H O H C H 3), 11.0 (C O C H C H 3), 8.4 
(C H 2C H 3); MS ( C I+ ) : m/z 216 (MH+, 100%), 198 (81), 171 (16), 142 (11), 116 (23), 
83 (1 1 ) ;  A n a l, ca lcd . fo r  C 10H 17N O 4: C 55.80%, H 7.96%, N 6.51% ; fo u n d  C 55.6%, 
H 7.9%, N 6 .6 %.
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Experimental
Hydrolysis of alcohol (4/7,2’/7,3’S)-5.2214
To a solution of alcohol (4/?,2’/?,3’S)-5.22 (0.080 g, 0.37 mmol) in THF/H20  (2 mL, 
80:20) at 0 °C, 30% aqueous hydrogen peroxide (15 pL) was added slowly. LiOH 
(0.012 g, 0.50 mmol) in water (1 mL) was then added and the mixture was allowed to 
stir at 0 °C for 2 hours. The reaction was quenched with a solution of Na2S03 in water 
(1.5 M, 1 mL) and stirred until peroxides were no longer detectable. The bulk of THF 
was removed in vacuo and the resulting mixture (pH 12-13) was extracted with DCM 
(3 x 1.5 mL) to remove the chiral auxiliary.
The aqueous layer was cooled in an ice bath and acidified to pH 1 by addition of 6  M 
HCI. The resulting cloudy solution containing the p-hydroxy acid (2fl,3S)-5.14 was 
then extracted with EtOAc ( 4 x 2  mL). The combined EtOAc extracts were dried over 
MgS04> filtered and concentrated in vacuo to give a yellow oil, which was dissolved 
in 5% aqueous NaHC03 (0.5 mL). This solution was extracted with DCM, acidified 
with 6  M HCI and extracted with EtOAc as before. The combined ethyl acetate 
extracts were finally dried (MgS04), filtered and concentrated in vacuo to afford p- 
hydroxy acid (2/?,3S)-5.14 as a yellow oil (0.023 g, 53%). Spectroscopic data and 
specific rotation were in accordance with those previously reported.
The combined DCM extracts were dried (MgS04), filtered and concentrated in vacuo 
to afford oxazolidinone (fl)-5.20 as a colourless oil (0.036 g, 82%).
(fi)-(+)-4-Ethyl-2-oxazolidinone (fl)-5.20
Yellow oil; [a] D30 = +5.5 (c 0.63, CHCI3), (Lit. 15 +5.8 (c 1.02, CHCI3); 1H NMR (300
CH2CH3),0.92 (3H, t, J=  7.5 Hz, CH2CH3); 13C NMR (75.5 MHz, CDCI3): 5C= 160.3 
(NCO), 70.0 (CH20), 53.8 (CHN), 28.2 (CH2CH3), 9.3 (CH3).
O
/
MHz, CDCI3): 8 h = 6.52 (1H, br s, NH), 4.48 (1H, app. t, J = 8.5 Hz, CHHO), 4.03 (1H, 
dd, J = 6.0 and 8.5 Hz, CHHO), 3.86-3.77 (1H, m, CHN), 1.66-1.55 (2H, m,
166
Claudia Neri - University of Bath
Chapter 7
Experimental
Hydrolysis of ester (4S,2'S,3,fl)-5.23 14
Hydrolysis of ester (4S,2'S,3'fl)-5.23 was carried out following the same procedure 
above described for hydrolysis of alcohol (4/7,2’/?,3’S)-5.22. Ester (4S,2'S,3'/?)-5.9 
(0.095 g, 0.37 mmol) was hydrolysed with LiOH (0 . 0 1 2  g, 0.50 mmol) in H20 2 to 
afford 4-ethyl-2-oxazolidinone (S)-5.20 as a colourless oil (0.037 g, 87%) and p- 
hydroxy acid (2S,3fl)-5,14 (0.022 g, 51%) as a yellow oil.
Spectroscopic data and specific rotation for p-hydroxy acid (2S,3fl)-5.14 were in 
accordance with those previously reported.
(S)-(-)-4-Ethyl-2-oxazolidinone (S)-5.20
Yellow oil; [cxJd30 = -5.3 (c 0.60, CHCI3). 1H and 13C NMR data were in accordance 
with those above reported for the (fl)-enantiomer (/?)-5.20.
O
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7.5 Experimental for Chapter 6
Preparation of /V-propionyl-carbamic acid ethyl ester 6.3019
o o
H
A mixture of carbamic acid ethyl ester (urethane) (2.9 g, 33.3 mmol) and propionyl 
chloride (32.0 mL, 36.8 mmol) was refluxed until H C I  evolution ceased 
(approximately 2 hours). The brown oil was cooled to room temperature and 
crystallised from petroleum ether to give 6.30 (2.8 g, 58%) as a white solid; mp 77-79 
°C (Lit. 16 81-82 °C); Rf (DCM/n-hexane/isopropanol, 60:35:5) = 0.65; IR (KBr): v = 
3260, 3190, 2975, 1760, 1515, 1240 cm'1; 1H NMR (300 MHz, CDCI3): 6 H = 7.95 (1H, 
br s, NH), 4.21 (2H, q, J = 7.1 Hz, COOCH^CH3), 2.78 (2H, q, J = 7.4 Hz, 
N C O C H 2 C H 3 ) ,  1.30 (3H, t, J = 7.1 Hz, C O O C H 2 C H3), 1.16 (3H, t, J = 7.4 Hz, 
N C O C H 2 C H3)\ 13C NMR (75.5 MHz, CDCI3): 5C = 176.1 ( C H 2 C O N ) ,  152.9 ( N C O O ) ,
62.6 ( C O O C H 2 C H 3 ) ,  29.9 ( N C O C H 2 C H 3 ) ,  14.6 ( C O O C H 2 C H 3) ,  8 . 6  ( N C O C H 2C H 3) ;  
MS (FAB+): m/z 146 (MH+, 39%); Anal, calcd. for CeHnNOa: C 49.65%, H 7.64%, N 
9.65%; found: C 49.3%, H 7.5%, N 9.8%.
Preparation of (/tfS)-(+/-)-M-propionyl-5-phenoxymethyl-2-oxazolidinone 6.3120
A solution of /V-propionyl-carbamic acid ethyl ester 6.30 (0.534 g, 3.67 mmol) and 
1,2-epoxy-3-phenoxypropane 6.25 (0.555 g, 3.70 mmol) in dry toluene (1 mL) was 
heated to 70 °C. DABCO (1,4-diazabicyclo[2.2.2.]octane) (0.010 g, 0.09 mmol, 2.5% 
mol) was added and the reaction mixture was refluxed for 3 hours under vacuum. 
The crude white solid was treated with boiling cyclohexane (50 mL) and filtered in hot 
to extract oxazolidinone 6.31, which crystallised from cyclohexane as white needles 
(0.295 g, 32%); mp 119-121 °C (Lit. 17 122-124 °C); Rf (/>hexane/EtOAc, 50:50) =
0.74; HPLC (Chiralcel® OD column, n-hexane/isopropanol 70:30, 1 mLmin'1, X = 254 
nm): tR = 16.1 and 21.8 min; IR (KBr): v = 1760, 1710, 1600, 1495, 1390, 1250, 1075
PhO r5
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cm'1; 1H NMR (300 MHz, CDCI3): SH = 7.33-6.87 (5H, m, OC6H5), 4.95-4.87 (1H, m, 
OCH), 4.37-4.02 (4H, m, CH^\, CH^Ph), 2.96 (2 H, q, J = 7.3 Hz, CH2CH3), 1.19 
(3H, t, J =  7.3 Hz, CH3); 13C NMR ( 1 0 0  MHz, CDCI3): 6 C = 174.3 (NCOCH2), 153.1 
(OCON), 157.9, 129.8 (2C), 122.1, 114.8 (2C) (aromatic C), 71.8 (OCH), 68.1 
(CH2OPh), 44.9 (CH2 N), 29.3 (CH2CH3), 8.7 (CH3); MS (EI+, 70 eV): m/z249 (M ++1 , 
10%), 107 (12), 94 (29), 77 (20), 57 (100), 28.8 (63); HRMS calcd. for C13H15N04: 
249.1001, found 249.1001; Anal, calcd. for Ci3H15N04: C 62.60%, H 6.07%, N 
5.62%; found: C 62.1%, H 6.0%, N 5.8%.
Preparation of /V-(3-hydroxy-2-methylbutanoyl)-5-phenoxymethyl-2- 
oxazolidinone 6.3212
Aldol adducts 6.32 were synthesised following the method previously described for 
the synthesis of aldol adducts 5.8, 5.16 and 5.22. A/-Propionyl oxazolidinone 6.31 
(0.230 g, 0.92 mmol) was reacted with acetaldehyde (260 pL, 4.60 mmol) in the 
presence of TiCI4 (1 M in DCM, 1.0 mL, 0.97 mmol), (-)-sparteine (210 pL, 0.92 
mmol) and NMP (90 pL, 0.93 mmol) to give rac-syn-6.32 (0.084 g, 31%) and other 
aldol adducts 6.32 (0.045 g, 17%).





Alcohol rac-syn-6.32 was obtained as a white solid; mp 119-121 °C; Rf (n- 
hexane/EtOAc, 50:50) = 0.31; HPLC (Chiralcel® OD column, n-hexane/isopropanol 
70:30, 1 mLmin'1, X = 254 nm): tR = 15.3 and 23.3 min; IR (KBr): v = 3465, 2915, 
1775, 1685, 1380, 1225 cm'1; 1H NMR (300 MHz, CDCI3): 8 H = 7.33-6.86 (5H, m, 
OC6H5), 4.94-4.88 (1H, m, OCH), 4.26-4.04 (5H, m, CHOH, C H ^, CH^Ph), 3.81 
(1 H, dq, J = 2 . 8  and 7.0 Hz, COCHCH3), 2.90 (1 H, s, OH), 1.25 (3H, d, J=  7.0 Hz, 
COCHCH3), 1.21 (3H, d, J=  6.4 Hz, CHOHCH3); 13C NMR (75.5 MHz, CDCI3): 8 C = 
177.2 (NCOCH), 152.8 (OCON), 157.8, 129.7 (2C), 121.9, 114.6 (2C) (aromatic C),
71.4 (OCH), 67.8 (CHOH), 67.7 (CH2OPh), 44.7 (COCHCH3), 42.9 (CH2 N), 19.5
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(CHOHCH3), 10.5 (COCHCH3); MS (CI+): m/z 294 (MH+, 100%), 276 (99), 266 (89), 
249 (45), 194 (97), 94 (56), 83 (30); Anal, calcd. for Ci5H19N05: C 61.42%, H 6.53%, 





Other anti aldol adducts 6.32 were obtained as a white solid; Rf (/7-hexane/EtOAc, 
50:50) = 0.21; HPLC (Chiralcel® OD column, n-hexane/isopropanol 70:30,1 mLmin'1, 
X = 254 nm): tR = 14.2 (8 %), 16.3 (85%) and 21.2 (7%) min; 1H NMR (400 MHz, 
CDCI3): §h = 7.33-6.81 (5H, m, OC6 H5), 4.94-4.89 (1 H, m, OCH), 4.25-4.01 (4H, m, 
CH2N, CHsOPh), 3.99-3.93 (1H, dq, app. m, CHOH), 3.79 (1H, dq, J = 7.0 and 14 Hz, 
COCHCH3), 2.52 (1H, d, J=  6.2 Hz, OH), 1.24 (3H, d, J=  7.0 Hz, COCHCH3), 1.21 
(3H, d, J =  6.2 Hz, CHOHCH3); 13C NMR (100 MHz, CDCI3): 5C = 176.4 (NCOCH), 
152.6 (OCON), 157.5, 129.5 (2C), 121.8, 114.4 (2C) (aromatic C), 71.3 (OCH), 70.1 
(CHOH), 67.7 (CH2OPh), 45.2 (COCHCH3), 44.7 (CH2N), 21.1 (CHOHCH3), 14.8 
(COCHCH3).
Isolation of m-chloroperbenzoic acid
Commercial m-chloroperbenzoic acid was freed from m-chlorobenzoic acid by 
dissolving 5.5 g in 150 mL of benzene and washing with an aqueous solution 
buffered at pH 7.4 (Na^PO^NaOH, 30 x 2 mL). The organic layer was dried over 
MgS04 and carefully concentrated in vacuo. m-Chloroperbenzoic acid (5.3 g, 97%) 
was recrystallysed from DCM and stored at 0 °C.
Preparation of trans-stilbene oxide 6.3321,22
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A solution of m-chloroperbenzoic acid (4.7 g, 27.5 mmol) in DCM (200 mL) was 
added to a solution of trans-stilbene (2.5 g, 13.8 mmol) in DCM (300 mL) under an 
atmosphere of nitrogen. After 20 hours, the reaction mixture was washed with sat. 
Na2S20 3 (400 mL) and H20  (400 mL), dried over Na2S04 and concentrated in vacuo. 
The residue was purified via flash chromatography (Si02, n-hexane/EtOAc, 95:5) to 
give trans-stilbene oxide 6.33 (2.3 g, 8 6 %) as white needles; Rf (n-hexane/EtOAc, 
95:5) = 0.38; 1H NMR (300 MHz, CDCI3): 8 H = 7.40-7.15 (1 0 H, m, 2  x C6 H5), 3.85 
(2 H, s, 2  x CHO); 13C NMR (75.5 MHz, CDCI3): 8 C = 137.1, 128.5, 128.3, 128.4,
125.5 (2 x aromatic C), 62.8 (2 x CHO). 1H and 13C NMR data were in accordance 
with those reported in literature.22
General procedure for the preparation of 4,5-diphenyl-M-propionyl-2- 
oxazolidinone rac-cis 6.34 and 4,5-diphenyl-2-oxazolidinone rac-cis-6.3520
Oxazolidinones rac-cis-6.34 and rac-cis-6.35 were synthesised following the 
procedure above described for the synthesis of A/-propionyl-5-phenoxymethyl-2- 
oxazolidinone 6.31. In a typical experiment, to a solution of 6.30 and 6.33, DABCO 
was added and the reaction mixture was refluxed under reduced pressure. For 
reaction conditions, see Table 6.1. At the end of reaction, the crude brown oil was 
purified by flash chromatography (Si02, n-hexane/EtOAc, 70:30) to give either rac- 
cis 6.34 or rac-cis 6.35 as main product (see Table 6.1 for yields).
(4/7,5S)- and (4/?,5S)-4,5-Diphenyl-/V-propionyl-2-oxazolidinone rac-cis 6.34
N-Acyl-oxazolidinone rac-cis-6.34 was isolated as a white solid; mp 119-121 °C; Rf 
(n-hexane/EtOAc, 70:30) = 0.52; [a] D30 = 0.0 (c 0.9, MeOH); IR (CH2CI2): v = 1780, 
1705, 1345, 1245, 1185 cm'1; 1H NMR (300 MHz, CDCI3): 8 H = 7.12-6.84 (10H, m, 2
CDCI3): 8 c = 173.3 (NCOC), 154.0 (OCON), 134.5-125.6 (aromatic C), 80.3 (CHO),
62.7 (CHN), 29.3 (CH2), 8.2 (CH3); MS (CI+): m/z 296 (MH+, 100%), 268 (31), 252
x C6 H5), 5.90 (1H, d, J = 7.6 Hz, OCHPh), 5.66 (1H, d, J = 7.6 Hz, NCHPh), 3.05 
(2H, app. q, J=  7 Hz, CH^CH3), 1.35 (3H, t, J =  7.5 Hz, CH3); 13C NMR (75.5 MHz,
171
Claudia Neri - University of Bath Experimental
Chapter 7
(50), 178 (61), 163 (90), 132 (41), 106.0 (38), 77 (2 1 ); Anal, calcd. for C18H17N03: C 
73.20%, H 5.80%, 4.74%; found: C 72.9%, H 6.0%, N 4.9%.





P l f  'Ph
Oxazolidinone rac-cis 6.35 was obtained as a white solid; Rf (n-hexane/EtOAc, 
70:30) = 0.12; [<x] D30 = 0.0 (c0.7, MeOH); 1H NMR (300 MHz, CDCI3): 5H = 5.18 (1H, 
d, J=  8.1 Hz, NCH), 5.35 (1H, s, NH), 5.96 (1H, d, J=  8.1 Hz, OCH), 7.12-6.92 (10H, 
m, 2 x C6 H5). 1H NMR data were in accordance with those reported in literature.23,24
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Table 1. Crystal data and structure refinement for 1.







Unit cell dimensions a = 8.28000(10)A a = 90° 
b = 12.4340(2)A p = 90° 
c = 14.2140(3)A y = 90°
Volume 1463.38(4) A3
Z 4
Density (calculated) 1.259 Mg/m3
Absorption coefficient 0.091 mm' 1
F(000) 592
Crystal size 0.50 x 0.40 x 0.35 mm
Theta range for data collection 3.78 to 27.48°
Index ranges -10<=h<=10; -16<=k<=15; -18<=l<=18
Reflections collected 16756
Independent reflections 3342 [R(int) = 0.0661]
Reflections observed (>2o) 2534
Data Completeness 0.994
Max. and min. transmission 0.9688 and 0.9558
Refinement method Full-matrix least-squares on F2
Data /  restraints /  parameters 3342/0/189
Goodness-of-fit on F2 1.024
Final R indices [l>2o(l)] Ri = 0.0359 wR2 = 0.0785
R indices (all data) R, = 0.0563 wR2 = 0.0863
Absolute structure parameter 0.0(9)
Largest diff. peak and hole 0.108 and -0.097 eA'3
Notes: H4 (OH group) located and freely refined.
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Table 2. Atomic coordinates ( x 104) and equivalent isotropic displacement
parameters (A2 x 1 0 3) for 1 .U(eq) is defined as one third of
orthogonalized Uij tensor.
Atom U(eq
he trace of the
0 (1 ) 4749(1) 7184(1) 6858(1) 58(1)
0 (2 ) 5622(2) 8722(1) 7467(1) 69(1)
0(3) 7282(1) 6611(1) 9549(1) 60(1)
0(4) 7910(2) 8080(1) 10926(1) 78(1)
N(1) 6197(1) 7074(1) 8169(1) 41(1)
C(1) 5530(2) 7763(1) 7506(1) 48(1)
0 (2 ) 4709(2) 6068(1) 7124(1) 53(1)
C(3) 5965(2) 5944(1) 7897(1) 46(1)
C(4) 7549(2) 5401(1) 7585(1) 54(1)
0(5) 8447(2) 5981(1) 6819(1) 49(1)
0 (6 ) 8195(2) 5769(1) 5872(1) 61(1)
0(7) 9020(2) 6331(2) 5182(1) 73(1)
0 (8 ) 10128(2) 7086(2) 5418(2) 78(1)
0(9) 10418(2) 7307(2) 6347(1) 75(1)
0 (1 0 ) 9587(2) 6755(1) 7043(1) 60(1)
0 (1 1 ) 6808(2) 7341(1) 9046(1) 43(1)
0 (1 2 ) 6894(2) 8509(1) 9340(1) 48(1)
0(13) 6671(2) 8614(1) 10409(1) 58(1)
0(14) 8474(2) 8995(1) 8974(1) 6 6 (1 )
0(15) 6638(3) 9772(2) 10729(1) 80(1)
177
Claudia Neri - University of Bath Appendices
Table 3. Bond lengths [A] and angles [°] for 1 .
0(1)-C(1) 1.3352(17) 0(1)-C(2) 1.4384(18)
0(2)-C(1) 1.1968(17) 0(3)-C(11) 1.2198(16)
0(4)-C(13) 1.426(2) N(1)-C(11) 1.3856(18)
N(1)-C(1) 1.3882(17) N(1)-C(3) 1.4704(17)
C(2)-C(3) 1.520(2) C(3)-C(4) 1.540(2)
C(4)-C(5) 1.504(2) C(5)-C(10) 1.385(2)
C(5)-C(6) 1.387(2) C(6)-C(7) 1.385(3)
C(7)-C(8) 1.355(3) C(8)-C(9) 1.370(3)
C(9)-C(10) 1.388(2) C(11 )-C(12) 1.513(2)
C(12)-C(14) 1.533(2) C(12)-C(13) 1.536(2)
C(13)-C(15) 1.510(2)
C(1)-0(1)-C(2) 110.46(11) C(11)-N(1)-C(1) 127.52(12)
C(11)-N(1)-C(3) 120.89(11) C(1)-N(1)-C(3) 1 1 1 .0 0 (1 1 )
0(2)-C(1)-0(1) 122.45(13) 0(2)-C(1)-N(1) 128.35(14)
0(1)-C(1)-N(1) 109.18(12) 0(1)-C(2)-C(3) 105.80(11)
N(1)“C(3)-C(2) 100.53(11) N(1)-C(3)-C(4) 112.54(11)
C(2)-C(3)-C(4) 114.78(12) C(5)-C(4)-C(3) 114.80(12)
C(10)-C(5)-C(6) 117.33(16) C(10)-C(5)-C(4) 120.20(15)
C(6)-C(5)-C(4) 122.47(14) C(7)-C(6)-C(5) 121.10(16)
C(8)-C(7)-C(6) 120.54(17) C(7)-C(8)-C(9) 119.82(18)
C(8)-C(9)-C(10) 120.04(18) C(5)-C(10)-C(9) 121.15(16)
0(3)-C(11)-N(1) 117.83(13) 0(3)-C(11)-C(12) 122.47(13)
N(1)-C(11)-C(12) 119.69(12) C(11 )-C(12)-C(14) 108.95(12)
C(11 )-C(12)-C(13) 110.44(12) C(14)-C(12)-C(13) 113.91(13)
0(4)-C(13)-C(15) 107.57(14) 0(4)-C(13)-C(12) 112.56(13)
C(15)-C(13)-C(12) 112.41(14)
Symmetry transformations used to generate equivalent atoms:
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Table 4. Anisotropic displacement parameters (A2 x 1 0 3) for 1 . The anisotropic 
displacement factor exponent takes the form: - 2  gpi2 [ h2 a* 2 U11 + ... + 2  h k a* b* U
Atom U11 U22 U33 U23 U13 U12
0(1) 72(1) 51(1) 51(1) 0 (1 ) -15(1) 3(1)
0(2) 106(1) 39(1) 62(1) 6 (1 ) -16(1) 9(1)
0(3) 72(1) 51(1) 57(1) 1 1 (1 ) -14(1) 4(1)
0(4) 84(1) 85(1) 64(1) -2 (1 ) -28(1) -2 (1 )
N(1) 44(1) 35(1) 46(1) 5(1) -1 (1 ) 2 (1 )
C(1) 57(1) 41(1) 45(1) 2 (1 ) 0 (1 ) 6 (1 )
0(2) 54(1) 47(1) 58(1) -4(1) -2 (1 ) -4(1)
0(3) 50(1) 35(1) 53(1) 3(1) 2 (1 ) -3(1)
0(4) 60(1) 40(1) 62(1) 4(1) 1 (1 ) 7(1)
0(5) 49(1) 43(1) 55(1) -2 (1 ) 2 (1 ) 1 2 (1 )
0(6) 56(1) 61(1) 6 6 (1 ) -1 2 (1 ) 0 (1 ) 1 0 (1 )
0(7) 73(1) 95(1) 49(1) -1 (1 ) 5(1) 2 2 (1 )
0(8) 77(1) 87(1) 71(1) 15(1) 15(1) 4(1)
0(9) 69(1) 74(1) 82(1) 1 (1 ) 8 (1 ) -1 1 (1 )
0(10) 60(1) 64(1) 56(1) -3(1) 1 (1 ) -3(1)
0(11) 39(1) 45(1) 46(1) 5(1) 0 (1 ) -2 (1 )
0(12) 46(1) 46(1) 52(1) 0 (1 ) -5(1) -2 (1 )
0(13) 51(1) 6 8 (1 ) 54(1) -5(1) -7(1) -6 (1 )
0(14) 6 6 (1 ) 55(1) 76(1) 0 (1 ) 8 (1 ) -13(1)
0(15) 89(1) 77(1) 74(1) -23(1) -2 (1 ) -5(1)
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (A2 x 1 0 3) for 1 .
Atom X y z U(eq)
H(2A) 4972 5614 6591 63
H(2B) 3646 5873 7355 63
H(3) 5497 5544 8425 55
H(4A) 8252 5338 8128 65
H(4B) 7304 4679 7369 65
H(6) 7458 5240 5698 73
H(7) 8812 6189 4551 87
H(8) 10689 7452 4951 94
H(9) 11173 7829 6511 90
H(10) 9799 6907 7672 72
H(12) 5999 8889 9036 57
H(13) 5635 8284 10576 69
H(14A) 8580 8845 8314 98
H(14B) 9370 8685 9306 98
H(14C) 8464 9759 9071 98
H(15A) 7636 10115 10561 1 2 0
H(15B) 6501 9798 11399 1 2 0
H(15C) 5757 10139 10430 1 2 0
H(4) 7840(30) 7440(20) 10713(16) 111(9)
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Appendix II
X-Ray crystal structure determination of (4/?,2’/?,3’S)-A/-(3-hydroxy-2- 
ethylbutanoyl)-4-benzyl-2-oxazolidinone (4/?,2’/7,3’S)-5.16
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Table 1. Crystal data and structure refinement for 1.
Identification code k0 2 jmjw2






Unit cell dimensions a = 6.53100(10)A a = 90° 
b = 9.77300(10)A p = 90° 
C = 24.2550(3)A y = 90°
Volume 1548.14(3) A3
Z 4
Density (calculated) 1.250 Mg/m3
Absorption coefficient 0.090 mm' 1
F(000) 624
Crystal size 0.50 x 0.45 x 0.30 mm
Theta range for data collection 3.27 to 30.06 °.
Index ranges -9<=h<=9; -13<=k<=13; -34<=l<=34
Reflections collected 28745
Independent reflections 4505 [R(int) = 0.0551]
Reflections observed (>2<?) 4210
Data Completeness 0.996
Max. and min. transmission 0.9736 and 0.9566
Refinement method Full-matrix least-squares on F2
Data /  restraints /  parameters 4505/0/192
Goodness-of-fit on F2 1.067
Final R indices [l>2a(l)] R1= 0.0337 wR2 = 0.0824
R indices (all data) Ri = 0.0380 w R 2 = 0.0847
Absolute structure parameter 0 . 0 0
Largest diff. peak and hole 0.240 and -0.252 eA 3
Notes: Flack parameter not definitive is determining absolute stereochemistry.
H-bonded chains in lattice.
Hydrogen bonds with H..A < r(A) + 2.000 Angstroms and <DHA > 110 deg.
D-H d(D-H) d(H..A) <DHA d(D..A) A
04-H4 0.840 1.967 170.81 2.799 03 [ -x+1, y+1/2,-z+3/2 ]
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Table 2 . Atomic coordinates ( x 1 0 4) and equivalent isotropic displacement
parameters (A2 x 1 0 3) for 1 .U(eq) is defined as one third of
orthogonalized Uij tensor.
Atom U(eq
he trace of the
0(1) 3871(1) 1681(1) 9697(1) 30(1)
0(2) 2823(1) 3684(1) 9363(1) 34(1)
0(3) 6225(1) 2271(1) 7994(1) 26(1)
0(4) 1685(1) 5265(1) 7607(1) 29(1)
N(3) 5004(1) 2238(1) 8859(1) 20(1)
C(2) 3790(2) 2651(1) 9306(1) 24(1)
0(4) 6123(2) 963(1) 8986(1) 20(1)
0(5) 4966(2) 486(1) 9501(1) 26(1)
0(6) 1250(2) 2907(1) 7769(1) 33(1)
0(7) 5857(2) 5281(1) 8136(1) 33(1)
0(8) 7102(2) 5546(2) 8659(1) 52(1)
0(9) 8418(2) 1232(1) 9086(1) 21(1)
0(10) 9606(2) -93(1) 9132(1) 21(1)
0(11) 9874(2) -743(1) 9641(1) 25(1)
0(12) 10901(2) -1990(1) 9675(1) 30(1)
0(13) 11687(2) -2595(1) 9205(1) 33(1)
0(14) 11465(2) -1949(1) 8700(1) 34(1)
0(15) 10425(2) -705(1) 8662(1) 28(1)
0(1) 5189(2) 2854(1) 8342(1) 20(1)
0(2') 4169(2) 4208(1) 8217(1) 21(1)
0(3') 2820(2) 4037(1) 7699(1) 22(1)
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Table 3. Bond lengths [A] and angles [°] for 1 .
0(1)-C(2) 1.3412(13) 0(1)-C(5) 1.4494(13)
0(2)-C(2) 1.1990(13) 0(3)-C(1') 1 .2 2 2 2 (1 2 )
0(4)-C(3‘) 1.4279(12) N(3)-C(1') 1.3959(12)
N(3)-C(2) 1.4028(13) N(3)-C(4) 1.4774(12)
C(4)-C(5) 1.5311(14) C(4)-C(9) 1.5408(14)
C(6)-C(3') 1.5165(15) C(7)-C(8) 1.5287(19)
C(7)-C(2) 1.5340(15) C(9K(10) 1.5133(14)
C(10)-C(15) 1.3941(15) C(10)-C(11) 1.3993(14)
C(11)-C(12) 1.3938(15) C(12)-C(13) 1.3817(18)
C(13)-C(14) 1.3873(18) C(14)-C(15) 1.3954(16)
C(1>C(2‘) 1.5130(13) C(2,)-C(3I) 1.5429(14)
C(2)-0(1)-C(5) 110.91(8) C(1')-N(3)-C(2) 128.27(8)
C(1>N(3)-C(4) 120.55(8) C(2)-N(3)-C(4) 111.16(8)
0(2)-C(2)-0(1) 122.37(10) 0(2)-C(2)-N(3) 128.94(10)
0(1 )-C(2)-N(3) 108.68(9) N(3)-C(4)-C(5) 100.50(8)
N(3)-C(4)-C(9) 111.75(8) C(5)-C(4)-C(9) 113.83(8)
0(1)-C(5)-C(4) 105.44(8) C(8)-C(7)-C(2,) 113.15(11)
C(10)-C(9)-C(4) 111.38(8) C(15)-C(10)-C(11) 118.63(10)
0(15)-C(10)-C(9) 120.19(9) C(11)-C(10)-C(9) 121.17(9)
C(12)-C(11 )-C(10) 120.52(10) C(13)-C(12)-C(11) 120.37(10)
C(12)-C(13)-C(14) 119.65(10) C(13)-C(14)-C(15) 120.31(11)
C(10)-C(15)-C(14) 120.50(11) O PK O 'hN P) 117.82(9)
0(3)-C(1>C(2') 120.83(9) N(3)-C(1 ,)-C(2,) 121.34(8)
C(1>C(2')-C(7) 107.90(9) C(1 ,)-C(2,)-C(3l) 108.69(8)
C(7)-C(2')-C(3') 112.44(8) 0(4)-C(3')-C(6) 106.18(8)
109.38(8) C(6)-C(3')-C(2') 111.98(8)
Symmetry transformations used to generate equivalent atoms:
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Table 4. Anisotropic displacement parameters (A2 x 1 0 3) for 1 . The anisotropic 
displacement factor exponent takes the form: -2 gpi2 [ h2 a* 2 U11 + ... + 2 h k a* b* U
Atom U11 U22 U33 U23 U13 U12
0 (1 ) 34(1) 28(1) 27(1) 4(1) 5(1) 2 (1 )
0 (2 ) 42(1) 31(1) 30(1) -1 (1 ) 1 0 (1 ) 1 2 (1 )
0(3) 28(1) 28(1) 24(1) -2 (1 ) 2 (1 ) 8 (1 )
0(4) 24(1) 26(1) 37(1) 13(1) -1 (1 ) 2 (1 )
N(3) 2 1 (1 ) 18(1) 2 2 (1 ) 0 (1 ) -1 (1 ) 4(1)
0 (2 ) 25(1) 26(1) 2 2 (1 ) -2 (1 ) 1 (1 ) 0 (1 )
0(4) 2 0 (1 ) 17(1) 24(1) 1 (1 ) -3(1) 2 (1 )
0(5) 2 2 (1 ) 2 2 (1 ) 33(1) 6 (1 ) 0 (1 ) -1 (1 )
0 (6 ) 29(1) 30(1) 40(1) 1 0 (1 ) -1 0 (1 ) -9(1)
0(7) 29(1) 24(1) 47(1) 3(1) -7(1) -6 (1 )
0 (8 ) 45(1) 44(1) 67(1) -8 (1 ) -2 1 (1 ) -14(1)
0(9) 19(1) 19(1) 27(1) 2 (1 ) -1 (1 ) 0 (1 )
0 (1 0 ) 17(1) 2 0 (1 ) 26(1) 2 (1 ) -3(1) -1 (1 )
0 (1 1 ) 2 0 (1 ) 26(1) 29(1) 5(1) 0 (1 ) 1 (1 )
0 (1 2 ) 24(1) 26(1) 40(1) 1 1 (1 ) -3(1) 0 (1 )
0(13) 27(1) 2 1 (1 ) 50(1) -2 (1 ) -1 1 (1 ) 4(1)
0(14) 32(1) 34(1) 38(1) -1 2 (1 ) -8 (1 ) 9(1)
0(15) 27(1) 31(1) 28(1) -2 (1 ) -5(1) 6 (1 )
c m 19(1) 19(1) 2 1 (1 ) -2 (1 ) -2 (1 ) 1 (1 )
0 (2 ') 2 1 (1 ) 18(1) 25(1) 1 (1 ) -1 (1 ) 2 (1 )
0(3') 2 1 (1 ) 2 1 (1 ) 24(1) 5(1) -1 (1 ) 0 (1 )
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Table 5. Hydrogen coordinates ( x 104) and isotropic displacement 
parameters (A2 x 1 0 3) for 1 .
Atom X y z U(eq)
H(4) 2431 5840 7446 35
H(1) 5942 286 8681 24
H(5A) 3999 -259 9407 31
H(5B) 5932 151 9784 31
H(6A) 419 2836 7433 49
H(6B) 363 3117 8083 49
H(6C) 1954 2036 7834 49
H(7A) 6793 4969 7841 40
H(7B) 5225 6150 8014 40
H(8A) 8149 6240 8584 78
H(8B) 7765 4695 8777 78
H(8C) 6191 5873 8952 78
H(9A) 8976 1781 8778 26
H(9B) 8588 1766 9430 26
H(11) 9351 -330 9967 30
H(12) 11061 -2426 1 0 0 2 2 36
H(13) 12375 -3449 9229 39
H(14) 12024 -2355 8377 41
H(15) 10274 -272 8314 34
H(2') 3288 4480 8535 25
H(3) 3703 3840 7371 26
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Appendix III 
CAL B activity assay
Lipase type B derived from Candida antarctica (Chirazyme® L-2, carrier-fixed, Carrier 
3, lyophilizate from Boehringer Mannheim) was tested, prior to use, for both 
hydrolytic and transesterification activity.
Hydrolytic activity
Lipases in nature hydrolyse tributyrin to dibutyrin, monobutyrin and glycerol. The 
activity assay measures the liberation of butyric acid by titration with sodium 
hydroxide. One lipase Unit is defined as the amount of enzyme that liberates one 
micromole of titrable butyric acid per minute at pH 7.0, with tributyrin as substrate.
Procedure: 40 mL 10 mM phosphate buffer, pH 7.0, was incubated in a thermostated 
vessel at 25 °C, equipped with a magnetic stirrer. After addition of tributyrin (1.16 mL, 
1 mmol), CAL B (40 mg) was added.
The pH was checked and kept constant at 7.0 with an automated pH-stat system 
(Mettler DL21 Titrator, NaOH 1M). The consumption of 1 M NaOH was monitored for 
20 minutes. The specific activity was calculated for the base consumption at the 
linear part of the resulting graph. The same assay was performed without enzyme 
and considered as a control.
In 20 min 3.125 mmol of NaOH 1M were consumed, which means that 3.125 x103 
mmol of tributyrin were converted by the enzyme
Units = (mmol substrate converted) /min = 156.25 U
40 mg of the used enzyme preparation contained 156.25 lipase Units, which 
correspond to an activity of 3.9 U/mg dryform-
Transesterification activity
Lipases are well known to catalyse transesterification reactions, if the reaction is 
performed in organic solvents such as n-hexane, toluene, dichloromethane, methyl 
ter-butyl ether, and tertiary alcohols. The reaction substrate is generally a secondary 
alcohol. Vinyl esters or anhydrides are used as acylating agents.
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Procedure: Organic solvent (10 mL n-heptane), vinyl acetate (275 ml, 3 mmol) and 
substrate (140 ml 1-phenylethanol, 1 mmol) were filled into the reaction vessel and 
stirred until the substrate was dissolved. CAL B was added and the suspension was 
stirred for 48 hours.
Conversion and enantioselectivity were followed by chiral HPLC (Chiralcel® OJ 
column, n-hexane/isoproanol 99:1, 1 mLmin'1, X = 254 nm). After 48 hours, the 
percentage of conversion was 61% and the enantiomeric excess was >99%.
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